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Abstract 
 
ABSTRACT 
Bioactive glasses (BG) are widely used in dentistry and medicine due to the ability to 
form a hydroxyapatite layer to bond to bone. Fluoride has been introduced into BG to 
provide additional effects, such as inhibition at enamel and dentine demineralisation, 
reduction of glass melting temperature and facilitating an acid durable fluorapatite 
formation etc.. Therefore, fluoride containing BG are attractive for remineralising 
toothpaste application. However, excessive fluoride is problematic.  
Chlorine is thought to behave like fluorine in terms of glass structure and properties. 
As the chloride ion is larger than fluoride ion, the incorporation of chloride could 
expand the glass volume that might result in a more open structure and a more 
degradable glass. These glasses are of interest for resorbable bone grafts and 
remineralising toothpastes. In this thesis, the investigation of chloride as an alternative 
to fluoride in the silicate BG was carried out for the first time. 
 Sodium free BG based on SiO2-P2O5-CaO-CaF2/CaCl2 or SiO2-CaO-CaF2/CaCl2 with 
varying calcium halide content were synthesised via a melt-derived route and 
characterised by various advanced techniques. The glass bioactivity was estimated in 
Tris and SBF. Ion release measurements were carried out by using ICP-OES and ion 
selective electrodes. The apatite formation was characterised by FTIR, XRD and MAS-
NMR. The crystallisation events of the glasses were explored by heat treatment. 
This study reveals that the majority of chloride is successfully retained in the Q2 type 
silicate BG. Glass transition temperature and density decrease with increasing halide 
content. The studied high phosphate containing BG are highly dissolvable and formed 
apatite-like phases within 3h in Tris. The glass dissolution rate was found to increase 
with CaCl2 content but not with CaF2. On heat treatment, fluorapatite or chlorapatite is 
the main crystalline phase in phosphate containing glasses, while CaF2/CaCl2 is likely 
the one for the glasses without phosphate. This is the first time to our knowledge that 
chlorapatite has been shown to crystallise from a glass. 
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Introduction 
1  Introduction 
Bioactive glass can degrade in a physiological environment and form a 
hydroxycarbonate apatite (HCA, Ca10(PO4)6CO3)) layer, which can bond to bone and 
induce bone regeneration [1-3]. This type of material is extensively used for dental and 
medical applications. Incorporation of various elements can alter glass properties, for 
example, sodium is able to reduce the glass melting temperature, glass transition 
temperature and therefore probably glass hardness. 
Addition of fluoride (CaF2) to a silicate glass also reduces the melting temperature 
and glass transition temperature, probably glass hardness. The fluoride 
containing bioactive glasses investigated recently [4, 5] favour formation of fluoride 
substituted apatite (FAP, Ca10(PO4)6F2) which has a better capacity for acid 
resistance and is less soluble in acidic conditions than HCA and is, furthermore, 
easier to form at a neutral or acidic pH. Thus, fluoride containing bioactive glasses 
are particularly attractive for remineralising toothpaste applications. 
In theory, the more fluoride is present in the glass the softer the glass is [6, 7]. 
However, an excess of fluoride in the bioactive glass will result in the formation of 
crystalline calcium fluoride (fluorite) instead of FAP. Additionally, there is a restriction 
on the fluoride content for over the counter toothpastes and the regulatory authorities 
set a restriction on the fluoride content in toothpaste at 1500 ppm in Europe, since the 
extra fluoride may lead to dental fluorosis and uncontrolled fluorite formation rather 
than FAP. Therefore the perception of “the more the better” is not suitable for fluoride. 
It is of critical importance to find the optimal concentration of fluoride addition to a 
bioactive glass composition – or to look for an alternative to fluoride. 
Chlorine is assumed to have similar effects on the property and structure of bioactive 
glasses as fluorine, such as reducing the melting and glass transition temperatures. It 
is also proposed that the structural role of fluoride and chloride in glasses are similar, 
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and that both associate in the glass structure with cations, e.g. forming F-Ca(n) and 
Cl-Ca(n). Owing to the presence of halide ions (F-, Cl-) and phosphate in the glass, the 
oxyhalide bioactive glasses can form apatite either upon crystallisation (during heat 
treatment of the glasses) or as a result of reaction with body fluids (e.g. saliva or blood 
plasma). 
Similar to fluoride containing bioactive glasses, which crystallise to fluorapatite, 
chloride containing glasses are likely to produce a chlorapatite (ClAP, Ca10(PO4)6Cl2)  
glass-ceramic upon crystallisation; this is of great interest for biomedical application 
and a number of other applications. In addition, since the chloride ion is larger than the 
hydroxyl and fluoride ions, chlorapatite is less stable and should be more resorbable 
than fluorapatite or hydroxyapatite (HAP, Ca10(PO4)6(OH)2). In solution, ClAP converts 
to hydroxyapatite [8]. Moreover, chloride is naturally present in the human body; there 
is no restriction on chloride content in toothpastes and biomedical materials unlike with 
fluoride.  
Because of the larger size of the chloride ion compared to the oxygen ion, the 
introduction of chloride would be expected to expand the glass volume leading to a 
more expanded open glass structure. The chloride containing bioactive glasses are 
therefore likely to be softer, less abrasive, degrade faster and form apatite more rapidly. 
Chloride or mixed fluoride and chloride containing bioactive glasses will be innovative 
and promising for medical and dental applications, especially for remineralising 
toothpaste and cutting dental cavities or polishing using air abrasion [6]. 
Novel sodium-free oxyhalide silicate bioactive glasses could eliminate the potential 
disadvantages causing by the presence of sodium, such as, glass phase 
hygroscopicity resulting in an uncontrollable degradation and high initial pH surge, 
which is undesirable for homeostasis. Surprisingly, a fluoride containing bioactive glass 
without sodium also presents high bioactivity, even forming fluorapatite within 6 hours 
in Tris buffer solution [9]. 
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Owing to the high volatilisation of chloride (normally as sodium chloride) during glass 
melting, chloride has been used as a refining additive used to remove bubbles from 
silicate glass melts. The difficulty of retaining chloride in glasses has resulted in a very 
limited literature available on chloride containing glasses, and no reports exist on 
chloride containing bioactive glasses. To our knowledge, the novel chloride containing 
bioactive glasses that are prepared and studied in this PhD thesis represent the first 
set of chloride containing bioactive glasses ever studied. Moreover, the chlorapatite 
glass-ceramics that are achieved upon heat treatment are the first ever made bioactive 
chlorapatite glass-ceramics. 
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2 Literature Review 
2.1 Bioactive Glass   
Bioactive glasses are well known for their bone regenerative properties [10, 11]. When 
immersed in physiological solutions, they can form an integrated bond with living bone 
via formation of an apatite layer on their surface. Recently, they have also drawn great 
attention for the application in soft tissue repair, due to their ability of promoting 
angiogenesis (formation of blood vessels) [12-14]. The bioactive glass (Bioglass® 
45S5 composition) was first developed by Larry Hench in late 1960’s for bone repairs. 
Since then, many new bioactive glass compositions have been developed. Strontium 
[15, 16], zinc [17, 18], cobalt [19], fluoride [20, 21] or magnesium [22] were 
incorporated into bioactive glass to combine therapeutic ion release and apatite 
formation with tailored glass properties for different applications. 
2.1.1 The First Bioactive Glass, Bioglass® 45S5 
The first bioactive glass, Bioglass® 45S5 was developed in response to the 
requirement to inhibit interfacial mobility in implanted bio-inert materials and form a 
bond between living tissue and the implant surface [23]. Bioglass® demonstrates a 
relatively high bioactivity and has a capacity to bond to living tissues. It is the most 
extensively investigated bioactive glass, which is composed of 46.1 mol% SiO2, 26.9 
mol% CaO, 24.4 mol% Na2O, 2.6 mol% P2O5. It has been in clinical use since 1985 [1] 
and is currently used in a range of applications including orthopaedic (e.g. 
NovaBone®), periodontal (PerioGlas®) and toothpastes (NovaMin®). In addition, a 
small concentration of 45S5 bioactive glass is able to stimulate angiogenesis [12, 14]. 
The bioactivity for 45S5 bioactive glasses had been investigated in buffer solutions. 
Research has shown that 45S5 could form hydroxyapatite  after immersing in Tris 
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buffer for 24 hours, while it took 3 days in Simulated Body Fluid (SBF) [12, 24]. 
Therefore, 45S5 presents favourable healing ability in many clinical programs. 
However, this glass exhibits some defects, the uncontrollably high dissolution rate is 
one of the primary problems [25], which is mainly caused by its high content of alkali 
(Na2O). Although, the presence of high alkali content is beneficial in reducing the 
melting temperature, the high dissolution rate may lead to an imbalance of natural 
bone remodelling and a gap between living tissue and the implanted materials [26]. 
The polymer composites incorporated with high alkali containing glass 45S5 are apt to 
uptake water by osmosis, leading to the swelling and cracking of the composites, 
hereby, accelerating the degradation of the materials [25]. Moreover, the relatively high 
hardness is the other shortcoming. The bioactive glass 45S5 is currently used in 
commercial toothpaste (as Novamin™) for reminalisation of teeth. It has a hardness of 
4.68 GPa, while enamel is about 3.50 GPa [27], consequentially, the enamel 
undergoes the potential risk of being worn away. Thus, the design of new bioactive 
glasses based on 45S5 in order to modify and avoid the deficiencies of 45S5 is highly 
desirable. 
2.2 General Glass Concept 
2.2.1 Definition of Glass 
Glass is well accepted as an optically transparent, brittle and chemically inert non-
crystalline solid material. It has been widely used for windows, drinking vessels and 
containers that can even store corrosive liquids for centuries. Bioactive glass does not 
fulfil completely this definition of glass as bioactive glass is not an inert material. 
However, various other glass definitions were proposed by scientists. The American 
Society for Testing Materials proposed that glasses are “inorganic products of fusion 
that have been cooled to a rigid condition without crystallising” [28]. McMillan [29] 
suggested that a glass is a transparent or translucent material with features of rigidity, 
brittleness and hardness. According to Doremus [30], glass is an amorphous solid 
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without long-range order; however, it exhibits a region of glass transition. This latter 
definition is perhaps the most general as it outlines the two special characteristics of 
glass, bioactive glass as well, the lack of a periodic arrangement in the glass network 
and a time-dependent glass transformation behaviour [31]. All the definitions above 
describe glass from different aspects, covering glass processing, physical and 
chemical properties. Indeed, any amorphous materials with a glass transition 
temperature independent of synthesis route can be defined as a glass. Glass differs 
from the crystalline solids in many aspects. For example, a single-phase crystalline 
solid melts at a well-defined melting temperature and converts into liquid, while the 
glass solid “ease” into a viscous liquid rather than melt at a well-defined temperature. 
In addition, when cooling down the melt from a high temperature, crystalline solids 
demonstrate an abrupt volume change at the solidification temperature. Conversely, 
glass changes from a liquid to a supercooled liquid and a continuous volume change is 
present during the whole process, which  was described as the liquid-like nature of 
glass according to McMillan [32]. Moreover, crystalline solids show a fixed structure 
with long-range order while the atoms in the glass are in a random arrangement 
without the structural periodicity and a fixed long-range order. In general, glass looks 
like a liquid, however, behaves like a solid. 
Glass and crystalline materials have different structures therefore different chemical 
and mechanical properties are presented. Their structural difference could be 
distinguished using a variety of techniques, such as X-Ray Diffraction (XRD), Raman 
Spectroscopy, Fourier Transform Infrared Spectroscopy (FTIR) and Solid State Magic 
Angle Spinning Nuclear Magnetic Resonance (MAS-NMR). 
2.2.2 Glass Transition 
Glass can be synthesised by the quenching of molten liquid. Rapid cooling is generally 
used to prevent crystallisation, as rapid cooling limits the available time for atomic 
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rearrangement to occur and the development of the long-range order associated with 
the crystal.  
As illustrated in the volume-temperature curve in Figure 2.2.1, when slowly cooling a 
molten liquid from high temperature, the melt will yield a drastic volume change at the 
solidification temperature and lead to the formation of crystalline phases. This could 
easily happen when the molten glass has a similar stoichiometry to a crystalline 
material. Turnbull [33] advocated that crystallisation could be avoided if the cooling is 
sufficiently fast. During rapid cooling, glass has a continuous decrease in volume with 
an increase in viscosity. At a relatively lower temperature, the glass viscosity drops to 
1012 Pa.s, where the melt starts to behave as a rigid glass, in addition, the slope of the 
volume-temperature curve changed similarly to the crystalline solid [34-36]. This 
temperature is defined as glass transition temperature (Tg). However, it is different 
from the melting temperature, the glass transition temperature is not a fixed  
temperature, it is cooling rate dependent and thus covers a wide range of 
temperatures [37]. Basically, the glass is an elastic solid below glass transition 
temperature and a viscous liquid above the temperature [38]. A fast cooling rate results 
in the Tg shifting to a higher temperature and the glass has a larger volume, higher 
conductivity and lower viscosity [39]. In contrast, a slow cooling rate leads to a lower 
Tg and volume but higher viscosity. The glass transition temperature is normally 
characterised by different techniques including Differential Scanning Calorimetry (DSC) 
and Dilatometry.  
30 
 
Literature Review 
 
 
Figure 2.2.1 Glass transition temperature (Tg) and its relationship with cooling rate 
adapted from Jones [40]. 
The glass transition temperature is an important parameter for investigating glass 
properties. Relationships between the glass composition, glass transition temperature, 
glass structure and glass properties have been extensively studied. According to 
O’Donnell [41], “the glass transition temperature can be calculated from molar 
compositions of bioactive glasses up to seven components”. However, determining Tg 
regardless of glass structure makes his approach oversimplified and not suitable for 
multi-component bioactive glass systems beyond certain compositional restrictions, 
such as those containing MgO and CaF2 [42]. Thus, when predicting Tg, both glass 
composition and structure should be taken into consideration. 
2.2.3 Glass Structure Theory 
The random network theory proposed by Zachariasen is the foundation of the most 
commonly used models for glass structure [31]. Zachariasen provided an approach 
31 
 
Literature Review 
 
which describes a structural model for glass based on a three dimensional structure. In 
order for a glass to form, long range order should be broken down that leads to a 
network distortion.  
Warren and co-workers advocated a model based on spectroscopy to justify the trends 
observed in the properties of glass with simple binary compositions.  This model can 
effectively be used to investigate the local structure and even somewhat for 
intermediate range of order, but is not suitable for the properties other than those 
controlled by structure at the short to intermediate range atomistic order. Thus, the 
comprehensive understanding of the structural model for glass is of particular 
importance before we accept the model.   
Shelby [31] has proposed that ‘no model can be considered to be valid unless that 
model can explain all of the available data’ as known ‘the Fundamental Law of 
Structural Models’ to evaluate any proposed model. 
2.2.4 Glass Forming Unit in Silicate Glass 
The understanding of the glass structure is extremely vital to the design of glass 
compositions and the tailoring them to specific applications. A glass is a network of 
atoms (silicon, phosphorus, boron etc.) bonded to each other through covalent bonds 
with oxygen atoms. The basic and most well-known glass structure is a continuous, 
three dimensional network based on a SiO4 tetrahedron. The silicon atom sits in the 
centre of the tetrahedron; four oxygens occupy the four corners as shown in Figure 
2.2.2. In a silicate glass, each oxygen atom is shared between two silicons or one 
silicon and another non-silicon species. When directly connecting to two silicons, the 
oxygen is defined as a bridging oxygen (BO), while sharing with one silicon and the 
other species, the oxygen is named a non-bridging oxygen (NBO). Bridging oxygens 
are indispensable to the framework of a glass network, as the silicon atoms are 
connected by them to form the glass network. In contrast, non-bridging oxygens 
interact with network modifier cations to form ionic bonds, which are much weaker 
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than Si-O bonds. Therefore, the formation of NBOs effectively breaks up the glass 
network structure and results in a more disrupted glass network. 
 
 
oxygen atom    silicon atom 
Figure 2.2.2 Diagram presenting the tetrahedral structure unit of silica 
2.2.5 Typical Components of the Silicate Bioactive Glasses 
In terms of how oxides affect glass formation and glass structure, the oxides are 
divided into three groups based on the electro negativity and their ability to form a 
glass [31].  
2.2.5.1 Network formers 
Cations such as silicon, phosphorus, boron and germanium which form bonds with 
oxygen with a fractional ionic character near covalent (> 50%) work as network 
formers. Network formers can form a cross-link network of the chemical bonds. In 
other words, they can form triangles or tetrahedra connected via bridging oxygens 
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(BO). These oxides have an ability to form glass on their own if rapidly cooled from the 
melt. 
2.2.5.2 Intermediates 
 Intermediates have slightly lower electro negativities. This includes elements like 
titanium, aluminium, zirconium, beryllium, magnesium, and zinc. They are not capable 
of forming a glass network by themselves. However, they can either enhance the 
network or weaken the network depending on the glass composition. 
2.2.5.3 Network modifiers 
Cations with low electronegativities are termed as network modifiers. These cations 
can not build up a network. Instead, they are able to form highly ionic-bonds, modify 
the network structure, the cations adjacent to non-bridging oxygen result in breaking 
Si-O covalent bond. Thus, they modify or disrupt the main network. Examples of such 
cations include sodium, calcium, potassium, and lithium. However, the monovalent 
cations (Na+) show more efficient network disruption compared with the divalent 
cations (Ca2+). This can be explained by an additional ionic bond forming between two 
non-bridging oxygens and the M2+ cation. The schematic is presented in Figure 2.2.3. 
 
Figure 2.2.3 Network modifiers in the glass structure 
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2.3 Bioactive Glass Structure and Bioactivity  
2.3.1 Qn notation and Network Connectivity (NC) 
A common nomenclature system known as “Qn” structures can be used to present the 
proportion of bridging oxygens per tetrahedron by different n values. The value of n is 
equal to the number of bridging oxygens per tetrahedron unit. Moreover, Qn is 
associated with the values of network connectivity. “The average number of bridging 
oxygen per network forming element” was defined as network connectivity (NC) [43].  
It is a very important parameter for the understanding of bioactive glass structure. 
Glasses of low network connectivity are expected to have a highly disrupted glass 
network.  
A pure silica glass with the BO average number of 4 would correspond to a NC of 4 
and the Q structure would correspond to Q4, while an isolated tetrahedron with no BO 
is described as Q0 unit, as orthosilicate species. A glass represented as a linear Si-O-
Si chain would have an average number of 2 BOs per tetrahedron which corresponds 
to a NC of 2 and Q structure equal to Q2. 
The NC can be used to predict the bioactivity of glasses and glass properties [44]. 
However, the prediction ability is reduced for more complicated glass compositions 
[43]. This is because NC is used to measure the average number of bridging oxygen 
per each silica tetrahedron, so we are assuming that the glass has homogenous 
structure. In general, the network connectivity of glasses could be calculated using [43, 
45]: 
G
NBOBONC −+= 2                                                  (2.3.1) 
Where “BO” is the total fractional number of bridging oxygens per network forming ion, 
“NBO” is the total fractional number of the non-bridging oxygen per network modifier 
ion and “G” is the total fractional number of glass forming units.  
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It is important to know the structural role of the glass component in order to used NC 
concept for the prediction of glass bioactivity. In this thesis, phosphate is assumed to 
be present as orthophosphate units (PO43-) which require modifier ions (Ca2+ and Na+) 
to charge balance itself instead of forming a part of the network. Thus, the equation for 
NC calculation can be written as following [44], 
[ ] [ ] [ ]
[ ]2
5222 624
SiO
OPOMOMSiO
NC
III ++−
=                                   (2.3.2) 
Where OM I2  (Na
+, K+) and OM II (Ca2+) are network modifiers. 
In the case of the GPF, GPCl and GPFCl glass series: 
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In the case of the GF and GCl glass series: 
[ ] [ ]
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2 24
SiO
CaOSiO
NC
−
=  = 2.0                                    (2.3.4) 
2.3.2 Definition of Bioactivity 
A bioactive material is a material that produces a bone-like apatite layer on its surface 
in the living body [46]. When such a material is immersed in physiological solution, it 
degrades and forms an apatite-like phase, which can act as an intimate bond between 
the material and living bone. This ability of degradation and forming apatite-like phase 
is often defined as bioactivity.  
In general, the bioactivity of a glass depends on the rate of glass degradation and 
apatite formation in a biological medium. Fast degradation and rapid apatite formation 
corresponds to a high bioactivity.  
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Strnad [47] predicted glass bioactivity using Stevel’s parameter (Y), where Y 
represents the mean number of bridging oxygen ions per polyhedron in the glass 
structure. According to the model, glasses show bioactivity when Y is less than 3 and 
are relatively bio-inert when Y exceeds 3. An optimum bioactivity is obtained when Y is 
equal to 2. However, this model failed to explain the hydrolysable phosphorus-oxygen 
bonds [48] and also neglects the structural role of phosphate in the glass network [49]. 
Hill and Brauer [44] used network connectivity which is considered as a useful tool to 
predict glass bioactivity and degradability. Nevertheless, for glasses with more than 
four components, the prediction is not as accurate as for simple glass compositions 
[43]. O’Donnell et al. focused on the positive influence of phosphorus content on the 
bioactivity of bioactive glasses that a higher P2O5 content in the glasses leads to a 
faster apatite formation [50]. Edén put forward the split network model to evaluate the 
bioactivity assuming the phosphorus in the glass remains predominantly as Q0 
orthophosphate tetrahedra and the average silicate network-polymerisation is 
‘favorable’ [49]; However, Edén did not define “favourable” when the NC beyond the 
value of 2.6, while Hill defined it as a network connectivity close to 2.0 but less than 
2.4.  
Hill describes the relationship between bioactivity and the glass network connectivity, 
as shown in Figure 2.3.1. The theoretical relationship was illustrated by the sharp cut 
off profile, as given in the figure.  
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Figure 2.3.1 The relationship between Bioactivity and Network connectivity adapted from 
Hill  [51]. 
What causes the dramatic change of the bioactivity around NC of 2.0? This could be 
associated with the change of the glass structure. A NC around 2.0 corresponds to a 
structure comprised mainly of Q2 linear silicate chains which is easily degradable by 
dissolving in buffer solution without breaking Si-O-Si bonds [42]. Thus, a Q2 glass 
structure has a favourable bioactivity. As the NC goes above 2.0, the glass structure 
gradually changes to a cross-linked three-dimensional network. Compared to a highly 
disrupted linear chain, a three-dimensional glass network is more resistant to 
dissolution, and therefore, results in fewer available ions in solution such as Ca2+, 
PO43- which are essential, for the apatite formation on the glass surface and, hence, a 
much slower apatite formation, which is known as low bioactivity. Thus, the low 
network connectivity (around 2) and highly disrupted silicate structures are favourable 
to obtain high bioactivity [22]. 
The sharp cut off profile in the figure infers that bioactivity only occurs when NC is 
equal to 2 or less, where the glass is represented as a Q2 linear chain. However, in 
practice, instead of the sharp cut off at 2, a curved relationship between bioactivity and 
NC is found. Glasses with a NC between 1.9 and 2.0 demonstrate favourable 
bioactivity, while the bioactivity decreases dramatically with increased NC (above 2). 
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When network connectivity is higher than about 2.4, glasses show very low bioactivity 
or no bioactivity [51]. This practical curved relationship might be caused by the 
presence of Q2 ring structures in the glass. For example, a combeite-type structure 
(Na2O-2CaO-3SiO2) which is a six-membered Q2 ring structure might exist in 45S5 
based glasses with a network connectivity of 2.14. The Q2 ring has a lower molar mass 
compared to a linear silicate chain, which may result in a more rapid degradation and 
a higher bioactivity. 
2.3.3 The Mechanism of Glass Degradation 
The most widely accepted glass degradation mechanism for bioactive glass was 
proposed by Larry Hench [52]. It is divided into 5 steps, as shown in the following 
schematic diagram: 
1. Si-O-Na+ + H+ + OH-  → Si-OH + Na+ + OH- 
2. Si-O-Si + H2O → Si-OH + OH-Si 
3. 2(Si-OH) → Si-O-Si ( forming rich SiO2 layer)   at the same time, phosphate 
released from glass into solution 
4. Ca2+ +PO43- (from solution)  →  CaO-P2O5 (amorphous rich film) 
5. CaO-P2O5 +OH- →  Ca5(PO4)3OH (Crystallisation) 
Firstly, sodium ion from the glass exchanges with hydrated protons from solution, the 
residual hydroxyl ions result in an increase in the pH value. Secondly, the Si-O-Si 
bridge breaks down as a result of alkaline hydrolysis with formation of the Si-OH 
silanol group, which leads to a breakdown of the glass network. Thirdly, a SiO2 rich 
layer (silica-gel) forms as a consequence of silanol condensation, at the same time, 
phosphate ions release from the glass to the solution. Fourthly, an amorphous calcium 
phosphate layer precipitates on the silica-gel. Finally, mineralisation occurs when the 
amorphous calcium phosphate layer gradually transforms into crystalline 
hydroxyapatite by combining with OH- [43].  
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However, this proposed mechanism does not predict the reactivity of bioactive glasses 
as a function of glass compositions. In addition, in the ion exchange step, the 
contribution of other network modifiers, such as calcium ions is ignored. A recent work 
carried out by Bingel et al. queries the second step of the mechanism. They found that 
it might be not necessary to break down Si-O-Si bond by alkaline hydrolysis, since 
after 3 days immersion no apatite-like phase formed in alkaline buffer solution at pH 9 
but a faster apatite formation was detected after 3 hours immersion at pH 5.0 [53].  
2.3.4 Evaluation of Bioactivity  
Bioactive materials are perfect candidates for bone regeneration, bone substitutions 
and dental applications, depending on their bioactivity. The ability to design novel 
biomaterials with controllable and satisfactory bioactivity is of significance. 
Researchers are interested in the bioactivity of the glasses and use different 
approaches to study it.  
Mneimne and Brauer used Tris buffer solution to investigate the bioactivity of fluoride 
containing bioactive glasses [9]. Kokubo and Takadama predicted and estimated the in 
vivo bioactivity of materials in SBF [54]. They suggested that the examination of 
apatite layer formation on a material in SBF is useful for predicting the bioactivity in 
vivo. The formation of bone-like apatite on the artificial material surface when 
implanted in a living body is the indispensable requirement for a material to bond to 
living bone and tissue. From the experimental results they found that in vivo bioactivity 
of the material can be reproduced in a simulated body fluid. While Bohner and co-
workers argued that even though many research publications test the bioactivity in 
SBF, there are still not enough scientific data to support this method [55]. Bohner 
pointed out that although SBF is chemically similar to human blood plasma, they are 
not the same. There are three big differences between the SBF composition and 
human blood plasma including the absence of proteins in SBF that are present in 
blood serum, the addition of Tris to SBF and the fixed CO2 partial pressure in serum at 
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0.05 atm. In addition, SBF is saturated with Ca2+, PO43- and other ions that could 
readily deposit in the presence of limited nucleation sites [56].Thus, the accuracy of 
predicting in vivo bioactivity by testing in SBF needs to be further assessed and 
improved [55]. 
It is not easy to perform the bioactivity test using SBF. First of all, SBF contains Mg2+, 
which is suggested to give a reduction in the apatite formation [57]. Secondly, SBF is a 
supersaturated solution and it is not stable, when the temperature or pH change, it will 
be prone to precipitate apatite or CaCO3, which will interfere with the study of the 
apatite precipitation from the actual tested sample. Therefore, it is vital to keep the 
conditions constant throughout the study. The bioactivity test in SBF is used 
systematically in this thesis and the SBF results can be used as a reference for 
comparison with other materials or glass series which were previously tested and 
published.  
Tris buffer solution was used in the earliest studies on ioglass 45S5 [58]. Cerruti et al 
[56] used Tris buffer solution to analyse the dissolution and reprecipitation processes 
involving Bioglass® alone. The bioactivity for the glasses with high phosphate content 
can be investigated in Tris buffer. Tris buffer with a pH value at 7.4 is considered more 
stable than SBF. The ions available for the apatite precipitation were conferred solely 
from the degradation of glass or tested sample, and therefore could provide a clearer 
picture on the apatite forming ability of the tested material with minimum external 
influence. Moreover, Tris buffer is common and used for kinetic ion release studies, as 
there are no interfering ions in solution.  
In this PhD project, bioactivity was quantified in terms of time to form apatite in both 
SBF (pH=7.4@37˚C) (corrected SBF published by Kokubo et al. [59], in Table 2.3.1) 
and Tris buffer solution. 
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Table 2.3.1 Ion concentrations of SBF and human blood plasma 
 Ion concentration (mmol/dm3)     
 Na+ K+ Mg2+ Ca2+ Cl- HCO32- HPO42- SO42- 
Human blood plasma 142.0 5.0 1.5 2.5 103.0 27.0 1.0 0.5 
Corrected SBF(c-SBF) 142.0 5.0 1.5 2.5 147.8 4.2 1.0 0.5 
2.3.5 Role of Glass Design and Glass Components on Bioactivity   
Bioactivity is an extremely significant property which needs to be taken into 
consideration for biomedical and dental applications. Higher bioactivity is favoured and 
needed. To obtain an enhanced bioactivity, low network connectivity (around 2) and a 
highly disrupted silicate structure are favourable [22]. Researchers are continually 
exploring methods from different aspects to enhance the glass bioactivity.  
2.3.5.1 Glass design 
Bioactive glasses with network connectivity between 1.9 and 2.0 show a favourable 
bioactivity [60]. These glasses demonstrate a chain-like structure and degrade easily. 
Thus, network connectivity around 2.0 can be considered as a guideline for designing 
a glass with high bioactivity.  
2.3.5.2 Role of SiO2 
The compositional dependence of the glass bioactivity has been investigated by many 
research groups. Some researches show that the glass bioactivity decreases with an 
increase in SiO2 content. This is explained since as glasses are more cross-linked, the 
glass degradation retards and release of the modifier ions to the solution reduces, thus 
silica-gel layer formation is inhibited and fewer sites are provided for apatite deposition 
[23, 47, 61]. Hench [52] found that the bioactive glass SiO2-CaO-Na2O-P2O5 series 
containing 40-52% SiO2 content can form a bond to hard and soft tissues within 5 to 
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10 days. However with a higher silica content (55-60%), the bioactive glasses require 
a longer time to bond to hard tissue, but fail to attach to soft tissue. When the SiO2 
content is more than 60%, the glass lose the ability to bond to living tissues [62]. Thus, 
the amount of SiO2 should be taken into account when designing new bioactive 
glasses. 
2.3.5.3 Role of CaO and Na2O 
Hench [52] considered that the presence of network modifier (CaO and Na2O etc.) is 
indispensable for apatite formation. However, some researchers suggest that the 
network modifier (Na2O) is not essential. Goel, Kapoor et al. [25] designed a series of 
alkali-free bioactive glasses and some of the glasses (TCP-20) formed hydroxyapatite 
on their surface within 1–12 h of immersion in SBF. In addition, recent studies showed 
that the degradation of SiO2-P2O5-CaO-Na2O based glass increased the pH value of 
the buffer to 7.9 [9]. The increased pH is caused by ion exchange between H+ and 
cations of the network modifiers. To some extent, the high pH (7.9) is a potential risk 
for the oral mucosa and living tissues if this type glasses were added into toothpaste 
or used as implant materials. Thus, the novel alkali-free glasses that do not generate 
high alkaline pHs were designed in this PhD project. 
2.3.5.4 Role of P2O5 
The role of phosphate in the glass structure has been studied in the literature. 
However, it is still under dispute. Historically, it was believed that phosphorus enters 
the silicate glass network and forms Si-O-P bonds [63, 64]. However, some researches 
showed that phosphorus exists as an orthophosphate species, rather than entering the 
silicate glass network by forming Si-O-P bonds [10, 65, 66]. According to Elgayar [66], 
the 31P NMR spectra for all the investigated glasses based on SiO2-P2O5-CaO-Na2O 
system have a single resonance with the chemical shift in the range 2.9-9.5 ppm, 
which is the evidence of a mixture of Ca-Na orthophosphate.  
43 
 
Literature Review 
 
O'Donnell and Hill designed two series silicate glasses with varying phosphate content 
(0-9.25 mol%) to study the role of phosphorus by using both 31P and 29Si MAS-NMR 
[65]. In series I, phosphate replaced SiO2 and kept the Na2O:CaO ratio constant, since 
phosphate was assumed as network former. In series II, phosphate was considered to 
form an orthophosphate phase instead of entering the silicate network as a network 
former. Sufficient CaO and Na2O were added to charge balancing the orthophosphate. 
With an increase in phosphorus content, the network connectivity of the glasses in 
series I increased, while the ones in series II did not show any change. The 31P MAS-
NMR spectra of series I and series II showed broad resonances around 9 ppm and 
10.5 ppm respectively, corresponding to the orthophosphate in an amorphous 
environment and indicating that there is no preferential association to one of the 
cations with the orthophosphate [65]. This agrees with the finding by Brauer et al. [4] 
but differs from the conclusions drawn by Lusvardi et al. who suggested an ultimate 
preference of the phosphate units for calcium cations [21]. 
Edén [49] summarised that ‘that as long as the phosphorus remains predominantly as 
orthophosphate and the network connectivity is less than 2.6, bioactivity can be 
enhanced monotonically for increasing phosphorus content of the bioactive glass’. 
According to Tilocca and Cormack [67], for the glasses with P2O5 lower than 10 mol%, 
a higher amount of P2O5 results in a higher bioactivity, while a further increase in P2O5 
content (> 10 mol%) affects the glass bioactivity in a negative way [25].  
O’Donnell et al. studied the effect of phosphate content on the bioactivity of soda-lime-
phosphosilicate glasses, two series of glasses discussed earlier were investigated in 
SBF [50]. From the FTIR spectra and XRD patterns, the high phosphate containing 
glasses (> 3.0 mol%) in both series exhibited crystalline apatite by 16 hours immersion 
in SBF, compared with 2 days for the equivalent low phosphate containing glasses (< 
3.0 mol%). This therefore suggests that the enhanced bioactivity can be achieved by 
increasing phosphate content, whilst the phosphate content has more significant 
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impact than network connectivity on bioactivity [50, 65]. Moreover, O'Donnell et al. 
compared the bioactivity of glass ICSW9 (Mol%: 38.14 SiO2, 29.62 Na2O, 25.91 CaO, 
6.33 P2O5) against 45S5 bioglass (2.6 mol% P2O5) from their FTIR spectra, clear 
apatite peaks were found after 1 day immersion in SBF for glass ICSW9, while the 
equivalent peaks for 45S5 were much weaker [50]. Furthermore, it was shown by 
Mneimne et al. that an increase in phosphate content in the fluoride containing 
bioactive glass favours apatite formation rather than fluorite [9]. Thereby, the high 
phosphate content leads to a superior bioactivity.  
However, the formation of HCA in SBF (20 days) from the phosphate free, CaO-SiO2 
glasses and wollastonite (CaSiO3) ceramics suggests that phosphate is not an 
essential component for achieving bioactivity [68, 69]. 
In order to have a better understanding of the role of phosphorus in glass structure 
and on glass properties, calcium halide containing glasses with high phosphate and no 
phosphate were synthesised and characterised in this work.  
2.3.5.5 Role of CaF2 
Biological Role of CaF2 
Fluoride is a natural ion which is found in many food products and drinking water. It is 
a significant micronutrient that exists in the mineralised tissues such as bone and teeth 
[70]. To a great extent, fluoride can benefit dental health by “strengthening” the tooth 
enamel, suppressing enamel and dentine demineralisation, enhancing enamel 
remineralisation and inhibiting the bacterial enzymes, it therefore makes tooth enamel 
more resistant to tooth decay [4]. Additionally, fluoride is introduced into the mineral 
component of bone during bone formation [71]. Grynpas and Rey [72] found that 
fluoride affects bone crystals, increasing the stability of the apatite lattice and reducing 
the solubility of the apatite crystals. This can be explained by forming a fluoride 
substituted apatite which has a smaller crystal volume compared with HAP and 
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increasing the crystallinity [73]. Fluoride has also been used for the treatment of 
osteoporosis. However, excess fluoride results in an anomalous enamel formation by 
retarding tissue maturation, dental fluorosis and an abnormal bone mineralization [74, 
75]. Due to the dual effect of the fluoride, a balance in between maximizing the 
benefits and minimizing the risks of excess fluoride is very important. 
Structural Role of CaF2 
Fluoride containing ionomer glasses have been used in dentistry and for biomedical 
applications and many studies about the structure of CaF2 containing glasses have 
been performed, the structural role of fluorine is still not clearly defined [76, 77]. 
Whether F- principally forms Si-F bonds or is coordinated with calcium ions, rather than 
acting to depolymerize the silicate network is still under debate. Stebbins et al. [77] 
considered that Si-F-Ca(n) bonds exist in molten slag of 39.2 mol% CaO - 58.9 mol% 
SiO2 - 2 mol% CaF2 quenched glasses. Dumas [78] has presented strong infrared and 
Raman spectroscopy evidence for the presence of Si-F interactions and [SiO3F] 
tetrahedral in fluorine doped silicate glass. In the high CaF2 (> 20%) containing 45S5 
based glasses, a negligible amount of Si-F bonds (< 2%) is noticed. However, the 
addition of a small amount of fluoride (≤ 15 mol%) does not seem to lead to the 
formation of the Si-F interactions and silicon is coordinated to oxygen atoms [21]. The 
MD simulation results produced by Lusvardi et al. [21] for bioactive glasses suggest 
that fluorine is almost exclusively bonded to network modifier ions (Ca and Na) and 
increases the polymerization of silicate tetrahedra by removing network modifier from 
the siliceous matrix. Brauer et al. [4] found that no Si-F interactions or non-bridging 
fluorine bonds formed to a significant extent in fluoride containing bioactive glasses. 
Instead, fluorine is present predominately as mixed calcium sodium fluoride species. In 
a Q2 silicate glass, it is unlikely to observe Si-F bonds, since there is a large 
concentration of non-bridging oxygens and silicon has a lower affinity for the F-  ion 
compared to the O2- ion, thus suggesting that fluorine is only coordinated with Ca2+ 
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and Na+ [79] . This is in agreement with the findings by Pedone [5], who found that F is 
entirely coordinated by the modifier ions Na+ and Ca2+, and no Si-F bonds are present 
in the real glass structure. 19F MAS-NMR shows that with an increase in CaF2, the 
sodium concentration reduces, indicating that fluorine preferentially complexes calcium 
rather than sodium [4]. However, there are some researchers believe that fluoride has 
no preference to Ca2+ or Na+ and it is normally present as a mixed species [5, 80, 81]. 
The presence of fluorine has a significant effect on reducing the glass transition 
temperature [82]. This effect was thought to be consistent with fluorine replacing 
bridging oxygens between silicons by non-bridging fluorines and disrupting the glass 
network. Brauer et al. [4] also found that Tg decreased with increasing CaF2 content. 
However, it is mostly believed to be caused by forming a “CaF+” species (Figure 2.3.2), 
which is analogous to the Na+ ion. The formation of CaF+ species reduces the 
electrostatic force between non-bridging oxygens appreciably and then leads to a less 
compact network and lower Tg. In contrast, in the CaF2 free glasses, calcium ions are 
present as ionic bridges between non-bridging oxygens and bind them together by 
electrostatic forces. In addition, fluoride can also reduce the melting temperatures by 
forming CaF+ species. 
 
Figure 2.3.2 Illustration of the hypothetical effect of CaF2 addition on silicate network 
adapted from Brauer et.al. [4] 
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The fluoride containing bioactive glasses investigated recently [4, 5] favour the 
formation of fluorapatite (FAP), which is more resistant to the acid attack compared to 
hydroxycarbonate apatite (HCA) [9, 80]. While excessive CaF2 leads to calcium 
fluoride formation instead of FAP. Moreover, a sodium-free glass with a composition of 
34.6 SiO2 - 5.74 P2O5 - 50.38 CaO - 0 Na2O - 9.28 CaF2 (in mol%) shows an enhanced 
bioactivity and forms FAP in Tris buffer solution within 6 hours of immersion [9]. When 
compared to sodium containing glasses, the glass with no sodium shows more 
pronounced and better resolved apatite peaks in the XRD pattern. This discovery 
implies that sodium-free CaF2 containing glasses might be more attractive for 
biomedical applications. 
Moreover, it is shown that when CaF2 is substituted for network modifiers (CaO or 
Na2O), network modifiers are removed from siliceous matrix, in order to form CaF+ 
species. As a consequence the available network modifier for forming non-bridging 
oxygens reduce and form a more cross-linked network, which leads to a reduced 
reactivity and bioactivity of the glass [4, 21]. In contrast, adding CaF2 and keeping the 
ratio of network former to network modifier constant, result in network connectivity 
staying constant [20]. The incorporation of CaF2 benefits glass bioactivity by forming 
fluorapatite, which has a lower solubility product. 
2.3.6 Fluoride Containing Bioactive Glasses 
Recent research showed that the incorporation of fluoride into silicate glasses is 
beneficial in reducing glass transition temperatures, probably glass hardness and 
forming FAP rapidly after immersion in physiological solution [4, 20]. These glasses 
are also attractive for bone substitutions and the remineralising toothpastes to treat 
dentine hypersensitivity [4]. However, it is important to control the fluoride content, as 
the excess fluoride leads to a formation of CaF2 which is insoluble and might reduce 
the glass bioactivity [20, 83].  
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2.3.7 Potential Chloride Containing Bioactive Glasses 
Chloride containing silicate glasses have rarely been investigated and only few papers 
on phosphate free, chloride containing (< 2 mol%) aluminosilicate glasses were 
published [84-86]. There are no commercial applications of oxychloride glasses to date, 
since virtually no chlorine is retained in the glass after the synthesis [87]. However, 
chlorine and fluorine are both halogen elements; it is assumed that chlorine takes a 
similar role in the glass structure and confers similar properties on the glasses, 
including reducing melting temperature, Tg and glass hardness and crystallising to 
ClAP. The chloride ion is larger than fluoride ion (1.67 Å vs 1.19 Å), the presence of 
chloride might be able to expand the glass network and result in a more open glass 
structure, thereby giving rapid glass degradation and a higher bioactivity. Moreover, 
CaCl2 is soluble unlike the fluorite. However, there is no chloride containing bioactive 
available at the moment. 
In order to achieve the benefits of chloride containing bioactive glasses, the problem of 
chloride volatilisation should be overcome. Research showed that chloride is lost in 
chloride containing glasses with NC of three or higher [85]. Nevertheless,  volatilisation 
may be possibly be overcome in a Q2 silicate structure [87]. 
2.4 Potential Applications of Fluoride and Chloride Containing 
Bioactive Glasses 
2.4.1 Remineralising Toothpaste 
Dentine hypersensitivity (DH) is characterised by a short, sharp pain responses to 
various stimuli, typically thermal, tactile, chemical or osmotic, that can not be ascribed 
to any other dental disease [88]. It arises from  the exposure of the dentinal tubules of 
the root [9]. Bioactive glass has been incorporated as a remineralising ingredient in 
dentifrice formulations for treating DH. It forms hydroxycarbonated apatite on the tooth 
surface and subsequently occludes the exposed dentinal tubules which contribute to 
49 
 
Literature Review 
an alleviation of the sensitivity [89]. Fluoride containing bioactive glasses are more 
attractive for this application [90]. Since FAP is more stable toward acid attack than the 
HAP and will provide a more durable option for treating DH.  
The chloride bioactive glasses could also be of interest for remineralising toothpastes, 
since chlorine is similar to fluorine in its structural role and its effects on glass 
properties. Additionally the large chloride is expected to expand glass volume and 
promotes glass degradation and apatite-like phase formation. The mixed fluoride and 
chloride containing bioactive glasses may even be more competitive as they might 
combine the advantages from both fluoride and chloride.  
The design criteria of a bioactive glass for toothpaste applications are summarised as 
below [91]: 
• Rapid apatite formation (< 6 hours) in the mouth.
• Formation of FAP rather than hydroxycarbonated apatite.
• Particle size distribution that includes small (< 3 µm) particles for entering
dentinal tubules and larger particles for more sustained release.
• Controlled fluoride release.
• pH rise < 8.0.
• No harder than enamel at 3.5 GPa.
• Fluoride content: less than 1500 ppm in Europe; less than 1100 ppm in the US.
2.4.2 Bone Grafts 
There is an increasing interest in using bioactive glasses as synthetic bone graft 
substitutes due to the fact that bioactive glasses degrade over time and bond to bone, 
release soluble silica and calcium ions that are thought to simulate osteoprogenitor 
cells [1, 92]. The incorporation of fluoride into bioactive glasses has shown promise in 
promoting an acid durable fluorapatite formation at low pH (< 6) condition, 
representative of those present during the inflammation phase of normal bone healing, 
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consequently the fluoride containing bioactive glasses are suitable for bone grafts [93]. 
Moreover, fluoride is also known to promote osteoblast differentiation [94]. As 
mentioned above, the presence of large chloride ion might result in a more degradable 
glass and forming HAP, which is more soluble than FAP on immersion. Since ClAP 
convers to HAP with the presence of water [95], the immersion of chloride containing 
bioactive glasses will form HAP rather than ClAP, more details will be discussion in the 
following sections. Thus, the chloride containing bioactive glasses are more attractive 
for resorbable bone grafts. 
2.4.3 Air Abrasion 
Air abrasion is a minimally invasive approach for cutting dental cavities, which uses the 
kinetic energy of a high velocity stream of abrasive particles, typically alumina [6, 96]. 
Bioglass® 45S5 has been investigated as an abrasive particle in air abrasion [97] and 
also is used clinically for teeth polishing [98]. However, as mentioned previously, 
Bioglass® 45S5 is harder than the enamel. Therefore a glass with desirable hardness, 
which is harder than the decayed tooth tissue but softer than enamel (3.5 GPa), is 
attractive for use in air abrasion to remove carious lesions without damaging the 
subsurface of the tooth structure. The presence of fluoride and chloride are expected 
to reduce the glass transition temperature, which has a strong correlation to the glass 
hardness, the lower the Tg, the lower the hardness [6, 27]. The designed calcium 
halide containing glasses are potential candidates for air abrasion application. 
Understanding the relationship between calcium halide content and Tg will have a 
significant part to play in tailoring the glass properties for air abrasion applications. 
2.4.4 Nuclear Waste Immobilisation  
Recently, the immobilization of spent nuclear fuel waste containing actinide and 
chloride ions, has received more attention [99]. Amorphous borosilicate glasses have 
been selected as one option for the nuclear waste storage [100]. However, chloride 
ions have very low solubility in borosilicate glasses and there are issues with chloride 
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volatilisation. It has been suggested that chlorapatite glass-ceramic could be used to 
retain Cl-bearing waste containing fission products, although with lower waste loadings 
[101]. However to date no chlorapatite glass-ceramics have been developed. 
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2.5 Apatite 
Apatites are a group of phosphate minerals, which form the mineral component of 
bones and teeth. Apatites include hydroxyapatite, fluorapatite and chlorapatite. The 
formula of these apatites are written as Ca10(PO4)6X2 (X=OH, F, Cl) [102]. To some 
extent, they are able to work as a “bridge” to bond implant materials to living tissues 
[25]. The materials which can form apatite when they are immersed in physiological 
solutions are defined as biomaterials that have bioactivity [55]. Apatites are 
increasingly used as bioactive materials for bone remodelling and replacement or for 
the coating of bone prostheses [102]. In addition, doped apatites are used as 
phosphors in fluorescent light tubes [102]. The versatility of apatites can be achieved 
by substituting a variety of ions. 
2.5.1 Hydroxyapatite (Ca10(PO4)6(OH)2) 
Hydroxyapatite has been paid much attention, as it is similar to the inorganic phase of 
bones and teeth [103]. Due to its excellent biocompatibility, osteoconductivity and good 
bioactivity, HAP has been used as a biomaterial [104]. However, the poor mechanical 
property is a big drawback [105]. 
The structure of HAP is a monoclinic structure with space group P21/b with lattice 
parameters a = 9.4214(8), b = 2a, c = 6.8814(7) Å (1 Å = 0.1 nm), γ = 120 °  [8, 106] 
(Table 2.4). The results of Neutron diffraction and X-ray diffraction show that hydroxyl 
oxygen and hydrogen atoms are located at 0, 0, 0.201 and 0, 0, 0.062 respectively, 
rather than OH ion straddles the mirror plane at z=1/4 [102]. This indicates that there is 
a short range ordering of OH- ions into columns, which run vertically down their 
structure in a head to tail fashion, that is, O-H O-H O-H. Apart from being a monoclinic 
form, HAP is also believed to be a hexagonal structure [106]. 
There are two types of Ca2+ ion site, Ca(I) and Ca(II) in the hydroxyapatite structure. 
Ca(I) ions are nine-fold coordinated by oxygen atoms, while Ca(II) ions are bonded to 
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six oxygen atoms and a OH- ion. Fluorapatite and chlorapatite have same types of 
Ca2+ ions. The OH- ion is in three-fold coordinated by Ca2+ ions. Three Ca (II) ions form 
a triangle, OH- sites above the centre of the triangle of Ca(II) ion (Figure 2.5.1) . 
 
Figure 2.5.1 Arrangement of the ions around OH- ion in hydroxyapatite 
2.5.2  Fluorapatite (Ca10(PO4)6F2) 
Investigations show that the incidence of dental caries is reduced when water supplies 
are fluoridated and some bone mineral disorders have been treated using NaF [102]. 
These can be explained by the fluoapatite formation in early caries lesions.  
Fluorapatite is chemically more stable in an acidic environment compared with 
carbonated hydroxyapatite [20]. Fluoride is beneficial in increasing bone density and 
the prevention of bone fracture. Therefore, fluorapatite is of particular interest in dental 
applications to prevent dental decay and for treating osteoporosis. In addition, 
fluorapatite is used as phosphors in fluorescent light tubes, when doped with antimony  
and manganese [102, 107]. 
Fluorapatite presents as a hexagonal prism with space group of P63/m and the lattice 
parameters a = 9.37523, b = 9.37523 and c =6.88033 Å [108]. In the FAP structure, 
the F-  ion locates at 0, 0, 1/4 rather than sitting at 0,0,1/2 [102]. The F- ion is at the 
centre and surrounded by three Ca(II), all four ions occurring at a mirror plane (Figure 
2.5.2). 
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Figure 2.5.2 Arrangement of the ions around F- ion in fluorapatite 
2.5.3  Chlorapatite (Ca10(PO4)6Cl2) 
Chlorapatite is a chloride substituted apatite, which has a similar functionality to 
fluorapatite. Mixed fluor/chlorocalcium/strontium apatites (Ca/Sr10(PO4)6(F/Cl)2) have 
been extensively  used as commercial lamp phosphors in fluorescent tubes. The 
recent research shows that chlorapatite ceramics can be the candidate waste forms for 
incorporation of chloride-bearing waste containing fission products when lower waste 
loadings are accepted [101]. 
The structure of chlorapatite is monoclinic, space group of P21/6 with lattice parameter 
a = 9.628 (5), b = 2a, c =6.764 (5) Å, γ=120° [102, 109]. There are two Ca sites exist in 
ClAP, the four 4f Ca (I) sites are 9-fold coordinated by oxygen ions while the six 6h 
Ca(II) are seven-fold coordinated by six oxygen atoms and a Cl- ion. The Cl- ions are 
occurring in the vertical channel and above the centre of the mirror plane, forming by 
the triangle of Ca(II) (Figure 2.5.3) [101]. The position of Cl- ion is 0.0016, 0.2493, 
0.4439. There is a distance of 6.7 Å between two Cl- ion column, these horizontal 
orders are continued by tilts of the PO43+ tetrahedral and 0.05 Å shifts of Ca (I) [102]. 
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Figure 2.5.3 Arrangement of the ions around Cl- ion in chlorapatite 
Table 2.5.1 Structures of apatites and cell parameters 
Formula Stucture Space group a (Å) b (Å) c (Å)  
Ca10(PO4)6(OH)2 Monoclinic P21/b 9.4214 18.8428 6.8814 
Ca10(PO4)6F2 Hexagonal P63/m 9.3752 9.3752 6.8803 
Ca10(PO4)6Cl2 Monoclinic P21/b 9.6285 19.257 6.764 
 
2.5.4 Comparison among Apatites 
The chloride ion has an ionic radius of 1.67 Å against 1.26 Å and 1.19 Å for the 
hydroxyl and fluoride ions, respectively. The fluoride ion is the smallest one, it is able 
to enter the apatite lattice much more easy and occupy the space in the triangle of 
Ca(II) ions, which results in a reduction in the volume of the unit cell and a more 
compact structure [73]. Therefore, FAP has a higher chemically stability than HAP and 
ClAP.  
Elliott [102] found that both of fluorapatie and chloraptite are thermally much more 
stable than hydroxyapatite. FAP has a melting temperature of 1644°C. Coarse FAP 
particles can be converted to HAP in  heat steam at 1360°C for 48h [102]. 
Comparatively speaking, ClAP is less stable and is readily converted to HAP when 
heated in steam above 800°C. In addition, ClAP can also convert to HAP with the 
presence of water [95].   
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The X-ray diffraction patterns of HAP, FAP and ClAP are given in Figure 2.5.4. 
Generally, the characteristic diffraction lines for these apatites are quite close to each 
other, although both HAP and FAP have three main peaks between 30° to 33° 2Ɵ but 
only two for ClAP. The diffraction line with 100% intensity for HAP, FAP and ClAP are 
at 31.766°, 31.82° and 32.284° 2Ɵ.  Since the apatite lattice is very tolerant of 
substitutions, vacancies and solid solutions occur readily [110], the diffraction lines 
shift or change in intensity with the substitution. Therefore it is difficult to distinguish 
among them using XRD alone.  The combination of using XRD, XRF, 19F, 31P and 35Cl 
MAS-NMR is very useful to identify apatites. 
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Figure 2.5.4 XRD patterns of hydroxyapatite, fluorapatite and chlorapatite 
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3  Aim and objectives 
3.1 Aims 
• To design and synthesise fluoride, chloride and mixed fluoride and chloride 
containing bioactive glasses. 
• To investigate their bioactivity and study their mechanism of degradation and 
apatite formation.  
• To investigate the crystallisation behaviors of the studied halide containing 
glasses. 
3.2  Objectives  
• Design and synthesis of the F, Cl, F-Cl containing bioactive glasses and 
characterisation by DSC, FTIR, XRD and MAS-NMR as follows: 
a. Synthesis and characterisation of the fluoride containing glasses series 
b. Synthesis and characterisation of the chloride containing glasses series 
c. Synthesis and characterisation of the mixed chloride and fluoride containing 
glasses series 
d. Synthesis and characterisation of the phosphate free glasses series with 
chloride and fluoride  
• Investigation of glass bioactivity in Tris buffer solution and SBF. 
• Study the structural role of F and Cl in silicate glasses based on simple models 
of P free glasses with the F/Cl.  
• Study the crystallisation behaviour of the glasses with view to forming apatite 
glass-ceramics based on FAP /ClAP or mixed F/ClAP. 
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4  Materials and Methods 
4.1 Diagram of Experiments 
 
XRD  
Glass synthesis 
Glass frit 
quenched into cold water  
melted at high Temperature 
ground and sieved through 38um 
Glass powder 
FTIR  
NMR  
Bioactivity test 
Ion release study 
XRD, FTIR, NMR  
ICP-OES 
F- ion measurement 
Heat treatment 
XRD, FTIR, NMR, 
SEM 
DSC Analysis 
Apatite formation 
pH measurement 
Density   Cl content 
DSC 
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4.2 Glass Synthesis 
The sodium-free glasses in the system of SiO2-CaO-P2O5-CaF2/CaCl2, SiO2-CaO-
CaF2/CaCl2 were designed and synthesised by a melt-quench route. In this project, 
rather than substituting CaF2 and/or CaCl2 for CaO, calcium halides were added to the 
SiO2-CaO-P2O5 and SiO2-CaO system, while keeping the ratio of other components 
and the NC constant. The glass compositions are summarised in Table 4.2.1. The 
CaF2 glass series (GPF series) were designed by introducing different amounts of 
CaF2 into the GPF 9.3 composition first studied by Mneimne et al. [9]. The CaCl2 glass 
series (GPCl series) were designed by replacing CaF2 with CaCl2·2H2O and the mixed 
CaCl2/CaF2 series (GPFCl series) by replacing 50% of the CaF2 by CaCl2·2H2O, since 
CaCl2 picks up water easily. The P free CaF2 series (GF series) and the P free CaCl2 
series (GCl series) were designed by keeping the ratio of SiO2: CaO: CaF2= 50:50:X 
(X is the CaF2 content in GF series) and SiO2: CaO: CaCl2·2H2O= 50:50:Y  (Y=X, 
30,40,50 and 60), respectively.  
 A 200 g batch size was made. Glass reagents (analytical grade silica (Prince Minerals 
Ltd., UK), calcium carbonate, calcium fluoride, calcium chloride dihydrate (all from 
Sigma-Aldrich) and diphosphorus pentoxide (AnalaR) were weighed, mixed and 
transferred into a Pt/10Rh crucible, heated up to 1320-1550˚С depending on the glass 
compositions for 1 hour in an electrical furnace (EHF 17/3 Lenton, Hope Valley, UK), 
quickly quenched into cold water to inhibit crystallisation. In this work, CaCO3 was 
used as a reagent instead of CaO, since CaCO3 decomposes to CaO and CO2 after 
melting but CaO reactives with CO2 forming CaCO3. After drying in an electric oven 
(85°C) overnight, 100 g of the glass frit was ground using a Gy-Ro mill (Glen Creston, 
London, UK) with two sets of 7 minutes. The obtained glass powder was sieved 
through a < 45 μm mesh analytical sieve (Endecotts Ltd., London, UK) to get fine 
powder. 
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The particle size and distribution of the studied glasses (< 45 μm) were estimated 
using a Mastersizer/E particle analyser (Malvern Instruments, UK). Small amount of 
glass powders were added to a circulating water bath. According to the actual powder 
particle size range, the particle size was measured by spherical volume in the range 
between 0.1 μm to 100 μm by a 45 mm lens or between 0.5 μm to 180 μm by a 100 
mm lens. The particle size distribution was evaluated with the span value defined as: 
]5.0,[
]1.0,[]9.0,[
vD
vDvDSpan −=                                       (4.2)  
Where ]9.0,[vD , ]5.0,[vD , ]1.0,[vD  indicate that the volume percentage of the 
particle with diameter of ]9.0,[vD , ]5.0,[vD , ]1.0,[vD  is 90%, 50% and 10%.  
Table 4.2.1 Experimental glass compositions (in Mol%). 
Glass SiO2 CaO P2O5 CaF2 CaCl2 Tfiring (°C) NC 
GPF/GPCl 0.0 38.1 55.5 6.3 - - 1550 
2.08 
GPF 3.0 37.0 53.9 6.1 3.0 - 1550 
GPF 4.5 36.4 53.0 6.0 4.5 - 1500 
GPF 6.0 35.9 52.2 6.0 6.0 - 1500 
GPF 9.3 34.6 50.4 5.7 9.3 - 1500 
GPF 13.6 32.9 48.0 5.5 13.6 - 1500 
GPF 17.8 31.4 45.7 5.2 17.8 - 1500 
GPF 25.5 28.4 41.4 4.7 25.5 - 1500 
        
GPFCl 2.6 37.1 54.1 6.1 1.5 1.1 1550 
2.08 
GPFCl 4.0 36.6 53.4 6.0 2.3 1.7 1520 
GPFCl 5.3 36.2 52.6 5.9 3.0 2.3 1500 
GPFCl 8.3 35.0 51.0 5.8 4.7 3.6 1500 
GPFCl 12.1 33.5 48.8 5.6 6.9 5.2 1500 
GPFCl 16.0 32.1 46.7 5.3 9.1 6.9 1500 
GPFCl 23.1 29.3 42.7 4.9 13.2 9.9 1500 
        
GPCl 2.3 37.3 54.3 6.2 - 2.3 1500 
2.08 
GPCl 3.5 36.8 53.6 6.1 - 3.5 1500 
GPCl 4.6 36.4 53.0 6.0 - 4.6 1500 
GPCl 7.2 35.4 51.6 5.9 - 7.2 1480 
GPCl 10.6 34.1 49.6 5.7 - 10.6 1480 
GPCl 14.0 32.8 47.7 5.4 - 14.0 1480 
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GPCl 20.6 30.3 44.1 5.0 - 20.6 1450 
   
GF 2.9 48.5 48.5 - 2.9 - 1550 
2.0 
GF 4.3 47.9 47.9 - 4.3 - 1540 
GF 5.7 47.2 47.2 - 5.7 - 1540 
GF 8.5 45.8 45.8 - 8.5 - 1500 
GF 12.0 44.0 44.0 - 12.0 - 1505 
GF 15.1 42.4 42.4 - 15.1 - 1495 
GF 20.3 39.8 39.8 - 20.3 - 1480 
  
GCl 0.0 50.0 50.0 - - 0.0 1550 
2.0 
GCl 2.2 48.9 48.9 - - 2.2 1550 
GCl 3.3 48.4 48.4 - - 3.3 1530 
GCl 4.3 47.8 47.8 - - 4.3 1480 
GCl 6.6 46.7 46.7 - - 6.6 1480 
GCl 9.3 45.3 45.3 - - 9.3 1490 
GCl 11.9 44.1 44.1 - - 11.9 1480 
GCl 16.1 41.9 41.9 - - 16.1 1470 
GCl 27.4 36.3 36.3 - - 27.4 1445 
GCl 33.5 33.3 33.3 - - 33.5 1420 
GCl 43.0 28.5 28.5 - - 43.0 1395 
GCl 53.1 23.5 23.5 - - 53.1 1320 
 
 
4.3 Glass Characterisation  
4.3.1 X-ray Diffraction (XRD) 
XRD is a powerful analytical technique for studying the long-range order, determining 
the different crystalline phases and the crystal structure. In addition, XRD can be used 
to identify whether glass is amorphous or partially crystalline. The amorphous glass 
gives a smooth and broad halo, while a crystalline phase shows distinct diffraction 
lines instead [9].  
In this PhD project, an X’Pert Pro X-ray diffractometer (PANalytical, Eindhoven, The 
Netherlands) was employed to characterise the glasses, the heat treated glass-
ceramics and the precipitates collected after immersion in buffer solutions. A small 
amount of sample was placed in the sample holder. A Bragg-Brentano flat plate 
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geometry was used along with Cu Kα radiation (λ1=1.54059 Å and λ2=1.54442 Å). The 
patterns of sample were collected from 5 to 70˚ 2θ with an interval of 0.0334˚ and a 
step time of 200.03 sec. Calibration was carried out using NIST standard reference 
material 660a (lanthanum hexaboride). XRD data were analyzed using X’Pert 
HighScore Plus (v2.0, PANalytical, Almelo, The Netherlands) in conjunction with the 
ICDD database. During the experimental manipulation, the samples were exposed to 
the atmosphere. The chloride containing glasses made in this project were particularly 
moisture sensitive and therefore any exposure of the samples to the atmosphere 
during the measurements including the XRD runs sometimes might result in some 
reaction with the atmospheric moisture as will be discussed later.  
4.3.2 Fourier Transform Infrared Spectroscopy (FTIR) 
Chemical bonds in the materials were evaluated by Fourier Transform Infrared 
Spectroscopy (Spectrum GX, Perkin-Elmer, Cambridge, UK) via interpreting the 
infrared absorption spectrum. Prior to sample scanning, the lens was cleaned with 
ethanol, followed by performing a background spectrum scan. After collecting the 
background, a sufficient amount of powder was transferred to cover the lens. A scan 
number of 20 was used. The background signal was automatically subtracted by 
software from the samples spectra. The data were recorded from 500 to 1600 cm−1 
(wavenumbers). 
4.3.3 Magic Angle Spinning-Nuclear Magnetic Resonance (MAS-NMR) 
Magic Angle Spinning - Nuclear Magnetic Resonance (MAS-NMR) is a powerful 
technique for characterising solids and gives information on co-ordination states, next 
nearest neighbours, bond lengths and bond angles [111]. Figure 4.3.1 illustrates the 
schematic of MAS-NMR technique. The solid sample is placed in a rotor, rotating with 
high frequency (5-30 kHz) at a magic angle (ө=54.7°, 3cos2ө-1=0) with respect to the 
diraction of main magnetic field (B0), in order to average the anisotropic interactions, 
narrow down the broad line and increase the resolution of the spectrum. The 
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information about chemical shift (atomic environment), the number of peaks (the 
number of chemically distinct species) and peak integral (the amount of chemically 
equivalent nuclei giving rise to the peak) can be obtained from the spectrum.  
 
Figure 4.3.1 Schematic representation of the MAS-NMR technique adapted from Alia et.al. 
[112].  
 
Both of 19F and 31P nuclei are 100% abundant with a nuclear spin of 1/2. The 19F 
nucleus has a large degree of chemical shift anisotropy, which is very sensitive to the 
cations next to it. The chemical shift of 31P is sensitive to the cationic substitutions. 
Therefore they are the well-known and excellent technique for providing on the local 
structure of fluorine and the phosphorus environments in the bioactive glasses [4, 5, 
113]. 29Si MAS-NMR is a very powerful technique which is widely used to determine 
the Qn structure [4]. However the low nature abundance (4%) of 29Si nucleus increases 
the cost of the experiment as it is time-consuming. 
Unlike 19F or 31P MNR, 35Cl NMR is technically challenging, though the nuclide consists 
75% of natural Cl [85]. The 35Cl is a quadrupolar nucleus with a spin of 3/2 and a large 
nuclear quadrupolar moment, which result in a severely broad NMR peak. Therefore 
only few studies on glass structure were carried out using 35Cl MAS-NMR [84-86].  
In this thesis, 19F MAS-NMR will be used to study the fluorine environment in the 
glasses and distinguish FAP formation from HAP and ClAP. In addition, 29Si and 31P 
NMR will also be employed to characterize the glass structure. The 31P, 19F and 29Si 
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MAS-NMR experiments were performed using a 600 MHz (14.1T) Bruker NMR 
spectrometer (AV 600 NMR, UK). 
For 31P MAS-NMR experiment, glass powder with a particle size less than 45µm and 
the solid collected after immersion or heat treatment were packed into a 4 mm zirconia 
rotor and placed in a magnetic field of 242.9 MHz frequency with spinning condition of 
8 KHz. Some 31P MAS-NMR measurements were also carried out using the Bruker 
probe with a 2.5mm rotor at  spinning speeds of 18 and 21 kHz. A recycle delay of 60 s 
was used and the number of scans was set to 16. The chemical shift was referenced 
using the primary reference, 85% H3PO4.  
The 19F MAS-NMR measurements were conducted at the resonance frequency of 
564.7 MHz using the “fluoride-free” double resonance Bruker probe with a low fluoride 
background and tuneable to the 19F NMR frequency using the 2.5 mm rotor spinning at 
18 kHz and 21 kHz. Either 32 or 64 scans were acquired with 8 preliminary dummy 
scans and 30 seconds recycling delay. The chemical shift was referenced using the 
signal from the 1 M NaF solution scaled to -120 ppm relative to the CF3Cl primary 
standard.  
A resonance frequency of 119.2 MHz was used for 29Si MAS-NMR. Glass powder was 
packed in a 4 mm zirconia rotor and spun at 5 kHz with a 120s recycle time. The data 
were collected after 432 scans. The chemical shift of the 29Si NMR spectra was 
referenced to 0 ppm frequency of the corresponding signal in tetramethylsilane 
Si(CH3)4) solution. 
NMR data were plotted using TopSpin® and Xwinplot® softwares (Bruker TopSpin 2.1 
software, Germany). The full width half maximum (FWHM) of the 31P MAS-NMR 
spectra were estimated by using Bruker TopSpin® software. Chemical speciation of 29Si, 
31P, 19F nuclei and glass structure were evaluated by the chemical shift and the shape 
of the peaks. 
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4.3.4 Differential Scanning Calorimetry (DSC) 
Differential scanning calorimetry (DSC) is a thermal analytical technique which can be 
used to observe fusion and crystallisation events, and measure the difference in the 
heat flow rate between a sample and reference when they are undergone a 
maintained heat treatment cycle. 
Both glass frits (1-2 mm) and fine powders (< 45µm) were used to determine the glass 
transition temperature, crystallisation (Tc) peak temperature, melting temperature (Tm) 
and assess the tendency toward surface or bulk nucleation by using a Stanton 
Redcroft DSC 1500 (Rheometric Scientific, Epsom, UK). A 50 mg sample was packed 
in a Pt-Rh crucible and heated under Nitrogen (60ml/min-1) from 25 ˚С to 1100˚С at a 
rate of 20˚С/min against an alumina reference. The glass transition temperature (Tg) 
was obtained from the DSC traces with an accuracy of ± 5 ˚С. 
4.3.5 Compositional Analysis 
The chloride contents in the initial chloride containing glasses were quantified using a 
chloride ion selective electrode (ELIT Cl- 2844, NICO 2000 UK). Glass powder (75mg) 
with particle size smaller than 45 um was dissolved in the 50 ml solution (48 ml 
deionized water, 1 ml 69% HNO3 and 1 ml 5M NaNO3 (ISA solution)). The samples 
were prepared in triplicate. The 1000 ppm Cl- stock solution was prepared by 
dissolving 1.649 g NaCl (Sigma-Aldrich, Gillingham, UK) into 1 L distilled water. The 
obtained Cl- stock was diluted to different concentrations to calibrate the electrode.  
4.3.6 Density Measurement 
The density of each glass was determined by Helium Pycnometry (AccuPyc 1330-
1000, Micromeritics, GmbH, Aachen, Germany). Two grams of glass powder (<45 µm) 
was used and measured with the pressure at 1.6 bar. The density values reported are 
the mean of ten measurements performed during the experiment.  
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The experimental molar volume of the glasses is calculated by using the relation [114]: 
D
MVm =                                                                         (4.3) 
Where M is the relative molecular mass of glass and D is the experimental density. 
4.4 Bioactivity Test 
Glass bioactivity in terms of glass degradation and apatite-like phase formation was 
investigated in both Tris buffer solution and SBF. The preparation of Tris buffer solution 
was according to that described by Mneimne et al., while SBF was prepared following 
the method described by Kokubo and Takadama [59] for the corrected SBF (c-SBF, in 
Table 2.3.1). A 75 mg glass powder (< 45 µm) was dispersed in 50 ml Tris and SBF 
respectively then transferred to a shaking incubator (KS 4000i Control, IKA, Staufen, 
Germany) set at 37±1 ˚C with an agitation rate of 60 rpm for different durations (1, 3, 6, 
9, 24, 72 and 168 hours). The samples were prepared in duplicate. At the end of the 
immersion period, samples were removed from the shaker, and pH values were 
measured by a pH meter with 35811-71 pH electrode (Oakton®, Malaysia). Solutions 
were subsequently filtered through a filter paper which has a pore size between 5 µm 
and 13 µm. The filter papers with the precipitates were dried in the oven at 37˚C 
overnight; the collected precipitates were used to investigate apatite formation by FTIR, 
X-ray diffraction and MAS-NMR. The filtered solution was kept in the fridge at 4˚C for 
subsequent ICP analysis.  
4.4.1 Inductively Coupled Plasma – Optical Emission Spectroscopy 
ICP-OES is a sensitive technique used to measure ion (Ca2+, Si4+, P5+, Na+) 
concentrations up to a very low concentration (as low as 0.1ppm). The advantages of 
ICP are high sensitivity, and many different elements can be measured at the same 
time, good precision and reproducibility.  
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In this work, the concentrations of Ca, Si and P were quantified using an inductively 
coupled plasma-optical emission spectroscopy (ICP-OES; Varian Vista-PRO, UK). 
Solutions were acidified using 69% nitric acid and diluted by a factor of 1:10 or 1:20 for 
measurements of calcium and silicon content and no dilution was used for 
measurements of phosphate ion content. According to the calculation of ion release 
level prediction, standard solutions were prepared by diluting the multi-element stock 
solution with deionized water.  Prior to the sample measurement, a calibration for each 
element was performed with the standards. 
4.4.2 Fluoride Probe Measurement 
It is known that the voltage of the probe measured in solution is directly proportional to 
the logarithms of the concentration of F-. Fluoride concentration in solution was 
therefore measured using a fluoride ion selective electrode (Orion 9609BN, 710A 
meter, South Burlington, VT, USA). A sequence of standard solutions with different F- 
concentrations (2, 10, 16, 20, 40 and 100 ppm) was prepared by diluting NaF stock 
solution (1000 ppm) with de-ionised water. A six-point calibration was applied to 
establish the relationship between the probe voltage and the F- concentration. 
Measurements started from high concentrations to low ones. 
4.5 Heat Treatment 
Glass frit (1-2 mm) and fine powder (< 45 μm) (1 g), which was compacted into a disc 
under 40 bar pressure for 30s, were placed on a platinum foil and heated up at a rate 
of 20°C/min from 400ºC to the heat treatment temperature (THT) in a porcelain furnace 
(CeramPress, NEY Dental International, USA) without holding. According to the width 
of the crystallization peak from the DSC traces, THT was Tc or approximately 10°C 
above Tc. After heat treatment, samples were immediately withdrawn from the furnace 
and air quenched. The resulting sintered glass-ceramics were then ground into powder 
and characterized using XRD, FTIR and MAS-NMR to identify the crystalline phases. 
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4.6 Scanning Electron Microscopy 
In order to investigate the morphology of the crystalline phases, the heat treated glass-
ceramics were embedded into epoxy resin (Epofix, Struers, Copenhagen, Denmark) to 
set, polished with a series of silicon carbide grinding paper (P120, P320, P600, P800, 
P1000, P2400 and P4000) and finished with 0.3 micron diamond paste (Met Prep Ltd. 
UK). The well-polished or powder form specimens were gold coated using an 
automatic sputter coater (Agar Scientific Ltd, Stansted, 108 A, England) at 40mA for 
100 seconds and viewed under a scanning electron microscope (FEI Inspect F, Oxford 
Instruments, UK) using back-scatter and secondary electron imaging modes. In 
addition, some of the grinding glass-ceramics were spread on the sample holders, 
gold coated and imaged by using SEM. 
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5  Sodium-Free CaF2 Containing Bioactive 
Glasses 
Foreword 
 
Due to the noticeable bioactivity, the first bioactive glass (Bioglass® 45S5) has been in 
clinical use since 1985 and is widely used under the trademark of NovaBone®, 
PerioGlas® and NovaMin®. This commercially available glass (Bioglass® 45S5) 
contains significant amounts of sodium oxide (24.4 mol%), which is beneficial in 
reducing the glass melting temperature, thus facilitating synthesis at low temperatures. 
In addition, according to Hench’s original mechanism of bioactivity, sodium is a critical 
component for glass degradation and apatite formation [52]. 
However, high sodium oxide content is problematic. It makes the bioactive glass phase 
hygroscopic, and thereby affects stability, degradation and mechanical performance of 
its composites. This reduces the applicability of conventional high sodium oxide 
content bioactive glasses as a filler in composites. In addition, according to the 
mechanism of glass degradation [43], sodium ions exchange with protons followed by 
the glass dissolution causing an increase in pH value, which is in favour of apatite 
formation but not beneficial for homeostasis.  
As presented in recent research articles, it is possible to form sodium-free fluoride 
containing bioactive glasses, which crystallise to FAP during quenching or degrade 
and form FAP upon immersion in buffer solutions [9, 20]. In this project we extended 
the sodium-free bioactive glass composition studied earlier [9] and developed a series 
of sodium-free glasses with varied fluoride content. 
The presence of fluoride in sodium-free bioactive glasses brings additional benefits to 
the bioactive material. Fluoridated apatite formed on immersion is less soluble in an 
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acidic condition than hydroxyapatite, the latter is the main component of enamel and 
dentine [115-117]. Fluoride is the well-known agent in preventing caries by inhibiting 
enamel and dentine demineralisation, enhancing remineralisation and inhibiting 
bacterial enzyme activity [116]. Therefore, fluoride containing bioactive glass is 
promising for reminerallising toothpastes to treat tooth hypersensitivity.  
The assessment of bioactivity for bioactive glasses is traditionally carried out on 
immersion of glass in a buffer solution simulating physiological conditions. Formation 
of the apatite-like phase on the surface of the solid as a consequence of the reaction 
with solutions is then evaluated. The earliest immersion time when an apatite-like 
phase can be determined is used as a measure of bioactivity. 
Glass bioactivity in terms of glass degradation and apatite-like phase formation can be 
modified by introducing specific elements, i.e. fluoride and phosphate, into the glass 
composition or changing the concentration of components. 
The rate and capacity of apatite-like phase formation is dependent on the type of 
buffer solutions. SBF and Tris buffer solution are the most commonly used buffer 
solutions. SBF, which was first introduced by Kokubo et al., has an ion concentration 
close to that of human blood plasma, but it is calcium and phosphate saturated [59]. 
Thus, potentially any surface exposed to SBF could favour apatite formation 
regardless whether it is bioactive or not. 
Tris buffer has a neutral pH and is used at an identical physiological temperature, but 
has no additional ions. The Ca2+ and PO43- ions release and apatite formation after 
immersion in Tris can be attributed entirely to the glass compositions. However, when 
glass compositions contain only low phosphate content, no apatite or very slow apatite 
formation is likely to occur in Tris buffer [50]. Thereby, only the bioactivity test for the 
phosphate-rich glasses can be evaluated in Tris. 
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In this chapter we present the results on sodium-free, high phosphate and fluoride 
containing bioactive silicate glasses and the bioactivity results in both SBF and Tris 
buffer solution. 
5.1 Results of the As-Quenched Glasses 
The structure of all the as-quenched glasses (Chapters 5-7) was characterised by 
XRD, FTIR, 31P and 19F MAS-NMR. Glass density presented in Chapters 5-7 and 9 
was determined using Helium Pycnometry. Both glass frits and fine powder were 
evaluated using DSC for glass thermal properties (Chapters 5-7 and 9). The as-
quenched glass frits were optically transparent with the exception of those with a CaF2 
content higher than 9 mol%. 
5.1.1 XRD Results of the As-Quenched Glasses 
Figure 5.1.1 shows the XRD patterns of the as-quenched sodium-free glasses with 
varying amounts of CaF2 (0.0 to 25.5 mol%). The typical amorphous halos at 30° 2θ 
were found in glasses with low CaF2 content (≤ 6.0 mol%); however, a minor peak at 
31.9° 2θ is seen for the 4.5 and 6.0 mol% CaF2 containing glasses. Clear diffraction 
peaks at 25.9°, 31.8°, 32.2° and 33° 2θ are noticed for the higher CaF2 containing 
glasses (≥ 9.3 mol%). These peaks match the characteristic diffraction peaks of apatite 
(FAP: 00-034-0011). A further increase in the CaF2 content up to 17.8 mol% results in 
the crystallisation of cuspidine (Ca4Si2O7F2, 00-011-0075) with major diffraction lines at 
26.5° and 29.1°. Meanwhile, additional lines at 28.3° and 47° 2θ corresponding to 
fluorite (CaF2, 00-004-0864) are also found in the glass with 17.8 or 25.5 mol% CaF2. 
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Figure 5.1.1 The XRD patterns of as-quenched CaF2 containing glasses. (о: Ca10(PO4)6F2; 
*: Ca4Si2O7F2; +: CaF2).  
5.1.2 FTIR Results of the As-Quenched Glasses 
The FTIR spectra of the as-quenched CaF2 containing glasses are given in Figure 
5.1.2. The non-bridging oxygen band at 920 cm-1 and the Si-O-Si stretching band at 
1030 cm-1 are found for the whole glass series. For the low fluoride (≤ 6.0 mol%)  
containing glasses, a small band around 600 cm-1 corresponding to amorphous 
calcium phosphate is noticed, while the typical apatite split bands at 560 and 613 cm-1 
are seen in high CaF2 (≥ 9.3 mol%) containing glasses [9]. The sharp band features in 
the region 800-1050 cm-1 in the spectrum of 25.5 mol% CaF2 containing glass are also 
detected suggesting the presence of a silicate crystalline phase.  
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Figure 5.1.2 The FTIR spectra of as-quenched CaF2 containing glasses.  
5.1.3 31P and 19F NMR Results of the As-Quenched Glasses 
The atomic environment of phosphate and fluoride in the synthesised glasses were 
investigated by 31P and 19F MAS-NMR. The 31P MAS-NMR spectra of CaF2 containing 
bioactive glasses are shown in Figure 5.1.3. The broad peak with a centre at 3 ppm is 
visible in the spectra of glasses with CaF2 contents lower than 9.3 mol%, indicating an 
amorphous calcium orthophosphate environment. An increase of CaF2 content (≥ 9.3 
mol%) resulted in a reduction of the line-width of the peak without altering the peak 
position. This suggests that glasses with CaF2 content at and above 9.3 mol% tend to 
partially crystallise to apatite.  
Figure 5.1.4 shows the 19F MAS-NMR spectra of the glasses. It is clear that three 
different fluorine environments are present. The low CaF2 containing glasses have 
broad peaks centred at about -96 ppm, suggesting an amorphous F-Ca(n) fluoride 
environment, while a tiny and sharp peak at -103 ppm appearing on the shoulder of a 
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broad glass signal in the high CaF2 containing glasses (≥ 9.3 mol% CaF2) is attributed 
to the fluorapatite (F-Ca(3)) environment. Furthermore, a distinctly sharp peak with the 
chemical shift of -108 ppm is visible in the spectrum of 25.5 mol% CaF2 containing 
glass, indicating the crystallisation of CaF2 (F-Ca(4)). The 19F MAS-NMR confirms 
fluorapatite crystallisation in the glasses with CaF2 content at and above 9.3 mol% and 
the crystallisation of CaF2 in the highest CaF2 containing glass (25.5 mol% CaF2). 
These are in accordance with the results of XRD, FTIR and 31P MAS-NMR.  
 
Figure 5.1.3 The 31P MAS-NMR spectra of as-quenched CaF2 containing glasses.  
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Figure 5.1.4 The 19F MAS-NMR spectra of as-quenched CaF2 containing glasses, the 
symmetrical signals labelled by asterisk present spinning side bands.  
5.1.4 Glass Density and Molar Volume 
The density and molar volume of CaF2 containing bioactive glasses are plotted as a 
function of CaF2 content (Figure 5.1.5). It is clear that the density values increase with 
an increase in CaF2 content. At the same time, the glass molar volume increases from 
21.47 to 22.26 cm3/mol with an increase of CaF2 content from 0 to 25.5 mol%.   
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Figure 5.1.5 Glass density and molar volume plotted as a function of CaF2 content. Note 
where error bars are not shown they are smaller than the data points. 
5.1.5 DSC results of the Na free CaF2 Containing Bioactive Glasses 
Figure 5.1.6 shows the DSC traces for glass frits of the sodium-free CaF2 containing 
glasses. The glass transition temperature (Tg), crystallisation peak temperature (Tc) 
and melting temperature (Tm) were defined from the DSC traces with an accuracy of 
±5 °C. The obtained Tg, Tc and Tm are summarised and listed in Table 5.1.1. Some of 
the glasses have more than one exotherm, corresponding to the crystallisation peak 
temperature of the first (Tc1), second (Tc2) and third (Tc3) etc.. The number of 
crystallisation events is not necessarily equal to the number of crystallisation phases. 
Since a crystalline phase might crystallise in more than one step or two crystalline 
phases might crystallise at the same temperature and produce a single exotherm in a 
DSC trace. In addition, there is a clear endotherm peak around 1115 °C in the DSC 
trace for most of the glasses corresponding to the melting effect.  
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Figure 5.1.6 DSC traces for the glass frits of CaF2 containing glasses.  
Table 5.1.1 Characteristic temperatures for fluoride containing glasses. For each glass 
composition, the first row is the characteristic temperature of glass frit and the second 
row is the characteristic temperature of fine powder. 
Glass Code Tg To1 Tc1 Tc2 Tc3 Tm 
GPF 0.0 
786 969 1013 - -  
790 901 925 - - - 
GPF 3.0 
736 837 868 901 968  
735 848 867 888 979 - 
GPF 4.5 
720 844 863 940 994  
722 819 860 - - - 
GPF 6.0 
695 806 821 912 - 1110 
693 790 817 844 942 - 
GPF 9.3 
662 771 780 835 1008 1116 
655 751 780 806 878 1120/1140 
GPF 13.6 
626 725 740 766 - 1120 
618 699 732 758 977 1112 
GPF 17.8 
606 712 724 - - 1120 
601 687 720 - - 1120 
GPF 25.5 
560 596 708 - - 1100/1124 
558 695 713 - - 1124 
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The Tg values of both glass frit and fine powder are plotted as a function of CaF2 
content in Figure 5.1.7. A dramatic reduction in Tg can be seen with an increment of 
CaF2 content. A linear relationship (Y= -13.331X+780.59,R2=0.9871) between Tg and 
CaF2 content is seen in the glasses with CaF2 content no more than 9.3 mol%, while a 
break in the Tg behaviour is found when CaF2 content was more than 9.3 mol% as a 
consequence of crystallisation of fluoride containing phases. As suggested from the 
XRD results of the as-quenched glasses, the glasses crystallise to fluorapatite, 
cuspidine and fluoride sequentially with an increase in CaF2 content above 6.0 mol%, 
thereby, effectively removing fluoride from the glass phase and consequently the 
reduction in Tg becomes smaller with increasing CaF2 content. In addition, glasses with 
different particle sizes have almost identical Tg values, suggesting that Tg is a 
substantial property of the glass and independent of particle sizes. 
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Figure 5.1.7 Glass transition temperature profiled as a function of CaF2 content. A linear 
relationship (Y=-13.331X+780.59, R2=0.9871) between Tg and CaF2 content was shown in 
the glasses with CaF2 content ≤ 9.3 mol%. 
Figure 5.1.8 plots Tc1 for both glass frit and fine powder against CaF2 content. Tc1 
values decrease significantly with an increase in CaF2 content. As shown in Figure 
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5.1.8, apart from the 0.0 mol% CaF2 containing glass, which exhibits a remarkable 
temperature difference between the Tc1 for frit and powder, the rest of CaF2 containing 
glasses show almost identical Tc1 values for different particle sizes.  
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Figure 5.1.8 First crystallization peak temperature (Tc1) for frit and fine powder plotted 
against CaF2 content. 
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5.2 Dissolution Study 
5.2.1 pH Measurement Results 
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Figure 5.2.1 pH measured at the end of the immersion time in Tris buffer. The numbers 
are nominal molar percentage of CaF2 in the compositions. Note where error bars are 
not shown they are smaller than the data point. 
Figure 5.2.1 demonstrates pH changes after immersion the glass powder in Tris buffer 
for different immersion time. The general trend is similar for all the glass compositions. 
The data points are joined with solid lines, which help to illustrate the general trend of 
the data. Solid lines are applied for the same purpose throughout the thesis except for 
where linear trends are discussed. As shown in Figure 5.2.1, for the lower CaF2 
containing glasses (< 9.3 mol%), pH initially increases after 1 hour followed by a nearly 
stable pH between 1 and 6 hours with a further increase by 9 hours. For the glasses 
with CaF2 content higher than 6.0 mol%, the pH typically increases in first 3 hours, 
decreases slightly from 3 to 6 hours and no significant change is found there 
afterwards. The pH became more alkaline after immersion as a consequence of ion 
exchange between protons and Ca2+ ions from glasses. Nevertheless, due to the 
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buffer capacity and the quantity of ions, which are available for ion exchange, pH does 
not increase all the time. Moreover, as major amount of calcium is released and the 
apatite-like phase starts forming, pH values do not increase any longer and may even 
decrease.  
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Figure 5.2.2 The pH rise in the solution after immersion of the glass powder in Tris (pH= 
7.3) for 1h plotted against CaF2 content. 
It is interesting to note that the fluoride-free glass seems to show a more pronounced 
rise in pH after 1 hour immersion compared to the CaF2 containing ones and a less 
significant pH rise is found in a higher CaF2 containing glass (Figure 5.2.2). These are 
consistent with the effects of fluoride incorporated into a bioactive glass to reduce an 
increase in pH on initial dissolution, which was previously seen and discussed [20, 
118].  
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5.2.2 Ion Release Results 
The assessment of glass degradation was performed by measuring the concentration 
of the ions released into the buffer solutions using Inductively Coupled Plasma Optical 
Emission Spectroscopy and F- ion selective electrode. 
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Figure 5.2.3 The concentration of elemental calcium in Tris presented as percentage of 
the total calcium content in the original CaF2 containing glasses as a function of time. 
The concentrations of Ca2+ ion measured after up to 9 hours immersion in Tris buffer 
presented as a percentage of total amounts of calcium in the nominal glass 
compositions are shown in Figure 5.2.3. The general trend is similar for all the glass 
compositions. The calcium concentrations increased to 33-48% after 1 hour; reached 
50-60% after 3 hours; was over 60% at 6 hours and remained nearly the same after 9 
hours. Thus the percentage of Ca cations released increased significantly from 1hour 
to 6 hours indicating continuing glass degradation. 
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Figure 5.2.4 The concentration of phosphate measured after up to 9 hours immersion in 
Tris for CaF2 containing glasses.  
Figure 5.2.4 presents the concentration of phosphate for CaF2 containing glasses in 
Tris up to 9 hours immersion. It is clear that two different trends are found according to 
whether glasses were amorphous or partially crystallised. In the case of amorphous 
glasses (≤ 6.0 mol% CaF2), very low concentrations (less than 3 mg/l) of phosphate in 
solution were detected. In the case of partially crystallised glasses, relatively higher 
concentrations (up to 7.5 mg/l) after 1 hour, followed by a decrease afterwards were 
obtained. This reduction is consistent with the consumption of phosphate for apatite-
like phase formation.   
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Figure 5.2.5 The concentration of silicon measured in Tris buffer in mg/l plotted as a 
function of immersion time.  
Concentrations of silicon in Tris buffer after the immersion of glass powder within 9 
hours for CaF2 containing glasses have similar trends to the release of calcium (Figure 
5.2.5). The silicon concentration measured remained nearly constant after the 
concentration reaches around 90 mg/l in first 3 hours, with a rapid silicon release 
particularly within 1 hour. 
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Figure 5.2.6 The concentration of fluoride measured after immersion glass powder in 
Tris buffer plotted as a percentage of total amounts of fluoride in the glass composition 
against the immersion time. Note where error bars are not shown they are smaller than 
the data point. 
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Figure 5.2.7 The percentage of fluoride concentration measured at 3 and 6 h in Tris for 
CaF2 containing glasses. Note where error bars are not shown they are smaller than the 
data point. 
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The fluoride ion concentrations measured after immersion time in Tris presented as a 
percentage of total amount of fluoride in the nominal glass composition against 
different immersion times are shown in Figure 5.2.6. The trends of fluoride 
concentration in solution for different glass compositions are quite similar. The level of 
fluoride release increases in the first three hours of immersion then decreases at 6 
hours and is almost identical after 9 hours. However, the release of fluoride is not 
identical for all the glass compositions, in the case of amorphous glasses (3.0, 4.5 and 
6.0 mol%), the more fluoride is present in the nominal glass composition, the higher 
percentage of fluoride in the solution is seen. In contrast, for those partially crystallised 
glasses (> 6.0 mol% CaF2), the lower percentage of fluoride in the solution is found in 
higher fluoride containing glasses. 
In Figure 5.2.7, the fluoride concentration measured after 3 and 6 hours of immersion 
in Tris plotted as a percentage of total amounts of fluoride in the glass composition 
against CaF2 content. Apart from the different trends of fluoride ion concentration 
between amorphous glasses and that of partially crystallised one discussed above, we 
can also see a small reduction of fluoride concentrations from 3 hours immersion to 6 
hours, indicating the possibility of a fluoride consumption by forming a fluoride 
containing phase, which is fluorapatite or/ and fluorite. The highest percentage of 
fluoride in solution (over 35% of the nominal fluoride content in the glass) is observed 
for the glass with 9.3 mol% CaF2. However, the lowest percentage of fluoride (about 
10%) is seen for the glass with the highest fluoride content (25.5 mol%), most of the 
fluoride in this original composition is present in the crystalline phases as shown from 
its 19F MAS-NMR spectrum in Figure 5.1.4 and after immersion the soluble fluoride 
was also consumed to form more CaF2 as we can see an increasing intensity of CaF2 
after immersion from XRD patterns (in Appendix, Figure 11.2.1). It is seen that the 
percentage of fluoride released increases with an increase in fluoride content in the 
glass as long as fluoride remains in the amorphous glass. Once a fluoride containing 
phase starts crystallising from the glass, the fluoride concentrations decrease. This 
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suggests that the amorphous fluoride containing glass phase is the primary source of 
the fluoride release, rather than the crystalline phase.  
5.3 Apatite-like Phase Formation in Tris Buffer and SBF Buffer 
Solution 
The apatite-like phase formation on immersion in Tris buffer and SBF buffer solution 
was evaluated using XRD, FTIR and 31P and 19F MAS-NMR. 
5.3.1 X-ray Diffraction Results 
XRD results of three glass compositions (GPF 0.0, GPF 4.5, GPF 17.8) after 
immersion in Tris and SBF were are selected and presented in Figure 5.3.1- Figure 
5.3.6. The as-quenched glasses with 0.0 and 4.5 mol% CaF2 were amorphous, 
whereas the glass with 17.8 mol% CaF2 was largely crystallised. An apatite-like phase 
is expected to be formed after immersing the CaF2 containing bioactive glasses in 
buffer solutions.  
Clear characteristic peaks of apatite are observed at 25.9° and 31.8° 2θ after 3 h 
immersion in Tris and 9 h in SBF (Figure 5.3.1-Figure 5.3.4), indicating apatite-like 
phase formation within 3 h immersion in Tris and 9 h in SBF. The diffraction lines 
intensify with an increase in immersion time to 9 h in Tris and 1 day in SBF. However, 
the intensities increase more rapidly in Tris compared to SBF. A further increase in 
immersion time after 9 h in Tris and 3 days in SBF does not show any significant 
changes in the XRD patterns. Similar results were obtained for other compositions with 
3.0 and 6.0 mol% CaF2. 
The 17.8 mol% CaF2 containing glass, which crystallised to mainly fluorapatite also 
exhibits bioactivity. Compared to the as-quenched glass, the intensity of the apatite 
diffraction lines grows after immersion. Unlike the amorphous glasses (≤ 6.0 mol% 
CaF2), there is no distinct difference in the intensity of the apatite diffraction lines 
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acquired in Tris or SBF for the same immersion time period. Similar results were 
obtained for other compositions with 9.3, 13.6 and 25.5 mol% CaF2.  
Owing to the presence of crystalline FAP in the as-quenched glasses with high CaF2 
content, it is clearly seen that the apatite diffraction lines are significantly broader for 
the glass with low CaF2 content (Figure 5.3.1 - Figure 5.3.4) than the ones for the 
glass compositions with high CaF2 content (Figure 5.3.5 and Figure 5.3.6). It is 
possible that FAP crystals in the initial glasses may serve as nuclei for the apatite-like 
phase formation during immersion. Thus, in this case the newly formed apatite-like 
crystals deposited on the surface of the pre-existing apatite phases. 
In addition, the XRD patterns also suggest that the crystalline phase of cuspidine in the 
as-quenched glass-ceramics (17.8 and 25.5 mol% CaF2) dissolve in the buffer 
solutions, though slower in SBF compared to the Tris solution, as we can see the 
intensity of the diffraction lines for cuspidine disappear after 1 day immersion in Tris 
and 7 days in SBF, whereas, the diffraction lines for CaF2 are still visible on the XRD 
patterns of glasses after 7 day immersion in both of Tris and SBF. 
89 
 
Sodium-Free CaF2 Containing Bioactive Glasses 
 
20 30 40 50 60
°°°°
°
°
°
°
1 h
In
te
ns
ity
 (a
.u
.)
7 d
3 d
1 d
9 h
6 h
3 h
0 h
2θ (°)  
Figure 5.3.1 The XRD patterns of the glass precipitates with 0.0 mol% CaF2 collected 
after immersion in Tris up to 1 week (о: Ca10(PO4)6(OH)2). 
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Figure 5.3.2 The XRD patterns of the glass precipitates with 0.0 mol% CaF2 collected 
after immersion in SBF up to 1 week (о: Ca10(PO4)6(OH)2). 
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Figure 5.3.3 The XRD patterns of the glass precipitates with 4.5 mol% CaF2 collected 
after immersion in Tris up to 1 week (о: Ca10(PO4)6F2). 
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Figure 5.3.4 The XRD patterns of the glass precipitates with 4.5 mol% CaF2 collected 
after immersion in SBF up to 1 week (о: Ca10(PO4)6F2). 
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Figure 5.3.5 The XRD patterns of the glass precipitates with 17.8 mol% CaF2 collected 
after immersion in Tris up to 1 week (о: Ca10(PO4)6F2; *: Ca4Si2O7F2; +: CaF2). 
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Figure 5.3.6 The XRD patterns of the glass precipitates with 17.8 mol% CaF2 collected 
after immersion in SBF up to 1 week (о: Ca10(PO4)6F2; *: Ca4Si2O7F2; +: CaF2). 
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5.3.2 Fourier Transform Infrared Spectroscopy Results. 
Glass degradation and apatite-like phase formation upon immersion of glasses in 
buffer solution were monitored by using FTIR. Figure 5.3.7- Figure 5.3.12 demonstrate 
the FTIR results for the same three compositions that were chosen for the XRD results. 
The spectrum at the bottom of each figure belongs to the as-quenched glass and was 
discussed above. Glass degradation and apatite formation occurred rapidly when the 
glasses were immersed in buffer solutions, which resulted in dramatic changes in the 
FTIR spectra. The intensity of non-bridging oxygen Si-O- band at 920 cm-1 reduces 
after 1 h immersion in both of Tris and SBF and disappears at longer immersion times, 
indicating rapid glass degradation. After immersion, the spectra show sharpening of 
the band at 1035 cm-1, which is assigned to both of Si-O-Si and crystalline 
orthophosphate. The formation of crystalline orthophosphate also leads to a 
development of the shoulder at about 1100 cm-1 [9, 20]. In addition, instead of a broad 
peak at 565 cm-1 the typical apatite split bands develops at 613 cm-1 and 560 cm-1 after 
3 h immersion in Tris and 9 h in SBF. The presence of crystalline apatite is also 
suggested based on another band at about 960 cm−1 in the spectra, which 
corresponds to the P-O stretch in the orthophosphate tetrahedron. Owing to the 
substitution of carbonate in the apatite-like phase, carbonate bands at 1450 cm-1, 1420 
cm-1 and 870 cm-1 are found [119]. The band at 790 cm−1 appearing in the spectra after 
immersion is assigned to Si-O-Si between the two adjacent silicate tetrahedra [20, 
120]. This forms as a result of condensation reactions during glass degradation and 
essentially presents as a silica-gel. The typical apatite bands at 1035, 613 and 560 cm-
1 sharpen and intensify with an increase in immersion period, however, no significant 
difference can be seen in the spectra after 9 h immersion in Tris and 1 day in SBF. 
Similar results are obtained for GPF 3.0 and GPF 6.0.  
The changes in FTIR spectra before and after immersion for glass GPF 17.8 (Figure 
5.3.11 and Figure 5.3.12) are similar to the one observed for GPF 0.0 or GPF 4.5. The 
spectrum of the untreated glass reveals the presence of crystalline apatite in addition 
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to the Si-O vibration bands. Upon immersion, the decrease of intensity for non-bridging 
oxygen Si-O- band at 920 cm-1 and the sharpening of crystalline apatite bands were 
noticed due to glass degradation and further apatite-like phase formation. These 
changes are identical for other high CaF2 containing glasses (9.3, 13.6 and 25.5 mol%) 
after immersion in buffer solution. However, the sharpening of the bands for glasses 
GPF 9.3 and GPF 13.6 occur at earlier time points after immersion in Tris than SBF, 
while no significant difference was seen for GPF 17.8 and GPF 25.5 in Tris and SBF. 
FTIR spectroscopy characterises both amorphous and crystalline species presenting 
in solids, unlike XRD, which generally reveals changes in the crystalline domains of a 
solid only. The wavenumber of FTIR band wavenumber values with the assignments 
for glass and apatite is summarised in Table 5.3.1. The presented FTIR results indicate 
that glass dissolution may occur faster in Tris buffer than in SBF for amorphous and 
partially crystallised bioactive silicate glasses. 
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Figure 5.3.7 The FTIR spectra of the glass precipitates with 0.0 mol% CaF2 collected after 
immersion in Tris up to 1 week 
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Figure 5.3.8 The FTIR spectra of the glass precipitates with 0.0 mol% CaF2 collected after 
immersion in SBF up to 1 week 
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Figure 5.3.9 The FTIR spectra of the glass precipitates with 4.5 mol% CaF2 collected after 
immersion in Tris up to 1 week 
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Figure 5.3.10 The FTIR spectra of the glass precipitates with 4.5 mol% CaF2 collected 
after immersion in SBF up to 1 week 
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Figure 5.3.11 The FTIR spectra of the glass precipitates with 17.8 mol% CaF2 collected 
after immersion in Tris up to 1 week 
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Figure 5.3.12 The FTIR spectra of the glass precipitates with 17.8 mol% CaF2 collected 
after immersion in SBF up to 1 week 
Table 5.3.1 The FTIR band wavenumber values with the assignments for glasses 
 
 
 
 
5.3.3 NMR Results of CaF2 Series Glasses 
31P and 19F MAS-NMR were employed to investigate the atomic environments of 
phosphate and fluoride in the collected precipitates and confirm the formation of an 
apatite-like phase on immersion. 
The 31P MAS-NMR spectra of glass GPF 4.5 before and after immersion in Tris and 
SBF are presented in Figure 5.3.13 and Figure 5.3.14. The spectra all show a single 
 Wavenumber / cm-1 Band 
Amorphous glass 1028/ 1030 Si-O-Si 
920 Si-O(NBO) 
565 P-O 
Apatite 613 and 560 P-O 
960/ 1035 and 1100 P-O(s) 
870 and 1420,1450 β type C-O 
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peak with a centre at 3.0 ppm, assigned to calcium orthophosphate. Prior to 
immersion, the peak is relatively broad, suggesting an amorphous orthophosphate 
environment. After 3 hours immersion in Tris, the line-width of the spectra reduces and 
further decreases with immersion time, but no changes in the chemical shifts are 
observed. This implies that amorphous orthophosphate converts to apatite (crystalline 
orthophosphate) on immersion and apatite-like phase forms within 3 hours of 
immersion in Tris. Only a small decrease in the line-width of spectra is found after 
immersion in SBF. The spectra for the rest of the glasses in this series show similar 
evolution. 
 
Figure 5.3.13 The 31P MAS-NMR spectra of the glass precipitates with 4.5 mol% CaF2 
collected after immersion in Tris. The bottom spectrum is for the untreated glass powder. 
The numbers are immersion times. 
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Figure 5.3.14 The 31P MAS-NMR spectra of the glass precipitates with 4.5 mol% CaF2 
collected after immersion in SBF. The bottom spectrum is for the untreated glass 
powder. The numbers are immersion times 
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Figure 5.3.15 FWHM for 31P MAS-NMR spectra plotted against immersion time, (a) for 
GPF 4.5; (b) for GPF 13.6. The estimated errors (10 Hz) are smaller than the data points. 
The full width half maximum (FWHM) of 31P MAS-NMR spectra for 4.5 (amorphous) 
and 13.6 (crystallised) mol% CaF2 containing glasses on immersion in Tris and SBF 
were estimated by using Bruker Top-Spin software and plotted as a function of 
immersion time (Figure 5.3.15 (a) and (b)). The statistically significant difference of the 
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results between different groups was carried by Student’s t-test. P value less than 0.05 
was considered to be significant. The obtained P values were summarized in Table 
11.2.2 (in Appendix). In general, the changes of FWHM before and after immersion for 
both glasses in SBF are smaller compared to the changes of the line-width in Tris. In 
addition, the line-width of the signal for the initially amorphous glass is wider than the 
partially crystallised one; therefore, the changes of line-width for amorphous glasses 
were more distinct than the partially crystallised glasses. As described previously, the 
FWHM of GPF 4.5 in Tris decreases with an increase of immersion time up to 9 hours, 
while the reduction of FWHM for GPF 13.6 mainly occurs within 6 hours immersion in 
Tris. An increase of FWHM is seen after up to 6 hours immersion in SBF. After 6 hours 
immersion the FWHM for GPF 13.6 remains nearly constant in both Tris and SBF. The 
increase of FWHM for the crystallised glass in SBF might be contributed to by forming 
a more disordered fluorapatite by the possibility of the presence of CO32- in the apatite 
lattice after immersion compared with the fluorapatite crystallised during quenching. 
 
Figure 5.3.16 The 19F MAS-NMR spectra of the glass precipitate with 4.5 mol% CaF2 
collected after immersion in Tris, the signals symmetrically situated on both sides of the 
main signal and labelled by asterisk present side bands. 
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Figure 5.3.16 presents the 19F MAS-NMR spectra of glass GPF 4.5 immersed in Tris 
up to 6 hours compared to the as-quenched glass. The symmetrical signals labelled by 
asterisks are side bands. The broad peak at -96 ppm in the spectrum of the as-
quenched glass was shown and discussed above. After 3 hours immersion, the line-
width of 19F NMR peak decreases, in agreement with the 31P MAS-NMR results and 
the peak shifts towards -103 ppm. A sharp feature at about -103 ppm which is found by 
6 hours immersion is attributed to the F-Ca(3) fluorapatite environment [4].  
Further Discussion 
The incorporation of fluoride leads to a significant reduction of the glass transition 
temperature and crystallisation temperature. These effects can both be associated 
with fluoride complexing calcium [4]. In the fluoride-free glass (GPF 0.0), divalent 
calcium ions bind together silicate anions by electrostatic forces and the calcium ions 
can effectively ionically bridge two non-bridging oxygens (NBOs), therefore it is less 
disruptive to the glass work compared to two sodium ions [10, 79]. Thus, the sodium-
free glass has relatively high Tg and Tc. When CaF2 is introduced, hypothetical ‘CaF+’ 
species, which acts like a Na+ cation forms and thus the electrostatic forces between 
NBOs reduces considerably, resulting in a decrease in Tg and Tc  [4, 121]. The effect of 
CaF2 on Tg is less pronounced at high fluoride contents as shown by the break in Tg 
dependence in Figure 5.1.7. This could be ascribed to the crystallisation of fluoride 
containing phases, which are FAP, Ca4Si2O7F2 and CaF2 during quenching. 
The XRD patterns, FTIR spectra and NMR spectra of the as-quenched glasses 
consistently indicate an increasing crystallisation tendency of the glasses with 
increasing CaF2 content, where fluorapatite, cuspidine and fluorite crystallised 
successively.  
The single peak with chemical shift around 3 ppm in the 31P MAS-NMR spectra 
suggests that in the studied sodium-free fluoride containing bioactive glasses 
phosphorus is present as an orthophosphate charge balanced with Ca2+ [20, 122]. 19F 
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MAS-NMR spectra confirm the presence of amorphous F-Ca(n) species in low CaF2 
containing glasses, spontaneous crystallisation of FAP (F-Ca(3)) in the high CaF2 (≥ 
9.3 mol%) containing glasses and a clear crystallisation of CaF2 with a F-Ca(4) 
environment for the glass with 25.5 mol% CaF2 on quenching. 
The presence of CaF2 in the glasses has an opposite effect on the density compared 
to its effect on Tg and Tc. As shown in the Figure 5.1.5, the introduction of CaF2 leads 
to an increase in glass density. Since CaF2 was added into the glass composition 
rather than being substituted for CaO, the resultant glasses have constant network 
connectivity. In addition, the 19F MAS-NMR spectra suggest that fluorine forms F-Ca(n) 
species in the glasses instead of forming Si-F bonds. Therefore, the density of glass is 
likely to consist of a combination of the densities of both silicate glass and CaF2-like 
phase, as presented in the paper by Brauer et al. [123]. In all designed glasses, the 
proportion of each component in the silicate glass matrix is the same as GPF 0.0 and 
thus the density of silicate glass part is same. However, the density of CaF2-like 
species is greater than the glass matrix (3.13 cf 2.94 g/cm3). With an increase in CaF2 
content, the proportion of silicate part decreases and therefore results in a reduction of 
glass density.  
The presence of significant amount of sodium oxide in the first discovered bioactive 
glass, 45S5 composition, 46.1SiO2-2.6P2O5-26.9CaO-24.4Na2O (mol%), suggests that 
sodium cations to play an essential role in mechanism of bioactivity. However, the 
results of FTIR, XRD and 31P MAS-NMR experiments performed on the collected 
precipitates after the immersion of sodium-free glass powders in buffer solutions, along 
with the pronounced pH rise and early release of calcium, fluoride and silicon into Tris 
and SBF upon immersion, all consistently show that excellent bioactivity can be 
achieved in the glass compositions without the presence of sodium. In the case of the 
initially amorphous glasses containing relatively low fluoride (≤ 6.0 mol%), rapid glass 
degradation was clearly observed after 1 hour immersion and fast apatite-like phase 
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formation was found within 3 hours immersion in Tris and 9 hours in SBF. In the case 
of high fluoride (≥ 9.3 mol%) containing glasses, which are partially crystallised to an 
apatite-like phase during quenching, rapid glass degradation was also found after 1 
hour immersion and an increased quantity of apatite occurred after 3 hours immersion 
in both of Tris and SBF. The rates of apatite formation are much higher than it is 
possible to achieve for the 45S5 glass composition, the latter contains large amount of 
sodium oxide and less than half amount of P2O5 than the glasses studied here and 
requires at least 24 hours of immersion under similar conditions for an apatite-like 
phase to form [50]. This result also illustrates that enhanced bioactivity can be 
achieved by having a higher phosphate content in the glass composition, as 
suggested by the earlier finding of Mneimne et al. [9] and by Eden [49]. 
The enhanced bioactivity of sodium-free glasses demonstrated here questions the 
initial steps of the accepted Hench mechanism of bioactivity.  The mechanism of glass 
bioactivity involves two processes, the glass degradation and apatite formation. The 
role of sodium cations appeared to be essential in the classical mechanism, especially 
for the glass degradation part. The first step in the widely accepted Hench mechanism 
of bioactivity assumes an ion exchange between sodium cations from the glass and 
protons from solution, which then enables the next step, the alkaline hydrolysis of the 
Si-O-Si linkages with the formation of the silanol Si-OH groups at the interface 
between glass and solution. 
In contrast, the results obtained here validate the view that these glasses are so 
sufficiently disrupted that it is not necessary for the Si-O-Si hydrolysis to occur [43]. 
The low level of polymerization or low network connectivity for this type of glasses 
controls the rate of glass degradation, rather than an ion exchange of the highly mobile 
alkali cations following by hydrolysis of Si-O-Si linkages. Thus, sodium is not 
necessarily an essential component of a bioactive glass. 
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For the dissolution studies in Tris buffer, due to the absence of ionic species in Tris 
buffer, the phosphate required for apatite formation originates entirely from the glass. 
Therefore, a high content of phosphate present as orthophosphate in the glass is 
beneficial for early apatite formation. The rapid glass degradation can be mirrored by 
the ionic concentration in the buffer solution. Interestingly, the phosphorus 
concentration measured after the immersion of glass powder into Tris buffer was low 
although an apatite-like phase formation was noticed at early immersion time. This 
indicates that phosphate might release at even earlier time points (< 1 hour) or in 
these sodium-free glasses the phosphate does not necessarily dissolve into the 
solution, prior to the precipitation of an apatite-like phase. The apatite formation could 
be achieved as consequence of phosphate re-arrangement in the glass without 
phosphate dissolution.  
Experimental results suggest that apatite formation readily occurred within 3 hours of 
immersion in Tris buffer and 9 hours in SBF for all the studied glasses regardless of 
whether the glass was amorphous or partially crystalline. Moreover, the FTIR and 31P 
MAS-NMR spectra, as well as XRD patterns were practically identical after 6 and 9 
hours of immersion in Tris for the same sodium-free compositions, which suggests that 
reaction has been completed by 6 hours in Tris. This is also consistent with nearly 
constant concentration of silicon, calcium and fluoride ions measured in solution 
between 6 and 9 hours. 
It is well known that a crystalline solid has a lower dissolution rate than the equivalent 
amorphous phase [124]. Therefore the crystalline ceramics are expected to exhibit a 
lower bioactivity than an amorphous glass. However, the studied glasses with CaF2 
content over 6.0 mol% that have partially crystallised to mainly FAP exhibit excellent 
bioactivity comparable to the amorphous glasses (≤ 6.0 mol% CaF2).  This is attributed 
to the fact that the existing FAP crystals reduce the activation energy required for 
forming apatite nuclei and serve as a seeding phase for further apatite crystal growth. 
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FAP is attractive in medical and dental applications, owing to its higher stability in 
acidic environment compared to hydroxyapatite. 19F MAS-NMR was used to obtain 
evidence for the formation of fluorapatite upon immersion of these fluoride containing 
bioactive glasses. By comparison with the 3 hours apatite formation from the XRD, 
FTIR and 31P NMR results, 19F NMR results show clear fluorapatite formation after 6 
hours for the amorphous glasses (GPF 3.0, GPF 4.5 and GPF 6.0), which is consistent 
with the decrease in fluoride concentration in solution between 3 and 6 hours (Figure 
5.2.7), suggesting the consumption of fluoride for fluorapatite formation before 6 hours. 
These results suggest that an apatite-like phase formed after 3 hours does not 
necessarily contain a significant amount of fluoride in the apatite. It is probably exist as 
a hydroxyapatite in a big scale. A mixed hydroxy-fluorapatite is likely to exist between 3 
and 6 hours immersion.  
By comparison, the glass degradation and apatite formation rate are lower in SBF than 
Tris. This can be attributed to a higher ionic strength and lower ionic diffusion of the 
SBF solution, which suppresses the dissolution of ionic species and thus delays the 
glass dissolution [125]. However, it is more likely the presence of Mg2+ in SBF inhibits 
the apatite-like phase formation [22, 57]. Therefore, the direct comparison of the 
results in Tris buffer with the results in SBF buffer is not strictly comparable [126].  
Summary 
The sodium-free, high phosphate bioactive silicate glasses with different CaF2 content 
have been synthesised. The crystallisation tendency of the glasses increases with 
increasing CaF2 content. Glasses with CaF2 contents less than 9.3 mol% are 
amorphous while the glasses with fluoride content above 6.0 mol% are partially 
crystallised. The presence of fluoride effectively reduces the glass transition 
temperature and crystallisation temperature, while increasing glass density. The 
amorphous glasses degrade rapidly and form an apatite-like phase within 3 hours 
(clear fluorapatite formation at 6 hours) in Tris and 9 hours in SBF. The partially 
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crystalline glasses show amorphous phase degradation and an increase in fraction of 
apatite-like phase by 3-6 hours in Tris and SBF. Therefore, sodium is not an essential 
component for enhanced bioactivity of glasses. 
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6 Sodium-Free CaCl2 Containing Bioactive 
Glasses 
Foreword 
In addition to the benefits of fluoride for biomineralisation and formation of FAP 
discussed in the previous chapter, adding fluoride into a silicate glass typically reduces 
the glass melting temperature, glass transition temperature and potentially reduces the 
glass hardness [6, 27].  
However, high fluoride content in bioactive glasses resulted in the uncontrolled 
crystallisation of calcium fluoride, rather than FAP on quenching. A fluoride content in 
the toothpaste for children is strictly controlled as high fluoride concentration might 
cause dental fluorosis [127]. The regulatory authorities set a restriction on the fluoride 
content of toothpastes for adults at 1500 ppm in Europe and 1200 ppm in the US. 
Therefore, an alternative component to fluoride in bioactive glass that behaves in a 
way similar to fluoride with regards to glass structure, bioactivity and other properties, 
e.g., reducing Tg and potentially reducing the hardness and abrasivity of the glass, is 
highly desirable. 
Chlorine belongs to the same halogen group as fluorine. It is likely to behave like 
fluorine within glass structure and might have similar effects on the glass properties. 
The chloride ion is substantially larger than the fluoride ion (1.67 Å vs 1.19 Å) and on 
incorporation into a glass, the large chloride ion might expand the glass volume 
resulting in a more open and less compact glass structure. This could contribute to 
forming softer and less abrasive chloride containing bioactive glasses that might also 
dissolve faster and form apatite more rapidly. Moreover, chloride containing glasses 
are expected to be less likely to crystallise compared to the equivalent fluoride glasses. 
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A more open glass structure is less likely to transform into a crystalline lattice around 
the bigger chloride compared to the more compact structure around the smaller 
fluoride ion.  
It is important to note that chloride is naturally present in the human body with 
relatively high concentrations and is biologically acceptable [128, 129]. Approximately 
81.7 g chloride is present in a normal adult human body and the normal serum 
chloride concentrations range from 96 to 106 mEq/l, i.e. 3.408-3.763 g/l. Although, it 
has been reported that sodium chloride at concentrations above 2.5 g/l produces 
hypertension, this effect is thought to be related to the excess sodium concentration 
rather than chloride [129].  The toxicity of chloride salts is believed to depend on the 
cation present; that of chloride itself is unknown. In addition, chlorides (strontium 
chloride and potassium chloride) have widely been incorporated into toothpaste for 
treating dentine hypersensitivity. There is no restriction on the chloride content in 
toothpastes unlike with fluoride [130].  
However, the incorporation of chloride into silicate glasses is fraught with the issues of 
chloride volatilisation during synthesis, resulting in most of the chlorine being lost [87]. 
Although the same problem might exist with incorporating fluoride, it is not as severe. 
As shown in the paper by Brauer et al., fluoride can be retained readily in silicate 
glasses, though 5-23 % fluoride can be lost as HF during melting [118]. Losses of 
chloride during melting of silicate glasses are known to be much higher and can reach 
up to 95% [87]. Chloride is known as a refining agent in silicate glass industry, due to 
its rigorous volatilisation, it reduces the amount of bubbles as it evaporates from the 
silicate melt and thus improves technical quality of a glass. As a consequence the 
incorporation of chloride in silicate glasses has rarely been investigated compared to 
fluoride. The limited number of oxychloride glasses that have been studied in the 
literature have chloride contents typically less than 2 mol% [85].  
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In this chapter, we investigate chloride as an alternative for fluoride in sodium-free Q2 
silicate bioactive glasses based on the SiO2-P2O5-CaO-CaCl2 system. Kiprianov et al. 
[87] proposed that chlorine is likely to volatise as NaCl when the glass contains sodium 
oxide. Hence, the absence of sodium should effectively minimise chlorine volatilization 
during melting. The bioactivity of these glasses was determined in Tris and SBF buffer 
solution.  
6.1 Results of the As-Quenched Glasses  
All the as-quenched sodium-free chloride containing (0-16.7 mol% CaCl2) glasses 
gave optically transparent glass frits.  
6.1.1 Compositional Analysis 
The percentages of the retained chloride in the initial glasses after volatilization are 
plotted against the as-designed chloride content (Figure 6.1.1). A large fraction (73-
87%) of chloride was retained in the glasses. This suggests that up to 16.7 mol% 
CaCl2 has been successfully incorporated into these phosphosilicate glasses.  
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Figure 6.1.1 The percentage of the retained chloride in the initial glasses plotted against 
the as-designed chloride content. 
Table 6.1.1 Glass compositions in mol%. For each glass, the first row is the nominal 
composition as-designed and the second row is composition re-calculated based on the 
chloride component analysis. 
Glass code SiO2 CaO P2O5 CaCl2 
GPCl 0.0 38.1 55.5 6.3 0.0 
38.1 55.5 6.3 0.0 
GPCl 2.3 37.3 54.3 6.2 2.3 
37.5 54.6 6.2 1.7 
GPCl 3.5 36.8 53.6 6.1 3.5 
37.2 54.1 6.2 2.5 
GPCl 4.6 36.4 53.0 6.0 4.6 
36.7 53.4 6.1 3.9 
GPCl 7.2 35.4 51.6 5.9 7.2 
35.7 52.0 5.9 6.3 
GPCl 10.6 34.1 49.6 5.7 10.6 
34.7 50.5 5.8 9.0 
GPCl 14.0 32.8 47.7 5.4 14.0 
33.6 48.9 5.6 11.9 
GPCl 20.6 30.3 44.1 5.0 20.6 
31.8 46.3 5.3 16.7 
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6.1.2 XRD Results of the As-Quenched Glasses 
The XRD patterns of the as-quenched CaCl2 containing glasses are shown in Figure 
6.1.2. The typical amorphous halos at 30° 2θ were found in all the glasses. However, 
there are some evidences of diffraction lines corresponding to apatite, which is likely to 
be hydroxy-chlorapatite. This detected apatite is likely to arise through reaction of the 
fine glass powder with moisture at the surface during the data collection.  
6.1.3 FTIR Results of the As-Quenched Glasses 
The FTIR spectra of the as-quenched CaCl2 containing glasses are given in Figure 
6.1.3. The non-bridging oxygen band (920 cm-1), the Si-O-Si stretching band (1030 cm-
1) and the amorphous calcium phosphate band (600 cm-1) appeared in the spectra. 
There is no clear evidence of crystalline apatite in the as-quenched glasses from the 
spectra.  
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Figure 6.1.2 The XRD patterns of as-quenched CaCl2 containing glasses 
(#:Ca10(PO4)6(OH/Cl)2). 
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Figure  6.1.3 The FTIR spectra of as-quenched CaCl2 containing glasses.  
6.1.4 31P NMR Results of the As-Quenched Glasses 
The 31P MAS-NMR spectra of CaCl2 containing bioactive glasses (Figure 6.1.4) show a 
single broad peak with a centre around 2-3 ppm, indicating that most of the 
phosphorus is present as orthophosphate charge balanced by Ca2+ cations [20]. In the 
series, the chemical shift moves from 3 ppm to 2 ppm with increasing CaCl2 content. 
This slight shift of the peak position is probably the consequence of the shielding effect 
by the presence of chlorine, which has a high electron density. Furthermore, there is 
no clear evidence of crystalline apatite in the as-quenched glasses.  
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Figure 6.1.4 The 31P MAS-NMR spectra of as-quenched CaCl2 containing glasses.  
6.1.5 29Si NMR Results of the As-Quenched Glasses 
The 29Si MAS-NMR spectra of the 2.3 and 20.6 mol% CaCl2 containing glasses are 
shown in Figure 6.1.5. Although the signal-to-noise of the spectra is relatively low it is 
possible to distinguish an asymmetric broad peak with the centre at around -80 ppm. 
This peak position corresponds to the Q2 silicate glass structure. 
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Figure 6.1.5 29Si MAS-NMR spectra of the as-quenched GPCl 2.3 and GPCl 20.6. The 
symmetrical signals labelled by asterisk represent spinning side bands. 
6.1.6 Glass Density  
The density and molar volume of CaCl2 containing bioactive glasses are plotted as a 
function of the CaCl2 content (Figure 6.1.6). It is clear that the density values decrease 
linearly (Y= - 0.0069X+2.9391, R2=0.9792) with an increase in CaCl2 content, while the 
molar volume increases linearly (Y=0.223X+21.423, R2=0.999) with increasing CaCl2 
content. This indicates that the incorporation of chloride leads to an expansion of glass 
volume, to some extent, diluting the glass network. 
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Figure 6.1.6 Glass density and molar volume profiled as a function of CaCl2 content. 
6.1.7 DSC Results of the Na free CaCl2 Containing Bioactive Glasses 
In Figure 6.1.7, the DSC traces for glass frits of sodium-free CaCl2 containing glasses 
are similar to the equivalent CaF2 containing glasses, the latter have been 
demonstrated and discussed in Chapter 5. In general, the first crystallisation peaks of 
chloride containing glasses are very sharp, while the second crystallisation peaks are 
relatively broad. The small endotherm peaks occur at about 1050°C when the chloride 
content is at and above 6.3 mol% that should correspond to a melting event. The 
recorded Tg, To1, Tc and Tm from DSC traces are summarised and presented in Table 
6.1.2.  
The glass transition temperature (Tg) of frit is plotted as a function of CaCl2 content in 
Figure 6.1.8. Tg values reduce with increasing CaCl2 content. A linear relationship (Y=-
12.505X+786.27, R2=0.989) between Tg and CaCl2 content is seen in the glasses with 
CaCl2 content up to 11.9 mol%, while the Tg of GPCl 20.6 is clearly off the trend. This 
suggests that CaCl2 percentage losses during glass melting in glasses with CaCl2 
content no more than 11.9 mol% are small and nearly identical.  
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Figure 6.1.7 DSC traces for the glass frits of CaCl2 containing glasses.  
Table 6.1.2 Characteristic temperatures for chloride containing glasses. For each glass 
composition, the first row is the characteristic temperatures of glass frit and the second 
row is the characteristic temperatures of fine powder. 
Glass Code Tg To1 Tc1 Tc2 Tc3 Tm 
GPCl 0.0 
786 969 1013 - -  
790 901 925 - - - 
GPCl 2.3 
765 882 903 1105 -  
765 886 891 952 987 - 
GPCl 3.5 
753 862 880 985 - - 
748 843 861 989 - - 
GPCl 4.6 
737 841 855 947 -  
726 826 846 903 - - 
GPCl 7.2 
699 800 811 917 955 1052 
701 792 803 855 - - 
GPCl 10.6 
671 763 775 874 - 1056 
670 762.5 775 825 -  1061 
GPCl 14.0 
645 731 740 760 850 1055 
639 731 741 793 - 890/1050 
GPCl 20.6 
601 695 706 780 860 892/1055 
600 688 704 805 857/880 900/1045 
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Figure 6.1.8 Glass transition temperature profiled as a function of CaCl2 content. 
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Figure 6.1.9 First peak crystallization temperature (Tc1) for frit and fine particles plotted 
against CaCl2 content. 
Tc1 for both of glass frit and fine powder are plotted against the CaCl2 content in Figure 
6.1.9. It is clear that Tc1 values decrease dramatically with an increase in CaCl2 
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content. With the introduction of 9 mol% CaCl2, Tc1 for different particle size are 
identical. 
6.2 Dissolution Study 
6.2.1 pH Measurements Results 
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Figure 6.2.1 pH values measured at the end of the immersion time in Tris buffer.  
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Figure 6.2.2 The measured pH values of the solution after immersion of the glass powder 
in Tris for 3h and 24h plotted against CaCl2 content. 
The pH values measured after immersion the glass powder in Tris buffer are plotted 
against immersion time (Figure 6.2.1). The general trend is similar for all the glass 
compositions. The pH values increase in the first 3 hours and decrease afterwards. 
There is no significant change after 6 hours. The increase in pH is ascribed to the ion 
exchange between Ca2+ in the glasses with protons in solution. The consumption of 
OH- for apatite-like phase formation leads to a reduction of pH.  
Figure 6.2.2 shows the pH values measured after 3 and 24 hours immersion in Tris 
buffer for each glass. Two trends of pH values after 3 and 24 hours immersion are 
distinct. After 3 hours immersion, an increase in pH is seen with increasing CaCl2 
content, while a reduction in pH is visible after 24 hours immersion. Overall, a 
reduction of pH from 3 hours to 24 hours is found and the change is more pronounced 
for the glasses with higher CaCl2 content. 
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6.2.2 Ion Release Results 
The glass degradation was mainly estimated by measuring the level of ions released 
into the buffer solutions using Inductively Coupled Plasma - Optical Emission 
Spectroscopy (ICP-OES). 
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Figure 6.2.3 The concentration of elemental calcium in Tris presented as percentage of 
the total calcium content in the glass composition plotted against the CaCl2 content. 
The concentrations of calcium measured after up to 9 hours immersion in Tris were 
plotted as a percentage of total amount of calcium in the nominal glass compositions 
against the CaCl2 content (Figure 6.2.3). The percentage of Ca2+ found in solution 
increases dramatically with an increase in CaCl2 content after each respective 
immersion time period. For the individual glasses, the percentage of Ca2+ also 
increases with immersion time from 3 to 6 hours.  Only slight increase in the 
percentage of Ca2+ concentration is seen from 6 to 9 hours. These consistently 
suggest that glass degradation and apatite formation mainly occurred before 9 hours 
immersion. As we can see, up to 83% of Ca2+ is detected in the solution after 6 hours 
immersion in Tris for the glass with 16.7 mol% CaCl2. This increasing percentage of Ca 
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release with an increase in CaCl2 content is ascribed to the expansion of glass volume 
by the presence of the large chloride ion.  
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Figure 6.2.4 The concentration of phosphate measured after up to 9 hours immersion in 
Tris for CaCl2 containing glasses.  
In general, the trends of the evolution for phosphate concentration measured in 
solution with increasing immersion time are similar for all the glasses and shown in 
Figure 6.2.4. A relatively low phosphate concentration (< 9 mg/l) is observed for all the 
glasses. In addition, the concentration of phosphate for each glass mainly increases in 
the first 3 hours and decreases afterwards. These indicate that large amounts of 
phosphate were likely consumed or converted to a crystalline phosphate in the first 3 
hours and a further consumption of phosphate for apatite-like phase formation was 
carried on with immersion time. 
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Figure 6.2.5 The concentration of silicon measured in Tris buffer in mg/l plotted as a 
function of immersion time. The numbers are nominal molar percentage of CaCl2 in the 
compositions. 
The silicon concentration (mg/l) measured in Tris buffer after up to 9 hours immersion 
plotted as a function of immerision time is shown in Figure 6.2.5. It is seen that the 
concentration of Si increases up to 60-70 mg/l in the first 6 hours immersion, with no 
distinct change after further immersion. There is no substantial difference in the 
measured silicon concentration among different glass compositions.   
6.3 Apatite-like Phase Formation in Tris Buffer and SBF Buffer 
Solution 
The apatite-like phase formation on immersion in Tris buffer and SBF buffer solution 
for the CaCl2 containing bioactive glasses was evaluated by using XRD, FTIR and 31P 
MAS-NMR. 
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6.3.1 X-ray Diffraction Results 
Similar evolution of the XRD patterns before and after immersion in Tris and SBF for 
each glass is seen. The XRD patterns of the bioactive glass with 3.9 mol% CaCl2 
content (GPCl 4.6) on immersion up to 24 hours in Tris and SBF are selected as an 
example and presented in Figure 6.3.1 and Figure 6.3.2. As mentioned previously, the 
as-quenched glass shows a broad amorphous halo centred at 30° 2θ. After 3 hours 
immersion in Tris and SBF, the amorphous halo broadened out and the diffraction lines 
corresponding to the typical apatite diffraction lines developed at 25.9° and 32° 2θ. 
The developed peaks intensified with immersion time up to 9 hours in Tris and 1 day in 
SBF. Interestingly, after 6 hours immersion in Tris and 1 day in SBF, the intensity of 
three main diffraction lines between 30-33° 2θ changed and the middle diffraction line 
at (32.2° 2θ) became predominant. After 24 hours in Tris, the peak at 25.9° 2θ slightly 
narrowed down, suggesting the growth of apatite crystals.  
Moreover, the XRD patterns of the collected precipitates after 3 hours immersion in 
Tris are summarised in Figure 6.3.3. It is clear seen that the XRD patterns for all the 
samples have diffraction lines at 25.9°, 31.5° 32.2° and 32.6° 2θ, which are identical to 
the major diffraction lines of apatite. The intensities of the diffraction lines increased 
with an increase in CaCl2 content, particularly, in the glasses with CaCl2 content lower 
than 9.0 mol%. However, the diffraction peaks are relatively broad, rather than sharp, 
suggesting the formed apatite crystals are quite small.  
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Figure 6.3.1 The XRD patterns of the glass precipitates with 3.9 mol% CaCl2 collected 
after immersion in Tris up to 1 day. The numbers are immersion time (Ap: apatite).  
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Figure 6.3.2 The XRD patterns of the glass precipitates with 3.9 mol% CaCl2 collected 
after immersion in SBF up to 1 day. The numbers are immersion time (Ap: apatite). 
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Figure 6.3.3 The XRD patterns of the glass precipitates collected after 3 hours immersion 
in Tris. 
6.3.2 Fourier Transform Infrared Spectroscopy Results. 
Glass degradation and apatite-like phase formation upon immersion of glasses in 
buffer solution were monitored by using FTIR. Figure 6.3.4 and Figure 6.3.5 
demonstrate the FTIR spectra for the 3.9 mol% CaCl2 containing glass before and 
after immersion in Tris and SBF up to 24 hours. The spectrum of the as-quenched 
glass shown at the bottom was discussed above. After 3 hours immersion in Tris, the 
considerable changes of the spectra are observed, including the elimination of non-
bridging oxygen bands at 920 and 850 cm-1, the sharpening of crystalline calcium 
orthophosphate band at 1030 cm-1, the appearance of typical apatite split peaks at 560 
and 613 cm-1 and the development of carbonate bands at 1420, 1450 and 870 cm-1. 
Similar evolution of FTIR spectra for the collected precipitates of other CaCl2 
containing glasses after 3 hours immersion were found and demonstrated in Figure 
6.3.6. On a further increase in immersion up to 9 hours in Tris, the typical apatite 
bands at 1030, 613 and 560 cm-1 sharpened and intensified, however, no significant 
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difference can be seen in the spectra after that. The FTIR spectra also changed after 
immersion in SBF. The non-bridging oxygen bands at 920 and 850 cm-1 were largely 
lost after 3 hours. The apatite split peaks started to appear after 9 hours immersion 
and sharpened with immersion time. Clear apatite bands at 1030, 613 and 560 cm-1 
were seen after 1 day immersion. 
1600 1400 1200 1000 800 600
92
0 
-
10
28
 -
- 5
60
- 6
13
- 7
90
- 8
70
-1
45
0
-1
42
0
-1
03
0
1 d
9 h
6 h
3 h
0 h
Ab
so
rb
an
ce
 (a
.u
.)
Wavenumber (cm-1)  
Figure 6.3.4 The FTIR spectra of the glass precipitates with 3.9 mol% CaCl2 collected 
after immersion in Tris up to 1 day. 
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Figure 6.3.5 The FTIR spectra of the glass precipitates with 3.9 mol% CaCl2 collected 
after immersion in SBF up to 1 day 
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Figure 6.3.6 The FTIR spectra of the glass precipitates collected after 3 hours immersion 
in Tris. 
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6.3.3 NMR Results of CaCl2 Series Glasses 
The apatite-like phase formation on immersion was investigated by using 31P MAS-
NMR. The FWHM values were estimated from Bruker Top-Spin software. The 
estimated errors are about 10 Hz.  
 
Figure 6.3.7 The 31P MAS-NMR spectra of the glass precipitates with 3.9 mol% CaCl2 
collected after immersion in Tris. The bottom spectrum is for the untreated glass powder. 
The numbers are immersion times. 
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Figure 6.3.8 The 31P MAS-NMR spectra of the glass precipitates with 16.7 mol% CaCl2 
collected after immersion in Tris. The bottom spectrum is for the untreated glass powder. 
The numbers are immersion times. 
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Figure 6.3.9 FWHM for 31P MAS-NMR spectra plotted as a function of immersion times in 
Tris buffer. The estimated errors (10 Hz) are smaller than the data point.  
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The 31P MAS-NMR spectra of glass GPCl 4.6 and GPCl 20.6 before and after 
immersion in Tris are presented in Figure 6.3.7 and Figure 6.3.8. The spectra for the 
as-quenched glasses were shown above in Figure 6.1.4. For both glass compositions, 
after 3 hours immersion the peaks narrow down. There is no clear change in chemical 
shift before and after immersion for glass GPCl 4.6, whilst the chemical shift for GPCl 
20.6 moved “downfield” to 3 ppm after immersion, suggesting rapid apatite-like phase 
(likely to be HAP) formation within 3 hours immersion. A further reduction of the line-
width of the peak was seen from 3 to 9 hours for both glasses. The similar evolutions 
were found in the other CaCl2 containing glass compositions.  
The full width half maximum (FWHM) of 31P MAS-NMR spectra for CaCl2 containing 
bioactive glasses before and after immersion in Tris are plotted as a function of 
immersion times in Figure 6.3.9. A clear reduction of FWHM with an increase in 
immersion period is seen for all the chloride containing glasses.  In the case of before 
immersion, the amorphous calcium orthophosphate results in a broad amorphous 
peak and a relatively large FWHM, since there are local variations in the local 
environment around the phosphorus. In the case of after immersion, the calcium 
orthophosphate peak gradually becomes sharper as the result of the formation of a 
crystalline calcium orthophosphate (apatite) and the amorphous calcium phosphate 
species in the glass dissolving. Thus, a progressive reduction in FWHM of 31P peak is 
noticed with an increase in immersion time. 
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Further Discussion 
The FTIR spectra and 31P NMR spectra of the as-quenched glasses consistently 
suggest that the resultant chloride containing bioactive glasses are amorphous, while 
the XRD patterns demonstrate a small fraction of diffraction lines corresponding to 
mixed hydroxy-chlorapatite in the glasses with CaCl2 content more than 1.7 mol%. The 
hydroxyl groups in the formed apatite might come from surface reaction with moisture 
during data collection since there is unlikely to be significant quantities of hydroxyl 
groups in the original glasses. The XRD experiments were carried out by placing the 
glass powder inside a sample holder (32 mm) and exposing sample to the air during 
the experiment, which requires a couple hours of contacting with atmosphere. The 
moisture in the atmosphere might aid the apatite (hydroxy-chlorapatite) formation on 
the glass surface. Compared with XRD experiments, powder samples were packed in 
the rotor with a small cross sectional area (2.5 or 4 mm) and spun in a closed chamber 
during the MAS-NMR spectra collection, whilst, the FTIR measurements took less than 
5 min to perform. Both of these studies minimise the contact between glass powder 
and atmospheric water. Therefore, no apatite was detected from the NMR and FTIR 
spectra.  
Owing to known chloride volatilisation during melting, resulting in most of the chloride 
being lost, and the incorporation of chlorine in silicate glasses is described in the 
literature as problematic and challenging. However, the results of chloride 
quantification in this study indicate that 70 - 90% of the chlorine is retained in the as-
quenched glasses after melting at 1500-1550oC. Thus, the majority of chloride is 
retained in the silicate glass during melting. Generally, the glasses with lower CaCl2 
content show higher amount of CaCl2 loss. This can be attributed to a higher melting 
temperature of 1550oC for synthesis of the lower CaCl2 containing glasses (1.7 and 2.5 
mol%). 
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It is important to note here that most chlorides with the notable exception of CaCl2 
have low boiling points (1413°C for NaCl, 1412°C for MgCl2, 1420°C for KCl, 1250 °C 
for SrCl2 and 756 °C for ZnCl2) and this has generally resulted in either no or very little 
chloride remaining in the silicate glass. Consequently chloride containing glasses have 
rarely been studied and those that have been looked at typically have very low CaCl2 
concentrations (< 2 mol%) [85, 86].  
The chloride volatilisation is probable by two routes; direct volatilisation as CaCl2 and 
loss as HCl by reaction with water vapour in the furnace atmosphere. If chloride 
volatilises as HCl, the CaO content in the actual glass composition would increase and 
the SiO2 and P2O5 contents would decrease. Therefore, the glass network connectivity 
(NC) would decrease with an increase in CaCl2 content and the glasses would tend to 
crystallise. However, if chloride volatilises as CaCl2, the CaO, P2O5 and SiO2 would 
increase in proportion and the glass NC would remain constant. 
The 29Si MAS-NMR spectra (Figure 6.1.5) suggest that the obtained glasses are 
mainly Q2 structure rather than a mixture of Q1 and Q2. Moreover, the FTIR and 31P 
MAS-NMR suggests that all the glasses are largely amorphous and there is no clear 
crystallisation tendency with an increase in CaCl2 content. Thereby, the chloride loss is 
likely to occur as CaCl2 rather than HCl. According to the fixed NC and actual CaCl2 
content, the actual glass compositions have been calculated and summarised in Table 
6.1.1. As can be seen, up to 16.7 mol% CaCl2 was retained in the glasses. 
The DSC and glass density results reveal that the incorporation of CaCl2 results in a 
very remarkable reduction in the glass transition temperature and glass density. It is 
proposed that in this CaCl2 containing glass system, that a Cl-Ca(n) species is formed 
in an identical fashion to the F-Ca(n) species in the CaF2 containing glasses [20, 111]. 
The formation of Cl-Ca(n) species has been found in very low CaCl2 (< 2 mol%) 
containing glasses by Sandland et al. [131]. 
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Possible formation of hypothetical “CaCl+” species, which has same field strength as 
Na+ but lower than Ca2+, weakens the electrostatic force between two NBOs in the 
glass structure. Therefore, the more CaCl2 is introduced into the glass composition, 
the weaker electrostatic forces between the two NBOs form and the lower is the glass 
transition temperature. 
As shown in Figure 6.1.6, the glass density decreases with an increase in CaCl2 
content. This is due to the fact that the chloride ion is large. Incorporation of chloride 
therefore increases the glass molar volume and results in a more open and less 
compact glass structure. Hence, to some extent the presence of chloride dilutes the 
glass network and expands the glass volume, which leads to a decrease in density 
and packing density of the glass. Moreover, the formation of large “CaCl+” species in 
the glasses results in a weakening of the silicate glass network. The effects observed 
in this study are comparable with the effect on the replacement of Na2O for CaO 
(replaced one Ca2+ ion by two Na+ ions) and K2O for Na2O (K+ is larger than Na+, ion 
radius: 1.52 Vs 1.16 Å) in the glass.  
The chloride ion is substantially large in size, the presence of chloride not only leads to 
a reduction of glass density but also a fast glass degradation rate. The ion exchange 
process between Ca2+ from glass matrix and protons from the Tris buffer in the present 
study is aided by incorporation of chloride ions, which have the capacity to expand the 
glass network. This more open and expanded glass structure allows ions to diffuse 
much more easily into and out of the glass and therefore facilitates ion exchange, 
particularly for short immersion times. As a consequence there is a more rapid release 
of Ca2+ ions and a more rapid rise in pH in the glasses with higher CaCl2 content 
during the first few hours of immersion compared to the glasses with the lower CaCl2 
content. However after a longer immersion period (24 hours), there is a less 
pronounced rise in pH of the glasses with more CaCl2 content. This can be attributed 
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to a decrease of non-bridging oxygen concentration as a result of dilution by the CaCl2, 
which provides Ca2+ to exchange with H+ with an increase in CaCl2 content. 
Rapid glass degradation and release of Ca2+ and PO43- ions facilitate apatite-like 
phase formation. Apatite-like phase formation of these CaCl2 containing bioactive 
glasses was evaluated in Tris Buffer and SBF. As discussed above, chloride promotes 
glass degradation as a result of expanding glass network and the rapid glass 
degradation provides ions, such as Ca2+, PO43- and OH- for apatite-like phase 
formation. 
From the ion release data, the highest amount of phosphate was present in solution is 
around 7.85% after 3 hours immersion, this indicates a probable consumption of 
phosphate for apatite-like phase formation at an even earlier immersion time than 3 
hours. The studied glasses are phosphate deficient, as the ratio of Ca:P ratio  in 
glasses is 4.4:1, while the Ca:P ratio in apatite is only 1.67:1. Therefore, the amount of 
apatite-like phase formation depends mainly on the phosphate content and high 
phosphate contents are favourable for apatite-like phase formation.  
All the XRD, FTIR and NMR results consistently suggested rapid apatite-like phase 
formation within 3 hours immersion in Tris and 9 hours in SBF, which is comparable to 
the equivalent CaF2 containing bioactive glasses in Chapter 5. For those studied 
chloride containing bioactive glasses, we would expect mainly HAP to form on 
dissolution, contrasting with FAP for the fluoride containing bioactive glasses. This is 
due to the fact that the size of hydroxyl ion (1.26 Å) is smaller than chloride ion (1.67 Å) 
but slightly larger than fluoride in (0.119 nm). In the apatite crystal lattice, the fluoride 
ion is situated at the centre of Ca(II) triangle, while the hydroxyl ion is too large to fit in 
the space at the centre of Ca(II) triangle and is displaced above the plane of the 
triangle. The substantially larger chloride ion displaces even further above the plane of 
the Ca(II) triangle compared with the hydroxyl ion. Therefore, chlorapatite is less stable 
than hydroxyapatite, which is less stable than fluorapatite, and is unlikely to form in an 
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identical fashion to fluorapatite after immersion of the bioactive glass. Furthermore 
chlorapatite is known to convert to hydroxyapatite with time in the presence of water 
[95]. These highly bioactive chloride containing glasses with their rapid dissolution rate 
are attractive for use in toothpastes and resorbable materials, especially bone grafts 
and scaffolds. 
As shown in the XRD patterns, the diffraction lines developed after 3 hours immersion 
in Tris matched to the typical diffraction lines of hydroxyapatite, however, the 
intensities of the three main peaks between 31° to 33° 2θ are not completely identical 
with those for hydroxyapatite. This suggests a disordered crystal structure and the 
possibility of the presence of CO32- or Cl- in the apatite lattice.  
Owing to the presence of Mg2+ in SBF, the apatite-like phase formation for the studied 
CaCl2 containing bioactive glasses is slower in SBF compared with being immersed in 
Tris. The details have been discussed in Chapter 5. Fagerlund et al. found that 
bioactive glasses 45S5 (2.6 mol%), S53P4 (1.6 mol%), 13-93 and 1-98 (0.86 mol%) 
formed Ca-P layer more readily and faster in SBF than in Tris [132]. It seems 
contradictive to what was found in this project. However, those glasses in fact have 
much lower phosphate content (0.86 - 2.6 mol%) compared with the ones (5.0 - 6.3 
mol%) studied here. Unlike simulated body fluid, which is rich in Ca2+ and PO43-, Tris 
buffer contains no Ca2+ or PO43-. In the case of the bioactivity study in Tris, the Ca and 
P detected in solution and any apatite detected entirely originated from the glass 
composition. For those low phosphate containing glasses, the lack of phosphate leads 
to no or much slower apatite formation in Tris while the PO43- from SBF effectively aids 
the formation of apatite. Therefore, the choice of immersion solution for the estimation 
of glass bioactivity is highly important.  
Summary 
The sodium-free, high phosphate CaCl2 containing (0 – 16.7 mol%) bioactive silicate 
glasses have been successfully synthesised by a melt-quench route and studied for 
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the first time. The compositional analysis demonstrates that a significant retention of 
chloride is achieved in the Q2 type silicate glass. The bioactivity study has revealed 
that the chloride containing bioactive glasses are highly degradable and form an 
apatite-like phase within 3 hours immersion in Tris buffer. Glass degradation rate 
increased with CaCl2 content. A reduction of density and an increase of glass molar 
volume on increasing CaCl2 suggests that chloride expands the glass volume and 
dilutes glass network, therefore, promoting ion exchange and glass degradation. The 
DSC results demonstrated a distinct reduction in the glass transition temperature (Tg) 
correlating linearly with an increase in chloride content up to 11.9 mol%. The decrease 
of Tg indicates a potential decrease in the glass hardness. These novel chloride 
containing bioactive glasses have outstanding potential for applications in 
remineralising toothpastes and resorbable bone substitutions.  
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7 Sodium-Free Mixed CaF2 - CaCl2 
Containing Bioactive Glasses 
Foreword 
The presence of fluoride in sodium-free bioactive glass resulted in formation of fluoride 
substituted apatite on immersion, as shown in Chapter 5. However, the crystallisation 
tendency of the as-quenched glasses increased dramatically with an increase in CaF2 
content and the excess CaF2 led to an uncontrolled crystallisation of fluorite during 
quenching or upon immersion in buffer solutions.  
As shown in Chapter 6, the crystallisation tendency of the chloride containing glasses 
was much lower than the fluoride ones. All the studied chloride containing glasses with 
CaCl2 content up to 16.7 mol% were largely amorphous. Moreover, chloride caused a 
reduced glass transition temperature, an increased glass molar volume and a faster 
glass degradation rate. However, a hydroxyapatite-like phase was the only phase 
formed on immersion. 
In this chapter we investigate the possibility of incorporating both fluoride and chloride 
into silicate bioactive glasses and to take advantage of the benefits associated with the 
presence of both.  Thus mixed fluoride/chloride series can serve as a prototype for a 
potential commercial product where an excessive amount of fluoride in the bioactive 
glass is replaced by chloride. A glass, which is able to form fluorapatite and also has 
lower abrasivity is particularly attractive for remineralising and desensitising 
toothpastes. In this chapter the results on a mixed fluoride/chloride system are 
presented. Glass bioactivity in terms of glass degradation and apatite formation was 
estimated in Tris buffer as for the other systems.   
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7.1 Results of the As-Quenched Glasses 
Except for the optically transparent glass with the lowest amount of fluoride and 
chloride (2.6 mol% CaX2 X=F+Cl) the as-quenched glass frits (>2.6 mol% CaX2 
(X=F+Cl)) were optically slightly opaque. 
7.1.1  Compositional Analysis 
The percentages of the retained chloride in the initial glasses after volatilization are 
plotted against the as-designed CaX2 (X=F+Cl) content in Figure 7.1.1. A large fraction 
(77-90%) of chloride is retained in the glasses, whilst the highest amount of CaCl2 
losses is found in the lowest CaCl2 containing glasses. Similar proportions of chloride 
(73-88%) have been retained in the chloride containing glasses as seen in Chapter 6. 
As discussed in detail in Chapter 6, chloride is likely to evaporate as CaCl2 rather than 
HCl. Therefore, based on this assumption and taking into account the results of 
chloride quantitative analysis the actual glass compositions recalculated are given in 
Table 7.1.1.  
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Figure 7.1.1. The percentage of the retained chloride in the initial glasses plotted against 
the as-designed CaX2 (X=F+Cl) content. Note where error bars are not shown they are 
smaller than the data point. 
Table 7.1.1 For each glass, the first row is the nominal composition as-designed and the 
second row is composition re-calculated based on the chloride component analysis and 
assumed chlorine losses as CaCl2. 
Glass code SiO2 CaO P2O5 CaF2 CaCl2 Total CaX2 
   GPFCl 0.0 38.1 55.5 6.3 0.0 0.0 0.0 
38.1 55.6 6.3 0.0 0.0 0.0 
GPFCl 2.6 37.1 54.1 6.1 1.5 1.1 2.6 
37.2 54.2 6.1 1.5 0.9 2.4 
GPFCl 4.0 36.6 53.4 6.0 2.3 1.7 4.0 
36.8 53.5 6.1 2.3 1.4 3.7 
GPFCl 5.3 36.2 52.6 5.9 3.0 2.3 5.3 
36.3 52.8 6.0 3.0 1.9 4.9 
GPFCl 8.3 35 51.0 5.8 4.7 3.6 8.3 
35.1 51.2 5.8 4.7 3.2 7.9 
GPFCl 12.1 33.5 48.8 5.6 6.9 5.2 12.1 
33.8 49.3 5.6 7.0 4.3 11.3 
GPFCl 16.0 32.1 46.7 5.3 9.1 6.9 16.0 
32.4 47.1 5.4 9.2 6.0 15.2 
GPFCl 23.1 29.3 42.7 4.9 13.2 9.9 23.1 
29.9 43.6 5.0 13.4 8.1 21.5 
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7.1.2  XRD Results of the As-Quenched Glasses 
Figure 7.1.2 shows the XRD patterns of the as-quenched mixed CaF2 and CaCl2 
containing bioactive glasses. The amorphous glass halo at 30° 2θ is found in all the 
CaX2 (X=F+Cl) containing glasses. The typical apatite diffraction lines at 25.9°, 31.8°, 
32.2° and 33° 2θ (FAP: 00-034-0011) are noticed in the glasses with CaX2 content 
higher than 2.6 mol%. The intensities of the apatite diffraction lines are relatively low in 
glass GPFCl 8.3. The additional minor diffraction lines at 28.3° and 47° 2θ possibly 
corresponding to fluorite (CaF2, 00-004-0864) are found in the GPFCl 16.0 and GPFCl 
23.1. Unlike in the GPF glass series, the crystallisation of cuspidine has not been seen 
in the mixed glass series.  
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Figure 7.1.2 The XRD patterns of as-quenched CaX2 (X=F+Cl) containing glasses (о: 
Ca10(PO4)6F2; +: CaF2).  
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7.1.3  FTIR Results of the As-Quenched Glasses 
The FTIR spectra of the as-quenched CaX2 containing glasses are shown in Figure 
7.1.3. The non-bridging oxygen band at 920 cm-1 and the Si-O-Si stretching band at 
1030 cm-1 are found in the whole glass series. The characteristic apatite split bands at 
560 and 613 cm-1 are seen in the spectra of most CaX2 containing glasses apart from 
glass GPFCl 2.6, the latter has a small band corresponding to amorphous calcium 
phosphate around 600 cm-1 [133]. 
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Figure 7.1.3 The FTIR spectra of as-quenched CaX2 (X=F+Cl) containing glasses.  
7.1.4  31P and 19F NMR Results of the As-Quenched Glasses 
The 31P MAS-NMR spectra of the as-quenched mixed CaF2 and CaCl2 containing 
bioactive glasses are shown in Figure 7.1.4. The single peak located at about 3-3.3 
ppm is visible in the spectra of all the glasses, suggesting that phosphate is present as 
calcium orthophosphate [4]. In general, for those glasses with CaX2 content higher 
than 2.4 mol%, the orthophosphate peak is slightly sharper and narrower with an 
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increase in CaX2 content down the series and clearly shows the presence of more 
than one signal strongly overlapping with each other. This can potentially indicate the 
minor presence of the crystalline phase and that the glasses with CaX2 content higher 
than 2.4 mol% tend to partially crystallise to apatite. Moreover, the peak position shifts 
downfield to a slightly higher ppm value when the glasses have CaX2 content equal 
and higher than 11.3 mol%. In other words, a higher deshielding of the phosphorus 
nuclei occurs in the glass with higher mixed CaF2 and CaCl2 local environment. A 
similar deshielding effect was illustrated in the 31P MAS-NMR spectra for mixed fluoro-
chloroapatite (Ca5(PO4)3F1-xClx, when X<0.5) by O’Donnell [134]. This suggests that 
presence of mixed fluoride and chloride might have similar effects on the phosphate 
environment in the glass phase as the ones in the mixed apatite phase.    
 
Figure 7.1.4 The 31P MAS-NMR spectra of as-quenched CaX2 (x=F+Cl) containing glasses.  
Figure 7.1.5 shows the 19F MAS-NMR spectra of the as-quenched mixed CaF2 and 
CaCl2 containing glasses. The single broad peak with a chemical shift about -96 ppm 
is seen in all the glass spectra. In addition, a small shoulder at -103 ppm 
corresponding to FAP appears in the spectra for the glasses with CaX2 contents higher 
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than 2.4 mol%. The broad peak contains signals from the amorphous F-Ca(n) 
environment in the glass, the F-Ca(3) site in the apatite structure in addition to the 
overlapping spinning side bands from both signals. Note that a clear increase in the 
line-width occurs in the spectra of GPFCl 16.0 and GPFCl 23.1. It can be attributed to 
the presence of an additional crystalline F-Ca(4) site at -108 ppm as a result of CaF2 
crystallisation and its spinning side bands in the spectra.  
 
Figure 7.1.5 The 19F MAS-NMR spectra of the as-quenched mixed CaF2 and CaCl2 
containing glasses.  
7.1.5  Glass Density  
The density and molar volume of CaX2 containing bioactive glasses are plotted as a 
function of the CaX2 content in Figure 7.1.6. The density values fluctuate between 2.90 
to 2.93 g/cm3, whereas the glass molar volume increases linearly and significantly with 
increasing calcium halide content. The black dotted line is just for eye guiding. Owing 
to the fact that the chloride ion is much larger than fluoride ion and therefore the 
expansion of glass volume is thought to be mainly contributed by the presence of 
chloride.   
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Figure 7.1.6 Glass density and molar volume plotted as a function of CaX2 (X=F+Cl) 
content.  
7.1.6 DSC Results of the Na free Mixed CaF2 and CaCl2 Containing 
Bioactive Glasses 
Figure 7.1.7 presents the DSC traces for glass frits of sodium-free mixed CaF2 and 
CaCl2 containing glasses. All the glasses have at least two exotherms, but no 
endotherm peak is found in any glass composition. The obtained Tg and Tc from the 
DSC traces with an accuracy of ±5 °C are summarised and listed in Table 7.1.2. 
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Figure 7.1.7 DSC traces for the glass frits of mixed CaF2 and CaCl2 containing glasses. 
The numbers are molar percentage of CaX2 (X=F+Cl) in the compositions.   
Table 7.1.2 Characteristic temperatures for mixed fluoride and chloride containing 
glasses. For each glass composition, the first row is the characteristic temperature of 
glass frit and the second row is the characteristic temperature of fine powder. 
Glass Code Tg To1 Tc1 Tc2 Tc3 Tm 
GPFCl 0.0 
786 969 1013 - -  
790 901 925 - - - 
GPFCl 2.6 
749 875 902 967 - - 
733 840 906 - - - 
GPFCl 4.0 
727 846 865 942 - - 
723 825 856 876 - - 
GPFCl 5.3 
707 821 840 930 - - 
705 807 830 867 - - 
GPFCl 8.3 
665 771 785 871 - - 
664 750 777 811 - - 
GPFCl 12.1 
626 725 737 825 - - 
625 713 733 786 - - 
GPFCl 16.0 
578 680 689 700 771 - 
581 675 695 758 - - 
GPFCl 23.1 
534 638 658 704 795 - 
534 578 655 710 - - 
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The glass transition temperature (Tg) of frit is plotted as a function of the mixed CaF2 
and CaCl2 content in Figure 7.1.8. It is clear that, an increase of CaX2 content results 
in a reduction in Tg. A linear relationship (Y= -13.609X+779.34, R2=0.9949)  between 
Tg and CaX2 content is seen in the CaX2 containing glasses with the exception of 
GPFCl 23.1, which contains crystalline CaF2 in addition to FAP.  
The visible linear relationship between Tg and CaX2 content could be the result of 
either no halide loss or similar proportion of halide loss for the compositions lying on 
the straight line. However, the XRD, FTIR and 31P NMR results of the as-quenched 
glasses consistently indicate that glass GPFCl 2.6 is largely amorphous and the 
glasses with CaX2 higher than 2.4 mol% are partially crystallised, whilst the results of 
chloride content in the as-quenched glasses show a similar proportion (10-23 %) of 
chloride loss during melting. Therefore a conclusion can be drawn that a relatively 
small and similar proportion of fluoride containing phases (FAP and CaF2) are formed 
during quenching in those glasses (GPFCl 4.0, GPFCl 5.3, GPFCl 8.3, GPFCl 12.1 
and GPFCl 16.0).  
Figure 7.1.9 shows that Tc1 values for both glass frit (1-2 mm) and fine powder 
decrease significantly with an increase in CaX2 content.  
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Figure 7.1.8 Glass transition temperature of the frit profiled as a function of CaX2 
(X=F+Cl) content. A linear relationship (Y=-13.609+779.34, R2=0.9949) between Tg and 
CaX2 content was shown in the glasses with CaX2 content ≤ 16.0 mol%. 
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Figure 7.1.9 First Crystallization Peak temperature (Tc1) for frit and fine particles plotted 
against mixed CaF2 and CaCl2 content.  
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7.2  Dissolution Study 
7.2.1  pH Measurement Results 
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Figure 7.2.1 pH values measured at the end of the immersion time in Tris buffer. The 
numbers are molar percentage of CaX2 (X=F+Cl) in the compositions. Note where error 
bars are not shown they are smaller than the data point. 
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Figure 7.2.2 pH values measured at the end of 3 and 24 hours immersion in Tris buffer 
plotted against CaX2 (X=F+Cl) content. 
Figure 7.2.1 demonstrates pH changes after immersing the glass powder in Tris buffer 
for different CaX2 contents. The general trend is similar for all the glass compositions, 
though some differences in compositions behaviour can be noticed. For the glasses 
with CaX2 content less than 11.3 mol%, pH increases in first 6 hours, decreases 
slightly from 6 to 9 hours and increases again afterwards. For the glasses with CaX2 
content higher than 7.9 mol%, pH initially increases after 3 hour following a reduction 
of pH between 3 and 9 hours with a further increase by 24 hours. 
Interestingly, Figure 7.2.2 shows two different trends for pH as a function of the CaX2 
content after 3 and 24 hours immersion. The pH of the solution increases with an 
increase in CaX2 content after 3 hours but decreases after 24 hours with the exception 
of GPFCl 2.6. The relatively high pH of GPFCl 2.6 after 3 hours is likely contributed by 
the faster glass degradation rate of the fully amorphous glass compared with the 
partially crystallised ones. As shown in Figure 7.1.6, the presence of mixed fluoride 
and chloride expands glass volume resulting in a more disrupted glass structure, 
therefore, facilitating the ion exchange between protons from solution and the Ca2+ 
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ions ionically connected to non-bridging oxygens from glass and, thus, aiding glass 
degradation. The latter causes an increase in Ca concentration found in solution, 
which will be shown in the next few paragraphs and the pH rise for glasses with higher 
CaX2 content after 3 hours of immersion.  
7.2.2 Ion Release Results 
0 3 6 9 12 15 18 21 24
0
10
20
30
40
50
60
70
80
Time (hours)
Ca
lci
um
 (%
)
 GPFCl 2.6 
 GPFCl 4.0
 GPFCl 5.3
 GPFCl 8.3
 GPFCl 12.1
 GPFCl 16.0
 GPFCl 23.1
 
Figure 7.2.3 The concentration of elemental calcium in Tris presented as percentage of 
the total calcium content in the original mixed CaF2 and CaCl2 containing glasses as a 
function of time.  
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Figure 7.2.4 The Ca concentration measured after 3 hours immersion in Tris buffer 
plotted as the percentage of the total calcium content in the glass composition against 
the CaX2 content. 
Figure 7.2.3 shows the concentrations of calcium measured after up to 24 hours 
immersion in Tris buffer presented as a percentage of total amounts of calcium in the 
glass compositions. The general trend is similar for all the glass compositions. The 
percentage of calcium detected in the solution increases in the first 9 hours 
(particularly in the initial 3 hours) with a nearly stable pH afterwards. This suggests that 
glass almost completely degrades before 9 hours, whereas apatite formation was very 
clear between 3 and 9 hours as will be shown further.  
The percentage of calcium retained in the solution after 3 hours immersion is plotted 
as a function of the as-quenched mixed CaF2 and CaCl2 content in Figure 7.2.4. Apart 
from GPFCl 2.6, the glasses with higher CaX2 content have higher percentage calcium 
release as a consequence of a more expanded glass volume caused by the presence 
of higher CaCl2 contents. The trend shown is in agreement with the trend for the pH 
measured after 3 hours immersion in Figure 7.2.2.  
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Figure 7.2.5 The concentration of phosphate measured after up to 24 hours immersion in 
Tris. The numbers are molar percentage of CaX2 in the compositions. 
The similar trends of the phosphate concentration measured up to 24 hours immersion 
in Tris buffer for mixed CaF2 and CaCl2 containing glasses are presented in Figure 
7.2.4. The phosphate concentration increased in the first 6 hours and decreased 
afterwards. Low phosphate concentrations (<3 mg/l) are seen for all the glass 
compositions at different immersion time points. 
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Figure 7.2.6 The concentration of silicon measured in Tris buffer in mg/l plotted as a 
function of immersion time.  
The silicon concentrations in Tris buffer after the immersion of glass powder within 24 
hours for mixed CaF2 and CaCl2 containing glasses have similar trends to the release 
of calcium (Figure 7.2.6), increasing to 55-65 mg/l in the first 9 hours and keeping 
nearly constant afterwards. 
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7.3 Apatite-like Phase Formation in Tris Buffer Solution 
Apatite-like phase (mixed hydroxyl-fluorapatite for GPFCl 2.6 and fluorapatite for the 
rest of glasses) was expected to precipitate after immersing the mixed CaF2 and CaCl2 
containing bioactive glasses in Tris buffer. The formation of apatite-like phase was 
evaluated using XRD, FTIR and 31P and 19F MAS-NMR. 
7.3.1  X-ray Diffraction Results 
The XRD patterns of the glasses before and after immersion in Tris are similar for all 
the mixed CaF2 and CaCl2 containing glasses. The ones for GPFCl 2.6 are selected 
and presented as an example in Figure 7.3.1.  
After 3 hours immersion in Tris, the amorphous glass halo (30° 2θ) broadens out, 
whilst the characteristic diffraction lines of apatite at 25.9°, 31.8° and 33° 2θ observed 
indicate rapid apatite-like phase formation within 3 h immersion. The intensity of those 
diffraction lines are enhanced within 9 h immersion.  
The XRD patterns of the precipitates collected after 3 hours immersion in Tris for all 
the mixed CaF2 and CaCl2 glasses are shown in Figure 7.3.2. The amorphous glass 
halos at 30°2θ largely disappear. The diffraction lines corresponding to apatite occur in 
all the XRD patterns. However, the intensity of diffraction lines for those partially 
crystallised glasses is much stronger than the equivalent amorphous glass (GPFCl 
2.6). Moreover, additional diffraction lines at 28.3° and 47°2θ associated with CaF2 
appear in the XRD patterns of GPFCl 16.0 and GPFCl 23.1.  
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Figure 7.3.1 The XRD patterns of the glass precipitates with 2.4 mol% CaX2 collected 
after immersion in Tris up to 1 day (о: Ca10(PO4)6F2). 
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Figure 7.3.2 The XRD patterns of the glass precipitates collected after 3 hours immersion 
in Tris (о: Ca10(PO4)6F2 ; +: CaF2). 
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7.3.2  Fourier Transform Infrared Spectroscopy Results. 
In addition to the ion release study by ICP-OES, FTIR was also used to monitor glass 
degradation and apatite-like phase formation upon immersion. Figure 7.3.3 shows the 
spectra of the precipitates collected after immersion in Tris up to 1 day for GPFCl 2.6, 
while Figure 7.3.4 summaries the spectra of precipitates collected after 3 hours of 
immersion for all the CaX2 containing glasses. After immersing glass powder in Tris for 
3 hours, the FTIR spectra changed significantly. The intensity of non-bridging oxygen 
Si-O- bands at 850 and 920 cm-1 reduces. The amorphous calcium orthophosphate 
bands disappear, while the crystallised orthophosphate (apatite) bands develop at 560, 
613 and 1035 cm-1. These typical apatite bands intensify with immersion time up to 9 
hours but do not alter significantly with a further increase in immersion time. In addition, 
carbonate bands at 1450 cm-1, 1420 cm-1 and 870 cm-1 are visible after 3 hours 
immersion, suggesting the substitution of carbonate in the apatite lattice. These 
evolutions are similar to the seen above in the previous Chapters and have been 
discussed in more details in Chapter 5.   
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Figure 7.3.3 The FTIR spectra of the glass precipitates with 2.4 mol% CaX2 collected after 
immersion in Tris up to 1 day. 
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Figure 7.3.4 The FTIR spectra of the glass precipitates collected after 3 hours immersion 
in Tris for mixed CaF2 and CaCl2 containing glasses. 
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7.3.3  NMR Results of Mixed CaF2 and CaCl2 Series Glasses 
 
Figure 7.3.5 The 31P MAS-NMR spectra of the glass precipitates with 2.4 mol% CaX2 
(GPFCl 2.6) collected after immersion in Tris. The bottom spectrum is for the untreated 
glass powder. The numbers are immersion times. 
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Figure 7.3.6 FWHM for 31P MAS-NMR spectra plotted as a function of immersion times in 
Tris buffer. The estimated errors (10 Hz) are smaller than the data point.  
 
Figure 7.3.7 The 19F MAS-NMR spectra of the glass precipitate with 2.4 mol% CaX2 
collected after immersion in Tris, the signals symmetrically situated on both sides of the 
main signal and labelled by asterisk present side bands. 
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Figure 7.3.8 The 19F MAS-NMR spectra of the glass precipitates collected after 
immersion in Tris for mixed CaF2 and CaCl2 containing glasses. (a) after 3 hours; (b) 
after 6 hours; (c) after 9 hours and (d) after 1 day. 
The atomic environment of phosphate in the precipitates collected after immersion was 
determined by using 31P MAS-NMR. As we can see in Figure 7.3.5, which 
demonstrates the 31P MAS-NMR spectra of GPFCl 2.6 after immersion in Tris, the 
single broad peak assigned to amorphous calcium orthophosphate narrows down 
gradually with increasing immersion time. However, the chemical shift is almost kept 
constant at 3 ppm. Similar changes are found in the rest glass compositions. 
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The full width half maximum (FWHM) of 31P signals for mixed CaF2 and CaCl2 
containing bioactive glasses before and after immersion in Tris are plotted as a 
function of immersion times in Figure 7.3.6. Before immersion, the glasses with CaX2 
content equal to and less than 11.3 mol% have bigger FWHM than glasses GPFCl 
16.0 and GPFCl 23.1, indicating that there is more apatite formed with the glasses with 
15.2 and 21.5 mol% CaX2. In addition, it is clear that, the FWHM of the 31P spectra for 
the glass before immersion is much larger than the ones after immersion. The FWHM 
values decrease with increasing in immersion time up to 6 hours. A smaller reduction 
is observed for further immersion from 6 to 9 hours, in particular for the glasses with 
CaX2 over 11.3 mol% that with a relatively higher crystallinity. Those changes suggest 
the transformation of orthophosphate from an amorphous state to a crystalline state on 
immersion, particularly before 6 hours immersion. Whilst, those high CaX2 containing 
glasses (≥ 11.3 mol%) have more pronounced apatite formation on immersion, as a 
result of the seeding effect arising from the presence of apatite nuclei in the initial 
glasses.    
Figure 7.3.7 presents the 19F MAS-NMR spectra of the precipitates collected after 
immersion in Tris up to 24 hours compared with the as-quenched glass for glass 
GPFCl 2.6. The symmetrical signals labeled by asterisks present side bands. After 3 
hours immersion, the line-width of 19F NMR peak decreases, suggesting the 
amorphous F-Ca (n) converts to the crystalline one. This is in good agreement with the 
31P MAS-NMR results in Figure 7.3.5. The asymmetric peak with a broad shoulder at 
low frequency shifts towards -103 ppm (F-Ca(3)) assigned to fluorapatite and indicate 
the presence of both fluorapatite and residual amorphous glass phase in the collected 
precipitates. A decrease in intensity of the broad low frequency shoulder and the 
increasing magnitude of fluorapatite peak at -103 ppm indicate a continuous process 
of glass dissolution and fluorapatite formation. Similar changes are found in the 
spectra of those glasses with CaX2 contents less than 16.0 mol % as presented in 
Figure 7.3.8 (a)-(d). Note that, the peak at -108 ppm corresponding to crystalline CaF2 
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appears in the spectra of GPFCl 12.1, GPFCl 16.0 and GPFCl 23.1 after 9 hours 
immersion and is more pronounced by 24 hours (Figure 7.3.8 (c)-(d)).  
Moreover, for the glasses with CaX2 content equal or higher than 16.0 mol%, the 
spectra are slightly different from the lower CaX2 containing glasses. For instance, 
after 3 hours immersion in Tris, apart from seeing a reduction in intensity of amorphous 
F-Ca (n) signal, the split peaks at -103 and -108 ppm corresponding to FAP and CaF2 
are also seen in the spectra of GPFCl 16.0. Whereas the distinct and sharp peak at -
108 ppm with a small shoulder at -103 ppm is observed in the spectra of GPFCl 23.1 
(Figure 7.3.8 (a)). These differences indicate that the glasses with high CaX2 content 
(≥ 16.0 mol%) are not only crystallised to fluorapatite but also CaF2. The CaF2 peak 
becomes more dominant with increasing immersion time (Figure 7.3.8 (b)-(d)). 
Furthermore, it is also worth mentioning that, in some of the spectra from Figure 7.3.8, 
a shoulder at - 88 ppm or / and a small peak at -123 ppm are also visible.  
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Further Discussion 
In the present study, 77-90% of the chloride has also been successfully retained in the 
Q2 type mixed CaF2 and CaCl2 containing silicate glasses similar to the GPCl glass 
series studied in Chapter 6. Therefore a conclusion can be drawn that adding chloride 
into a Q2 type silicate glass effectively minimizes the chlorine loss.   
The incorporation of mixed CaF2 and CaCl2 content above 2.4 mol% into glass 
compositions results in the crystallisation of FAP and an additional CaF2 phase in glass 
GPFCl 16.0 and glass GPFCl 23.1. It is unlikely to see ClAP crystallisation in an 
identical fashion of FAP in those glasses. The fundamental cause is the fact that 
fluoride ion is much smaller than chloride ion. The formation of FAP requests less 
lattice energy compares with equivalent ClAP. In addition, the studied glass system is 
phosphate deficient and the fluoride content in the composition is sufficient to combine 
all the phosphate for FAP formation.     
Experimental results provide an overwhelming evidence to reveal the fact that adding 
fluoride and chloride into a silicate bioactive glass allows one to obtain the benefits 
associated with the presence of both fluoride and chloride. The presence of chloride 
expands glass volume dramatically, resulting in faster glass degradation, in agreement 
with the pH data (Figure 7.2.2) and Ca ion release data by 3 hours immersion (Figure 
7.2.4). Meantime, the presence of fluoride favors a more acid resistant FAP formation 
on immersion. However the mixed halide glasses crystallised more readily on 
quenching than the fluoride glasses (GPF series).  
It is well-known that the Ca:P:F ratio in fluorapatite is 5:3:1. However, the studied glass 
GPFCl 2.6 is fluoride deficient as the ratio of Ca:P:F is 17.9 : 4.05 : 1, whilst the rest 
glasses are phosphate deficient and F rich. Therefore, a mixed hydroxyl-fluorapatite is 
likely occur for glass GPFCl 2.6 after immersion in Tris buffer, while fluorapatite is 
expected for the glasses with CaX2 content higher than 2.4 mol%. Moreover, the 
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excess fluoride, which is over the stoichiometric F in FAP, could lead to CaF2 
precipitation or fluoride rich phase formation after immersion. These consistently 
account for the fact that FAP is the dominating phase formed after immersion in Tris for 
the GPFCl glass series, though CaF2 and some fluoride containing phases with 
chemical shifts at -88 and -123 ppm are present in some 19F MAS-NMR spectra. 
A previous 19F MAS-NMR study by Yi et al. [135] reported that a signal at - 88 ppm  
corresponds to a second fluorine environment in the apatite structure, which is 
different from the signal assigned to channel fluoride ions in the FAP structure at -103 
ppm [136]. This second fluorine environment is the candidate for the electrostatic 
charge compensation of carbonate groups forming (CO3F)3-, which is incorporated at 
the B-site (the site for the phosphate tetrahedron) of the apatite structure. The 
occurrence of such (CO3F)3- would require the concentration of 6.0 wt% of CO32- and 
higher F content than the stoichiometric F content in FAP.  
The substitution of a carbonate group which is locally charge-compensated by fluoride 
ion at the tetrahedral phosphate site in the apatite structure accounts for the existing 
chemical shift of fluorine at - 88 ppm in the present study, in agreement with the 
observed carbonate stretching bands at 1420 and 1450 cm-1 and the carbonate 
bending band at 870 cm-1 from FTIR spectra in Figure 7.3.4.   
Moreover, with the exception of 19F NMR signals at -88 ppm, an additional peak at -
123 ppm is consistent with the non-specifically adsorbed fluoride (NSAF) signal 
detected previously [137-139]. This NSAF peak originally proposed by Arends et al. 
[137] and latter verified by White et al. and is described as the fluoride that is 
hydrogen-bonded to the phosphate protons on the apatite surface. It is proposed by 
White et al. that the NSAF species may have significant contributions to anticaries 
reactivity of fluoride [139]. The quantity of NSAF formation is mainly determined by the 
size of the apatite crystal and F- concentration in the solution, due to the fact that 
fluoride reacts only with a small portion of the crystalline lattice on the surface layers.  
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Summary 
A series of high phosphate, mixed CaF2 and CaCl2 containing bioactive silicate glasses 
were synthesised. With the exception of glass GPFCl 2.6, which is largely amorphous, 
the studied glasses are partially crystallised to fluorapatite during quenching. In 
addition, CaF2 is also found in glass GPFCl 16.0 and 23.1.  The result of chloride 
content analysis suggests that about 77-90% of chloride is retained in the glasses after 
melting. The glass transition temperature and crystallization temperature decrease 
with an increase in CaX2 content. In contrast, the glass molar volume increases 
significantly with increasing CaX2 content, therefore promotes glass degradation. The 
rapid fluorapatite formation is detected within 3 hours immersion, which is comparable 
to GPF and GPCl glass series. It is clear that the mixed CaF2 and CaCl2 containing 
bioactive glasses combine the benefits from the presence of both CaF2 and CaCl2. 
Based on these results it is possible to design silicate glass compositions with the high 
phosphate, low fluoride and high chloride content that will be particularly of interest to 
remineralising toothpastes.  
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8 A Preliminary Study of Bioactive Glass-
Ceramics Based on Apatite  
Foreword  
Glass-ceramics are polycrystalline materials that consist of amorphous phases and 
crystalline phases, which can be produced by heating the base glasses at or above 
their crystallisation temperature [140, 141]. Their properties depend on the amount and 
composition of the crystalline phase formed and the residual glass composition. It is 
important to note that glass-ceramics are not the products of a physical mixture of 
glass and crystals but the formation of crystals in a base glass [142].  
The controlled crystallisation of glasses is an effective way to synthesise a wide range 
of glass-ceramics with unusual microstructures and characteristic physical and 
chemical properties fulfilling a variety of potential applications. The glass crystallisation 
process consists of two stages, namely nucleation and crystal growth [143]. In the 
former stage, a high density of the small and stable nuclei are formed throughout the 
interior of the base glass. In the latter stage, the subsequent growth of the small nuclei 
occurs. In the first simple approximation, the crystallisation mechanism type can be 
indicated by measuring the crystallisation temperature of the same glass powder but 
with different particle sizes. Compared with frit, fine powder has a larger surface area, 
which provides more nucleation sites for crystallisation. Therefore fine powder is prone 
to crystallise at a lower temperature [57] if crystal nucleation occurs on the surface. In 
contrast, when the crystallisation peak temperature is independent of particle size, 
then this may indicate bulk crystal nucleation. 
Bioactive glass-ceramics are promising materials as bone grafts, bone fillers and 
implants that have received attentions for their favourable biocompatibility and 
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osteoconductivity arising from the presence of apatite [144-146]. There are two main 
bioactive glass-ceramics systems: 1). apatite wollastonite (AW) system developed by 
Kukobo et al. [144, 147] and 2). apatite mullite (AM) system synthesised by Hill and 
co-workers [145, 148]. The AW glass-ceramics system has a fairly high mechanical 
strength and even exhibits excellent integration with living tissue. However, because of 
the strong tendency towards surface nucleation of wollastonite, AW glass-ceramics are 
difficult to cast to the desired shape directly. It has to be sintered and machined to 
complex shapes using diamond tooling and consequently it is less commercially 
attractive. Moreover, the relatively low CaF2 (< 1 mol%) content used in the AW system 
results in a restricted content of fluoride substitution in the apatite lattice and formation 
of a mixed oxy-fluorapatite crystal [145]. In contrast to this, the glass-ceramics that are 
derived from internal nucleation and crystallisation of bulk glasses are more 
advantageous, in particular they have ability to be cast into complex shapes. 
The apatite mullite (AM) glass-ceramics based on the CaO-Al2O3-SiO2-P2O5-CaF2 
system, predominantly bulk nucleates, via prior amorphous phase separation and 
crystallise to fluorapatite (FAP) and mullite crystals. These bioactive glass-ceramics 
exhibit high fracture toughness and strength and as a consequence of exhibiting bulk 
nucleation can be readily cast to shape. AM glass-ceramics also show excellent 
osseo-intergration similar to the AW system [146, 149]. Nevertheless, the possibility of 
toxicity caused by the release of aluminium in vivo is perceived as being problematic 
for AM glass ceramics, although the aluminium is incorporated in the mullite phase that 
is insoluble and almost completely inert.  
Brauer et al. [4, 150] studied two glass-ceramic series with different amounts of P2O5 
in the system of Na2O-CaO-SiO2-P2O5-CaF2. Mixed sodium calcium fluoride phosphate, 
FAP, and combeite (Na2Ca2Si3O9) were detected as the main crystalline phases in the 
glasses with high P2O5 content (> 4.7 mol%) [150], whilst no FAP crystallised from low 
P2O5 (< 1.1 mol%) containing glasses [4]. In addition, Brauer et al. also found that a 
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sodium-free CaF2 containing glass with high P2O5 content crystallised to FAP upon 
heat treatment [150]. These findings reflect the possibility of apatite crystallisation from 
aluminium free glasses is strongly influenced by the phosphate content.  
Fluorapatite glass-ceramics are attractive in dental and orthopaedic application, as a 
result of their excellent osteoinductivity and osteoconductivity contributed by the FAP 
crystals and the well-documented bone-regenerative properties of the bioactive glass 
phase [1, 146, 151]. FAP is comparatively chemically stable in acidic environment and 
is not very resorbable, FAP glass-ceramics are used for dental crowns [152, 153]. 
However, in the case of those medical and dental applications particularly where 
resorption and replacement by bone is desired, HAP glass-ceramics are of particular 
interest and more attractive compared with FAP glass-ceramics, as hydroxyapatite is 
more readily dissolved under acidic conditions than fluorapatite. On the other hand, 
considering glass-ceramics, it is important to note that hydroxyl groups are volatilised 
during glass melting and are unlikely to be retained in the glass at a sufficient 
concentration to form hydroxyapatite. This is the main reason for incorporating fluoride 
and forming the fluorapatite analogue of hydroxyapatite. The substitution of fluoride for 
hydroxyl has been used with a wide range of glass-ceramics [111, 154, 155].   
Elliott and Young [95] have shown that chlorapatite converts to hydroxyapatite in the 
presence of water. Esther et al. [156, 157] also showed that millimetre-size 
hydroxyapatite single crystals can be obtained from ClAP crystals via the ionic 
exchange of Cl- for OH- under high temperature hydrothermal conditions. Compared 
with fluorapatite glass-ceramics, ClAP glass-ceramics would be a more favourable 
alternative to FAP glass-ceramics for medical and dental applications that requires 
high resorption rate. 
Chlorapatite and fluorapatite exhibit extensive solid solution phase formation [108, 134, 
158], although the substitution of chlorine and fluorine in the lattice may not be 
completely random. Forming a mixed fluor-chlorapatite should enable the solubility of 
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the apatite to be controlled. The solubility could be further optimized by substitution of 
strontium for calcium, which is known to occur in hydroxyapatite [159] and fluorapatite 
glass-ceramics [160]. 
In this chapter the crystallisation events observed via thermal analysis of oxyhalide 
bioactive glasses were followed. The investigation of the crystallisation was carried out 
by using DSC, while the identification of crystallisation phases was performed using 
XRD, FTIR, MAS-NMR and SEM.  
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8.1  Crystallisation Exotherm 
 
Figure 8.1.1 Tc1 for glass frit plotted as a function of the actual CaX2 (X=F/Cl/F+Cl) 
content. (■ = GPF series, ● = GPCl series, ▲= GPFCl series). 
Figure 8.1.1, the first crystallisation temperature of glass frit for GPF glass series, 
GPCl glass series and GPFCl glass series are plotted against the actual CaX2 content 
(the chloride volatilisation as CaCl2 was taken into account). It is clear that TC1 
decreases with an increase in CaX2 content mirroring the Tg behaviour (Figure 10.2.1). 
In addition, the reduction of Tc1 for the glasses with CaX2 content less than 10 mol% is 
more pronounced than the glasses with CaX2 content higher than 10 mol%, in 
particular for CaF2 containing glasses. This is attributed to the crystallisation of fluoride 
containing phases on a large scale for GPF glass series (> 9.3 mol%) while 
crystallisation occurs at a relatively small scale for GPFCl series, in good agreement 
with the glass characterisation results in Chapter 5, 6 and 7.  
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Figure .8.1.2 DSC traces for frit and PS<45 µm powder of GPF 0.0 demonstrating surface 
nucleation of the first crystallisation phase. 
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Figure 8.1.3 DSC traces for frit and PS<45 µm powder of GPCl 20.6 (16.7 mol% CaCl2) 
demonstrating bulk nucleation of the first crystallisation peak. 
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DSC traces for frit (1-2 mm) and fine powder (< 45 µm) of GPF 0.0 and GPCl 20.6 are 
shown in Figure .8.1.2 and Figure 8.1.3 respectively. Tc1 of frit is much higher than the 
equivalent one for powder in glass GPF 0.0, while Tc1 of powder and frit are pretty 
much identical for glass GPCl 20.6. This indicates two different crystallisation 
mechanisms of the first crystallisation phase for GPF 0.0 and GPCl 20.6. 
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Figure 8.1.4 The difference of first crystallisation temperature between frit and fine 
powder (Tc1frit-Tc1fine) plotted against mixed CaF2 and CaCl2 content. 
The difference of first crystallisation temperature between frit and fine powder (Tc1frit-
Tc1fine) for GPF, GPCl and GPFCl glass series are plotted against CaX2 content in 
Figure 8.1.4. It is obvious that, for the glass without the presence of CaX2 (GPF 0.0), 
the first crystallisation temperature of frit is much higher than the one for fine powder. 
The incorporation of CaX2 results in a marked reduction of Tc1frit-Tc1fine from 88 °C to 
< 20 °C. This reveals that the Tc1 for glass GPF 0.0 is particle size dependent, thus, 
the first crystalline phase is strongly surface-nucleated, while the Tc1 in the CaX2 
containing glasses tends to be particle size independent and the first crystalline phase 
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is likely to bulk-nucleate. Thereby a conclusion can be made that the incorporation of 
calcium halide favours a bulk nucleation. 
 
Figure 8.1.5 FWHM for first crystallisation exotherm (Tc1) plotted against CaX2 
(X=F/Cl/F+Cl) content. (■ = GPF series, ● = GPCl series, ▲= GPFCl series) The errors 
in determining the FWHM are estimated to be<1ºC, which is about the size of the data 
points. 
The FWHM of the first crystallisation peak temperature for the three glass series are 
illustrated in Figure 8.1.5. In general, the FWHM reduces first, then increases with 
CaX2 content for all three glass series and exhibits minimum values at about 6-9 mol% 
CaX2 content, but there is no clear trend for the FWHM data for the GPF series 
glasses with CaF2 content above 6.0 mol%. This reflects the fact that these glasses 
are largely crystalline and crystallised to FAP, cuspidine and fluorite. As mentioned in 
Chapter 5, both cuspidine and fluorite have an F-Ca(4) structure with one fluoride ion 
surrounded by four Ca2+, while fluorapatite has an F-Ca(3) structure with three Ca2+ 
ions surrounding each fluoride.  Therefore, cuspidine and fluorite are likely to form at 
higher fluoride contents relative to fluorapatite. The minimum values of FWHM at 6-9 
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mol% CaX2 content for all three glass series suggest that these glasses with the first 
crystallisation phase crystallised from the bulk are the most suitable for forming apatite 
glass-ceramics. 
8.2 XRD Results of Heat Treated Glasses 
XRD patterns of heat treated glasses GPF 0.0, GPF 4.5, GPF 17.8, GPCl 4.6 and 
GPFCl 23.1 are shown in Figure 8.2.1 - Figure 8.2.5 and the phases identified are 
summarised in the Table 8.2.1 and Table 8.2.2. The typical apatite (HAP: 01-074-0565) 
and β-CaSiO3 (04-012-1776) diffraction lines developed at the heat treatment 
temperature of 1030°C for halide-free composition (GPF 0.0) are found.  In the case of 
the amorphous glass GPF 4.5, upon heat treatment at 860°C, the amorphous glass 
halo disappears and distinct diffraction lines corresponding to FAP (00-003-0736) and 
wollastonite (CaSiO3-2M, (00-010-0489)) occur. The same crystalline phases are 
formed for GPF glass series with CaF2 less than 9.3 mol%. In the case of the partially 
crystalline glass GPF 17.8 that already crystallised to FAP, Ca4Si2O7F2 and CaF2 in the 
initial glass show an increase in the diffraction line intensities, particularly the ones for 
Ca4Si2O7F2 and CaF2 suggesting a further crystallisation after heat treated at 720°C. 
Similar changes were found in glasses GPF 13.6 and GPF 25.5. The XRD patterns of 
4.6 mol% CaCl2 containing glass, which is thought to be almost amorphous show the 
crystallisation of chlorapatite on heat treatment at 865°C and 962°C, as the diffraction 
lines match that of ClAP although some hydroxyl substitution in the apatite lattice can 
not to be entirely ruled out. There is also a trace of wollastonite present. In the case of 
GPFCl 23.1, the XRD pattern of glass after heat treated to 659°C is similar to the 
equivalent initial glass but higher in intensity which corresponds to FAP and CaF2. At 
708°C, cuspidine is found as an additional crystalline phase, while the intensity of 
CaF2 reduces slightly compared to the one at 659°C. The XRD results of these heat 
treated sample confirms that the first crystallisation exotherm evaluated above is a 
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crystallisation of a single phase for GPF 9.3, GPCl 2.3, GPCl 14 and GPCl 20.6 but 
crystallisation of several phases for the rest glasses. 
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Figure 8.2.1 The XRD patterns of the as-quenched and heat treated GPF 0.0. (ν: 
Ca10(PO4)6(OH)2; I: β-CaSiO3 (Pseudowollastonite)). 
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Figure 8.2.2 The XRD patterns of the as-quenched and heat treated GPF 4.5. (о: 
Ca10(PO4)6F2; ∇: CaSiO3). 
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Figure 8.2.3 The XRD patterns of the as-quenched and heat treated GPF 17.8. (о: 
Ca10(PO4)6F2; *: Ca4Si2O7F2; +: CaF2) 
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Figure 8.2.4 The XRD patterns of the as-quenched and heat treated GPCl 4.6. (●: 
Ca10(PO4)6(OH+Cl)2; ν: Ca10(PO4)6(OH)2) 
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Figure 8.2.5 The XRD patterns of the as-quenched and heat treated GPFCl 23.1. (о: 
Ca10(PO4)6F2; *: Ca4Si2O7F2; +: CaF2) 
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Table 8.2.1 Summary of phases crystallising on heat treatment for GPF series. β-CaSiO3: 
pseudowollastonite, Ca10(PO4)6(OH)2: hydroxyapatite, Ca10(PO4)6F2: fluorapatite, CaSiO3: 
wollastonite-2M, CaSiO3 (hexagonal): wollastonite-1A, Ca4Si2O7F2: cuspidine, CaF2: 
fluorite. 
Glasses THT (°C) Crystalline Phases 
GPF 0.0 1030 β-CaSiO3 and Ca10(PO4)6(OH)2 
GPF 3.0 
867 
Ca10(PO4)6F2 and CaSiO3 
888 
979 
GPF 4.5 860 
GPF 6.0 
817 
844 
942 Ca10(PO4)6F2 and CaSiO3 (hexagonal) 
GPF 9.3 
780 Ca10(PO4)6F2 
806 
Ca10(PO4)6F2 and Ca4Si2O7F2 
878 
GPF 13.6 
732 
758 
977 
GPF 17.8 720 Ca10(PO4)6F2, Ca4Si2O7F2 and CaF2 GPF 25.5 713 
 
Table 8.2.2 Summary of phases crystallising on heat treatment for GPCl series. β-CaSiO3: 
pseudowollastonite, Ca10(PO4)6(Cl+OH)2: chlorapatite with OH- substitution, CaSiO3: 
wollastonite-2M 
Glasses THT (°C) Crystalline Phases 
GPCl 2.3 913 Ca10(PO4)6(Cl+OH)2  1020 Ca10(PO4)6(Cl+OH)2 and CaSiO3 
GPCl 3.5 890 
Ca10(PO4)6(Cl+OH)2 and CaSiO3 GPCl 4.6 865 962 
GPCl 7.2 821 Ca10(PO4)6(Cl+OH)2 and β-CaSiO3 932 
GPCl 10.6 785 Ca10(PO4)6(Cl+OH)2 and trace amount of CaSiO3 889 Ca10(PO4)6(Cl+OH)2  and β-CaSiO3 
GPCl 14.0 751 Ca10(PO4)6(Cl+OH)2 775 
GPCl 20.6 716 795 Ca10(PO4)6(Cl+OH)2 and unidentified phase 
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8.3 FTIR Spectra of Heat Treated Glasses 
Figure 8.3.1- Figure 8.3.3 show the FTIR spectra of heat treated glasses GPF 4.5, 
GPF 17.8 and GPCl 4.6. For the initially amorphous glasses GPF 4.5 and GPFCl 4.6, 
upon heat treatment, the broad peak at about 500 - 600 cm-1 disappears and distinct 
split peaks at 560 and 613/605 cm-1 occur corresponding to P-O bending in the 
crystalline orthophosphate. The sharp peak at 1035 cm-1 corresponding to P-O 
stretching also appears. In addition, the spectrum for glass GPF 4.5 heat treated at 
860 °C also presents sharp band features in the region of 620-1000 cm-1, suggesting 
the formation of an ordered Q2 silicate crystalline phase, that CaSiO3 is one of the 
examples [161, 162]. This result is consistent with the presence of CaSiO3 in the XRD 
patterns (Figure 8.2.1). The partially crystallised glass GPF 17.8 (Figure 8.3.2), that 
demonstrates apatite split peaks and a sharp crystalline orthophosphate peak at 1035 
cm-1 in the initial glass shows the disappearance of amorphous Si-NBOs at 920 cm-1, 
increasing amplitude of the peaks at 845, 950 and 1090 cm-1 which corresponding to 
Q1 silicate in cuspidine and the presence of an additional distinctly sharp peak at 645 
cm-1 after heat treatment. This additional unidentified peak matches the OH bending in 
hydroxyapatite [163]. However, it is unlikely to form HAP in the heat treated glass-
ceramics, since in this glass composition the F/P ratio is higher than 1:3 and 
consequently phosphate is preferential to combine with F. It is worth noting that the 
intensity of the split peaks (P-O bending) do not change significantly on heat treatment 
for these partially crystalline glasses, while a sharpening of P-O stretching at 1035 cm-
1 is visible.   
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Figure 8.3.1 The FTIR Spectra of the as-quenched and heat treated GPF 4.5. 
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Figure 8.3.2 The FTIR Spectra of the as-quenched and heat treated GPF 17.8. 
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Figure 8.3.3 The FTIR Spectra of the as-quenched and heat treated GPCl 4.6 
8.4 MAS-NMR Spectra of Heat Treated Glasses 
8.4.1 31P MAS-NMR Spectra of Heat Treated Glasses 
The 31P MAS-NMR spectra for heat treated glasses GPF 4.5, GPF 17.8 and GPCl 4.6 
are presented in Figure 8.4.1-Figure 8.4.3. The spectra for all the heat treated samples 
show a progressive sharpening of the calcium orthophosphate peak at about 3 ppm. 
This sharpening of the peak is an indicative of apatite crystallisation. In the initial 
amorphous glasses GPF 4.5 and GPCl 4.6, phosphorus is randomly arranged in the 
glass and consequently the peaks are relatively broad. After heat treatment, most of 
the phosphorus in the glass matrix crystallises to apatite, which has a much more 
ordered structure, resulting in a sharp peak at 2.9 ppm. Moreover, for the largely 
crystallised glass GPF 17.8, most of the phosphorus has converted to apatite during 
the quench and only a small amount of amorphous phosphorus that did not have 
enough time to crystallise can convert to apatite upon heat treatment. Therefore a 
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relatively small change is seen for GPF 17.8 in Figure 8.4.2. Similar changes are 
shown in other partially crystalline glasses. 
 
Figure 8.4.1 The 31P NMR-NMR Spectra of the as-quenched and heat treated GPF 4.5. 
 
 
Figure 8.4.2 The 31P NMR-NMR Spectra of the as-quenched and heat treated GPF 17.8. 
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Figure 8.4.3 The 31P NMR-NMR Spectra of the as-quenched and heat treated GPCl 4.6 
8.4.2  19F MAS-NMR Spectra of Heat Treated Glasses 
Figure 8.4.4 - Figure 8.4.6 present the 19F MAS-NMR spectra of the heat treated GPF 
4.5, GPF 17.8 and GPFCl 23.1. As can be seen, the NMR spectra change significantly 
upon heat treatment for all the glass compositions. The spectrum for glass GPF 4.5 
heat treated at 860 °C has a sharp maximum at -104.5 ppm and an additional broad 
shoulder at -118 ppm corresponding to nonspecifically adsorbed F- [138]. In the case 
of GPF 17.8 on heat treatment at 720 °C, the full-height half width of the spectrum 
reduces considerably compared to the equivalent as-quenched glass and the 
maximum sits at -108 ppm corresponding to CaF2, the F-Ca(4) species. In addition, a 
shoulder at about -103 to -104 ppm assigns to FAP, F-Ca(3) species and cuspidine, F-
Ca(4) is also observed [164], which is in accord with the XRD patterns in Figure 8.2.2 
and Figure 8.2.3.  
As mentioned in Chapter 7, owing to the overlapping of different fluoride signals 
(amorphous F-Ca(4), crystalline F-Ca(3), crystalline F-Ca(4) and spinning side bands), 
a broad peak is observed for the as-quenched glass GPFCl 23.1. Upon heat treatment, 
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the amorphous fluoride species converts to a crystalline one which results in a 
reduction in FWHM of the signal, in particular for the sample heat treated at 708 °C. In 
addition, a distinctly sharp peak at -107.5 ppm with a shoulder at -103.5 ppm is 
detected (Figure 8.4.6), indicating the crystallisation of CaF2 and FAP after heat 
treatment at 708°C. 
 
Figure 8.4.4 The 19F NMR-NMR Spectra of the as-quenched and heat treated GPF 4.5. 
 
Figure 8.4.5 The 19F NMR-NMR Spectra of the as-quenched and heat treated GPF 17.8. 
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Figure 8.4.6 The 19F NMR-NMR Spectra of the as-quenched and heat treated GPFCl 23.1. 
 
8.5 SEM Results of Apatite Glass-ceramics 
  
  (a) (b) 
 
 
Figure 8.5.1 SEM of the fractured surface of GPF 4.5 (4.5 mol% CaF2) glass-ceramics 
heat-treated at 860 °C. 
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  (a) (b) 
 
 
Figure 8.5.2 SEM of the fractured surface of (a) GPCl 3.5 (2.5 mol% CaCl2) glass-
ceramics heat treated at 890 °C and (b) GPCl 4.6 (3.9 mol% CaCl2) glass-ceramics heat-
treated at 962 °C. 
The surface morphologies of GPF 4.5, GPCl 3.5 and GPCl 4.6 glass-ceramics 
investigated by SEM are shown in Figure 8.5.1 and Figure 8.5.2. Glass GPF 4.5 
crystallised to FAP with an elongated and interlocking crystal structure (dendritic) upon 
heat treatment at 860 °C with coexisting FAP and wollastonite phase (Figure 8.5.1 (a)). 
The typical needle-like and hexagonal crystal morphology of fluorapatite is also seen in 
Figure 8.5.1 (b) [148, 152, 165]. In contrast, the microstructure that consists of short 
polyhedra of chlorapatite is visible for GPCl 3.5 glass-ceramics heat-treated at 890 °C 
and GPCl 4.6 glass-ceramics heat-treated at 962 °C, in agreement with the equiaxed 
prisms of chlorapatite morphology detected by Esther et.al. [166]. To some extent, 
Figure 8.5.2 (a) suggests that on heat treatment the equiaxed chlorapatite crystals 
grew from the glass surface, whereas they are likely to form a spherical shape first 
then grow to a uniform equiaxed hexagonal crystal. 
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Further Discussion 
As both glass transition temperature and crystallisation temperature  are dependent on 
the strength of the chemical bonding in the glass, the marked reduction in the both Tg 
and TC1 with increasing in CaX2 (X=F/Cl/F+Cl) content suggests formation of a less 
strongly bound network in higher halide containing glasses [150]. This reduction is the 
consequence of forming “CaX+” species, which is also the key factor resulting in the 
decrease in Tg that has been discussed in detail in Chapter 5. 
The halogen free glass composition exhibits a marked temperature difference between 
the Tc1 values for frit and fine powder, while Tc1 of frit is higher than the equivalent 
powder. In addition the FWHM of the first exotherm increases markedly for the frit 
particles compared to the fine powder indicating pronounced surface nucleation of the 
first crystallisation phase. XRD shows that this zero halide containing glass crystallises 
largely to β-CaSiO3 along with apatite. β-CaSiO3 is a Q2 ring silicate, which is a phase 
known to strongly surface nucleate. The apatite is thought to be a hydroxyapatite, 
presented in hexagonal-like morphology (in Appendix, Figure 11.2.2). It is interesting 
but surprising that an apatite formed in the absence of fluoride, since in AM glass-
ceramics system apatite only forms when fluoride is present [148]. Here the detected 
hydroxyapatite is either thought to form initially as an oxyapatite, which subsequently 
reacts with water or a consequence of water vapour in the furnace atmosphere 
diffusing into the glass and enabling apatite formation from the glass surface. 
The incorporation of calcium halide (CaF2 / CaCl2 / CaF2+CaCl2) reduces the 
difference between the Tc1 values for frits and fine powder and leads to a largely bulk-
nucleated haloapatite being formed as the first crystallisation phase. As can be seen, 
the diffraction patterns of the heat treated glasses for the CaF2 series matched that of 
FAP, while the ones for CaCl2 series matched to chlorapatite diffraction lines although 
some hydroxyl substitution in the lattice cannot be entirely ruled out. Note that the 
diffraction patterns of the heat treated glasses for the mixed CaF2 and CaCl2 system 
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with the exception of GPFCl 2.6 are consistent with fluorapatite formation, rather than 
chlorapatite. This is simply because the fact that F- ion is smaller than Cl- ion and the 
FAP is more stable than ClAP. Once there is sufficient fluoride available for apatite 
formation, FAP will form preferentially. In the case of GPFCl 2.6, a mixed fluor-
chlorapatite is possible to form upon heat treatment, since the F/P ratio in glass 
composition is 1: 4.07 which is smaller than the equivalent 1:3 in FAP. The relatively 
excess P could combine with Cl to form chlorapatite.  
Upon heat treatment, all the GPF glass series with CaF2 lower than 9.3 mol% CaF2 
crystallised to FAP along with wollastonite. The heat treatment temperatures are too 
high to see FAP crystalline phase without wollastonite. The wollastonite phase was 
expected on the grounds that the residual glass phase following crystallisation of FAP 
would have a Q structure close to Q2 and also close to the stoichiometry of 
wollastonite. In the case of GPCl glass series, ClAP and wollastonite are typical 
crystallisation phases on heat treatment, while FAP and CaF2 are the major crystalline 
phase for GPFCl glass series.  It is worth noting that in these glasses the Q structure 
does not change on crystallisation and remains at about 2 (NC=2.08) irrespective of 
how much apatite crystallises, as it is the orthophosphate phase which crystallises. 
This is an attractive feature of these glass-ceramics, since the essentially Q2 
speciation of the residual amorphous glass will confer bioactivity.  The formed apatite 
may provide seed crystals for the formation of more apatite as the Q2 residual glass 
phase dissolves in body fluids. These glass-ceramics may combine the beneficial 
effects of a bioactive glass phase and the apatite crystals. 
In the case of glasses (GPF series) with CaF2 content over 6.0 mol% and GPFCl 23.1, 
FAP, cuspidine and CaF2 are found as the crystalline phases following heat treatment. 
Due to the fact that cuspidine is a Q1 species, the further increase of cuspidine 
formation upon heat treatment would probably lead to a more cross-linked glass 
network of the residual glass, which might reduce the bioactivity of the formed glass-
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ceramics. Although the initial glasses with cuspidine and CaF2 crystals showed a 
comparable glass degradation rate in Chapter 5 and 7. The comparison of bioactivity 
of the as-quenched glass and glass-ceramics formed upon heat treatment will be a 
subject for further research.  
Interestingly, the FTIR spectra of the heat treated CaF2 samples (in Appendix, Figure 
11.2.3) indicate that the amount of apatite formed during quenching for the glasses 
with CaF2 contents higher than 9.3 mol% is already as high as is possible to crystallise 
in total from these glasses. The spectra of those initially amorphous glasses (GPF 3.0, 
GPF 4.5 and GPF 6.0) demonstrate a clear development of the apatite split band at 
approximately 610 and 560 cm-1 on heat treatment and more pronounced in intensity 
with increasing heat treatment temperature. In contrast, the spectra (in Appendix, 
Figure 11.2.4) of those partially crystallised glasses that already contain the split bands 
at 560 and 613 cm-1 do not show a significant increase in intensity following heat 
treatment. This indicates that a further significant FAP formation did not happen. 
However, the further crystallisation of cuspidine was suggested from both of XRD and 
FTIR.  The sharpening of 1030 cm-1 band might be attributed to the loss of some Si-O 
stretching vibrations which reduces the overlapping of PO43- and Si-O stretch at 1030 
cm-1. 
Moreover, it is important to realize that the studied chloride glasses (GPCl series) are 
very reactive and appear to react with atmospheric water, as the glass is thought to 
contain calcium chloride like structural domains. It is possible that these domains 
inherit the extreme ability of the crystalline CaCl2 to absorb water causing structural 
transformations due to hydration reactions. This can account for the formation of 
chlorapatite with OH- substitution rather than pure chlorapatite upon heat treatment. 
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Summary 
The crystallisation temperature for the three glass series reduces with an increase in 
CaX2 content. The halogen free glass predominantly surface nucleates and crystallises 
to pseudowollastonite and apatite. The glasses with fluoride or chloride crystallised 
first to a haloapatite (FAP/ClAP/F-ClAP). The obtained chlorapatite glass-ceramics is 
the first set of ClAP glass-ceramics based on phosphosilicate glasses in the world. 
Glasses with 2.3 to 9.3 mol% CaX2 have a reduced tendency to surface nucleate to a 
haloapatite and are attractive for potential apatite glass-ceramics. The second 
crystallisation phase of low CaF2 containing glasses, chloride containing glasses and 
low CaX2 glasses is wollastonite. This strongly surface nucleated wollastonite is 
undesirable and would probably stop the AW glass-ceramics being produced by a 
direct casting route. However, it would be possible to crystallise these glasses to only 
apatite to form apatite glass-ceramics with a bioactive residual glass phase. The 
bioactive glass-ceramics with FAP as the only crystalline phase are potentially 
attractive for bone regeneration in medical and dental application, while the ClAP 
glass-ceramics are more promising as fully resorbable bone substitutes. Tailoring the 
fluoride and chloride ratio enables mixed haloapatites glass-ceramics with specific 
microstructures and in vivo resorbability to be produced.  
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9 Preliminary Results of Sodium and 
Phosphate-Free CaCl2 Glasses  
Foreword 
Bioactive glasses are silicate glasses that generally contain phosphate and that 
dissolve in physiological solutions forming hydroxycarbonated apatite on their surface 
[1, 52].  
Hench has expressed the bioactivity of bioactive glass in terms of composition on a 
phosphate free ternary SiO2-CaO-Na2O diagram. The region of bioactivity does not 
extend to the binary SiO2-CaO line, which would indicate that a wollastonite 
stoichiometry glass and especially one with the absence of phosphate would not be 
expected to be bioactive. 
Ebisawa and Ohura et al. [167, 168] investigated the bioactivity of wollastonite 
stoichiometry (SiO2-CaO) glass in simulated body fluid and found this glass to be 
bioactive and to form an apatite layer on its surface, although it is widely believed that 
bioactive glasses must contain sodium in order to be bioactive.  
Spilman et.al [169] first investigated the incorporation of CaF2 in the 45S5 glass 
composition and substituted CaF2 for CaO or Na2O in the original composition. 
However based on the 19F solid state nuclear magnetic resonance studies of silicate 
glasses by Hill et al. [79, 111, 113, 170], the studies of Brauer et al. [7, 150] and the 
computer simulations of Christie et al. [171] fluoride ions would be expected to be 
complexed by Ca forming F-Ca(n) species. The substitution of CaO by CaF2 would 
therefore result in a reduction in the non-bridging oxygen content and an increase in 
the network connectivity of the glass [20]. The resultant glasses with a more cross-
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linked network structure are expected to exhibit a reduced solubility and bioactivity [83]. 
Conversely, adding CaF2 as carried out by Brauer et al. [14-16] does not lead to the 
change in the silicate speciation or network connectivity. Under these circumstances, 
adding CaF2 would be expected to favour glass degradation and apatite-like phase 
formation. Therefore, in this work, the dissolution behaviour and crystallisation event of 
a simpler SiO2-CaO glass system to which CaF2 and CaCl2 have been added were 
investigated. 
Chlorine is expected to behave in a similar fashion as fluoride by forming Cl-Ca(n) 
species analogous to F-Ca(n) species. In addition, the large chloride ion is expected to 
expand glass volume and result in a much less compact glass structure. Moreover, a 
large chloride ion is likely to have the calcium cations more randomly arranged around 
it, therefore it is possible that a large amount of CaCl2 could be introduced into the 
glasses without significant crystallisation occurring.   
The simpler ternary glass system (SiO2-CaO-CaCl2) is expected to simplify the 
characterisation of glass structure and crystallisation events, and therefore could 
provide a better understanding of the role of Cl in the glass structure and glass 
properties. The extensive crystallisation in the SiO2-CaO-CaF2 glass series seen in the 
previous work [172] substantially complicated the characterisation; with the exception 
of the glass with 2.9 mol% CaF2, the rest of glasses were largely crystallised to 
wollastonite, psedowollastonite, cuspidine and CaF2. However, significant 
crystallisation was not expected to occur in the chloride containing silicate glasses, 
therefore, in the following the dissolution behaviour and crystallisation events of this 
glass series are presented and discussed. 
9.1 Results of the As-Quenched Glasses 
All of the studied glass frits of GCl series are optically transparent. Note that the 
glasses GCl 43.0 and GCl 53.1 were extremely reactive, the as-quenched glass frits 
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largely dissolved before being taken out from the water used for quenching the glass. 
The glass frits collected from the crucible of GCl 43.0 and GCl 53.1 were used for the 
further characterisation. .  
9.1.1 Compositional Analysis 
Figure 9.1.1 demonstrates the percentages of the retained chloride in the initial 
glasses after volatilization as CaCl2 against the as-designed chloride content. About 63 
-75 % of chloride was retained in the P free Q2 silicate glasses. The actual glass 
compositions were re-calculated based on the chloride component analysis and 
presented in Table 9.1.1. Note that, due to the fact that glass GCl 53.1 is very reactive, 
no fine glass powder (< 45 μm) was obtained for the compositional analysis. Here the 
actual glass composition for glass GCl 53.1 was calculated according to the linear 
relationship between Tg and CaCl2 content, which will be presented in section 9.1.4. 
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Figure 9.1.1 The percentage of the retained chloride in the initial glasses plotted against 
the as-designed chloride content. 
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Table 9.1.1 Glass compositions in mol%. For each glass, the first row is the nominal 
composition as-designed and the second row is the actual glass composition. 
Glass code SiO2 CaO CaCl2 
GCl 0.0 50.0 50.0 0.0 
50.0 50.0 0.0 
GCl 2.2 48.9 48.9 2.2 
49.2 49.2 1.6 
GCl 3.3 48.4 48.4 3.3 
48.8 48.8 2.4 
GCl 4.3 47.8 47.8 4.3 
48.5 48.5 3.1 
GCl 6.6 46.7 46.7 6.6 
47.6 47.6 4.7 
GCl 9.3 45.3 45.3 9.3 
46.7 46.7 6.5 
GCl 11.9 44.1 44.1 11.9 
45.9 45.9 8.2 
GCl 16.1 41.9 41.9 16.1 
44.8 44.8 10.5 
GCl 27.4 36.3 36.3 27.4 
40.4 40.4 19.2 
GCl 33.5 33.3 33.3 33.5 
38.8 38.8 22.5 
GCl 43.1 28.5 28.5 43.0 
36.3 36.3 27.3 
GCl 53.1 23.5 23.5 53.1 
 34.2 34.2 31.6 
 
9.1.2  XRD Results of the As-Quenched Glasses 
Figure  9.1.2 shows the XRD patterns of the as-quenched Na and P free glasses with 
varying amount of CaCl2 (0.0 to 27.3 mol%). In the case of CaCl2 free SiO2-CaO glass 
composition (GCl 0.0), clear diffraction peaks at 25.99°, 27.56°, 31.7°and 45.91° 2θ 
are noticed. These peaks match the characteristic diffraction peaks of 
Pseudowollastonite (β-CaSiO3: 04-012-1776). It is clear that all the studied CaCl2 
containing glasses are amorphous, as the XRD patterns only show amorphous halos. 
194 
 
Preliminary Results of Sodium and Phosphate-Free CaCl2 Glasses 
 
Taking a closer look, the maxima of the amorphous halos move slightly to a higher 2θ 
value (32° 2θ) when the CaCl2 content is over 10.5 mol%, while the glasses with CaCl2 
content lower than 19.2 mol% have the halos at about 30° 2θ.  
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Figure  9.1.2 The XRD patterns of as-quenched P free CaCl2 containing glasses. (I: β-
CaSiO3).  
9.1.3 FTIR Results of the As-Quenched Glasses 
The FTIR spectra of the as-quenched P free CaCl2 containing glasses are given in 
Figure 9.1.3. With the exception of glasses GCl 0.0, GCl 33.5 and GCl 43.0, the 
spectra of the rest of the glasses are similar to the ones for GPCl glass series in 
Chapter 6, which have the non-bridging oxygen (Si-O-) band at 920 cm-1, a band 
centred at 860 cm-1 assigned to the Si-O stretching band with two non-bridging 
oxygens per SiO4 tetrahedron and the Si-O-Si stretching band 1030 cm-1 [9, 173, 174]. 
The spectrum of GCl 0.0 shows in addition to those bands mentioned above the sharp 
band features at 720, 937 and 985 cm-1 corresponding to an ordered Q2 silicate 
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crystalline phase [161], which is CaSiO3 as suggested by XRD results (Figure  9.1.2). 
In the case of GCl 33.5 and GCl 43.0, an additional peak emerges at 683 cm-1. 
1600 1400 1200 1000 800 600
- 1
03
0 
- 6
83
 
- 9
20
 
98
5 
- 
86
0 
- 
93
7 
- 
  7
21
 - 
Wavenumber (cm-1)
Ab
so
rb
an
ce
 (a
.u
.)
GCl 43.0
GCl 33.5 
GCl 27.4
GCl 16.1 
GCl 11.9
GCl 9.3 
GCl 6.6 
GCl 4.3
GCl 3.3 
GCl 2.2 
GCl 0.0 
 
Figure 9.1.3 The FTIR spectra of as-quenched P free CaCl2 containing glasses.  
9.1.4 Glass Density and Molar Volume 
A reduction of glass density with an increase in CaCl2 content is shown in Figure 9.1.4. 
There is a break in density behaviour at the CaCl2 content of 19.2 mol%. The glasses 
with CaCl2 content either less or more than 19.2 show a linear relationship (Y=-
0.0139X+2.8886 R2=0.9883 or Y=-0.0301X+3.2175, R2=0.9972) between density and 
CaCl2 content for the both ranges. 
 
196 
 
Preliminary Results of Sodium and Phosphate-Free CaCl2 Glasses 
 
0 5 10 15 20 25 30
2.3
2.4
2.5
2.6
2.7
2.8
2.9
Y=-0.0301X+3.2175
R2=0.9972
Y=-0.0139X+2.8886
R2=0.9883
CaCl2 content (mol%)
De
ns
ity
 (g
/c
m
3 )
 
Figure 9.1.4 Glass density plotted as a function of the CaCl2 content. Note where error 
bars are not seen they are smaller than the data point. 
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Figure 9.1.5 Glass molar volume plotted as a function of CaCl2 content. Note where error 
bars are not seen they are smaller than the data point. 
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In Figure 9.1.5, glass molar volume is plotted as a function of the actual CaCl2 content. 
In contrast with the change of density with increasing CaCl2 content, the glass molar 
volume increases markedly from 20 cm3/mol for GCl 0.0 to 30.34 cm3/mol for GCl 43.0. 
This is due to the fact that the large chloride ion expands glass volume, to some extent 
diluting the glass network. A break in Vm behaviour is observed at the CaCl2 content of 
19.2 mol%, the identical transition point was seen in Density behaviour in Figure 9.1.4. 
Linear correlation (Y=0.5489X+15.276, R2=0.9966 or Y=3076X+20.041, R2=0.9989) 
was observed between glass molar volume and CaCl2 content before and after the 
transition point. 
9.1.5 DSC Results of the Na and P Free CaCl2 Containing Bioactive 
Glasses 
Figure 9.1.6 presents the DSC traces for glass frits of P free CaCl2 containing glasses. 
The obtained Tg, Tc and Tm from DSC traces with an accuracy of ±5 °C are 
summarised in Table 9.1.2. As shown in the Figure and table, all the glasses have at 
least one clear exotherm. Generally, Tc1 moves to lower temperatures with an increase 
in CaCl2 content and also reduces in amplitude. Whilst, the onset temperature for 
crystallisation occurs at least 140 °C above the Tg for the glasses with CaCl2 content 
lower than 27.3 mol%, but less than 100°C for those glasses with CaCl2 content of 
27.3 and 31.6 mol%. Furthermore, the clear endotherm peak around 120-150 °C 
corresponding to loss of water is found in the DSC trace for glasses with CaCl2 
contents higher than 19.2 mol%. This could be attributed to the CaCl2-like behaviour of 
chloride in the glass, which therefore absorbs water in the glass. The absorbed water 
is driven out on heating, resulting in an endothermic peak. This phenomenon is more 
pronounced in the high CaCl2 containing glasses. In addition, several other endotherm 
peaks also appear at about 782 °C, 895°C and 1060°C. 
Figure 9.1.7 shows the Tg, Tc1 and Tm1 of glass frit and melting point of CaCl2 plotted 
as a function of CaCl2 content. The circles represent the Tg values and the squares 
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represent Tc1 values. Additionally, the red squares belong to the glasses with CaCl2 
content less 19.2 mol%, while the blue squares belong to the glass compositions with 
higher CaCl2 (≥ 19.2 mol%). The dark cyan diamond represents Tm1 of the glasses, 
while the magenta triangle represents the melting point of CaCl2 (782 °C). It can be 
seen that, the Tg values decrease linearly (Y= -13.183X+786, R2=0.9991) from 783 to 
370 °C on adding 31.6 mol% CaCl2, suggesting that it is possible to keep large amount 
of CaCl2 in the glasses, whilst Tc1 values also reduce significantly with increasing 
CaCl2. Taking a closer look, a break in Tc1 behaviour is seen at 19.2 mol% of CaCl2 
content, which is analogous to that of glass density and molar volume. The Linear 
relationships (Y= -10.775X+955, R2=0.9753 or Y= -21.806X+1157, R2=0.9994) 
between Tc1 and CaCl2 content were observed in the glasses with CaCl2 content either 
lower or higher than 19.2 mol%. Additionally, it is interesting to note that the 
intersection of two linear relationships between Tc1 and CaCl2 meet at the melting point 
of CaCl2 at 782 °C. Furthermore, the glasses with CaCl2 content equal to or higher 
than 19.2 mol% have the Tm1 values close to 782 °C. 
The first crystalline phase of the glasses with CaCl2 contents less than 19.2 mol% is 
thought to be wollastonite, while the first crystalline phase of the glasses with higher 
CaCl2 (≥ 19.2 mol%) is thought to be CaCl2. Since these high CaCl2 containing 
compositions crystallise at lower temperature than 782°C, which is the melting point of 
CaCl2 and they all have a low melting temperature shown by the magenta triangles 
close to 782 °C. Thereby, the studied chloride glasses could have crystallised to CaCl2 
though they cannot do this, until the crystallisation temperature falls below the melting 
point of CaCl2. This indicates that in the chloride containing glasses, the chlorine is 
likely to be present as a Cl-Ca(n) species in an analogous fashion to F-Ca(n) in 
fluoride containing glasses [4, 79, 150]. The formation of Cl-Ca(n) species is supported 
by the limited study by Sandland et al [84]. 
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Figure 9.1.8 and Figure 9.1.9 show the DSC traces for frit (1-2 mm) and fine powder of 
GCl 0.0 and GCl 2.2. As mentioned in previous chapters, Tg is an inherent 
characteristic of glasses and is independent of particle size, which agrees with the 
identical Tg values for the glass with different particle sizes shown in Figure 9.1.8 and 
Figure 9.1.9. In contrast with the Tg behaviour, Tc1 for both glass compositions are 
particle size dependent, while the Tc1 for frit is much higher than the equivalent one for 
fine powder. This indicates that the first crystallisation phase for both GCl 0.0 and GC 
2.2 is likely to crystallise from surface. The same crystallisation mechanism is shown 
for the glasses with CaCl2 content no more than 10.5 mol% in the GCl series. This is 
consistent with the assumption proposed above that the first crystalline phase of the 
glasses with CaCl2 less than 19.2 mol% is wollastonite.   
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Figure 9.1.6 DSC traces for the glass frits of P free CaCl2 containing glasses. The 
numbers are nominal molar percentage of CaCl2 in the compositions   
 
 
 
200 
 
Preliminary Results of Sodium and Phosphate-Free CaCl2 Glasses 
 
Table 9.1.2 Characteristic temperatures (°C ) of glass frits for P free CaCl2 containing 
glasses. 
Glass Code Tg To1 Tc1 Tc2/c3 Tm1 Tm2/m3 To1-Tg 
GCl 0.0 782 922 958 1020 - - 140 
GCl 2.2 768 919 948 - - - 151 
GCl 3.3 757 906 927 - - - 149 
GCl 4.3 749 892 913 - - - 143 
GCl 6.6 728 875 901 - - - 147 
GCl 9.3 697 850 880 - - - 153 
GCl 11.9 673 837 867 - - - 164 
GCl 16.1 639 803 842 - 1061 - 164 
GCl 27.4 528 700 736 - 806 891 172 
GCl 33.5 491 637 669 - 822 890/1062 146 
GCl 43.0 429 528 560 - 778 892/1060 99 
GCl 53.1 370 432 450 607/605 782 898/1060 62 
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Figure 9.1.7 Glass transition temperature, first crystallisation temperature, first melting 
temperature and the melting point of CaCl2 profiled as a function of CaCl2 content.  
Linear relationship (Y=-13.183X+786, R2=0.9991) between Tg and CaCl2 content are 
shown in the glasses. Another liner relationships (Y=-10.775X+955, R2=0.9753 or Y=-
21.806X+1157, R2=0.9994) between TC1 and CaCl2 content are shown in the glasses with 
CaCl2 content either lower or higher than 19.2 mol%. 
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Figure 9.1.8 DSC traces for frit and <45 µm powder of GCl 0.0 demonstrating surface 
nucleation of the first crystallisation phase. 
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Figure 9.1.9  DSC traces for frit and <45 µm powder of GCl 2.2 demonstrating surface 
nucleation of the first crystallisation phase. 
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9.2 Dissolution Study in Tris Buffer Solution 
The dissolution study of the P free CaCl2 containing glasses was carried out in Tris 
buffer solution. The characterisation of the collected precipitates was performed by 
using XRD and FTIR. Note that only those glasses with CaCl2 content no more than 
10.5 mol% underwent the dissolution study and are presented in this chapter. This is 
because glasses with high CaCl2 content (≥ 19.2 mol%) are extremely hygroscopic 
which makes studies problematic. 
9.2.1 X-ray Diffraction Results 
XRD patterns of glass compositions GCl 0.0 and GCl 2.2 before and after 3 days 
immersion in Tris are selected and presented in Figure 9.2.1 and Figure 9.2.2. The 
partially crystalline glass GCl 0.0 that crystallised to β-CaSiO3 during quenching 
showed a reduction in intensities of the β-CaSiO3 diffraction lines after 3 days 
immersion, suggesting the dissolution of the β-CaSiO3 crystals. It is clear that the 
amorphous glass phase dissolves much faster than the crystalline phase (β-CaSiO3). 
In addition, the amorphous glass halo disappears at 30° 2Ө 2Ө while another halo 
appears at 22° 2Ө, indicating the degradation of glass phase and the formation of an 
ion-depleted glass [9, 20]. In the case of the initial amorphous glass GCl 2.2, the 
position of amorphous halo has shifted to 22° 2Ө compared to the untreated glass, this 
is thought to be attributed to formation of an ion-depleted glass or silica-gel [20]. A 
similar evolution was observed in the rest of the CaCl2 containing glasses, which are 
shown in Figure 9.2.3.  
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Figure 9.2.1 The XRD patterns of the glass precipitates with 0.0 mol% CaCl2 collected 
after 3 days immersion in Tris (I: β-CaSiO3). 
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Figure 9.2.2 The XRD patterns of the glass precipitates with 1.6 mol% CaCl2 collected 
after 3 days immersion in Tris. 
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Figure 9.2.3 The XRD patterns of the glass precipitates collected after 3 days immersion 
in Tris (I: β-CaSiO3). 
9.2.2 Fourier Transform Infrared Spectroscopy Results 
Figure 9.2.4 and Figure 9.2.5 show the FTIR results of glasses GCl 0.0 and GCl 2.2 
that were chosen above for the XRD results after 3 days immersion in Tris buffer. The 
spectrum at the bottom of each figure belongs to the as-quenched glass that was 
discussed above. For those two glasses, after three days immersion the non-bridging 
oxygen bands at 920 and 860 cm-1 disappear, while the clear peaks at 792 (the Si-O 
bending vibrations), 945 and 1042 cm-1 (Si-O stretching) and a broad band at 1200-
1250 cm-1 (Si-O-Si stretching) develop [174-176]. The changes suggest the loss of the 
non-bridging oxygen bands due to leaching of Ca2+ and dissolution of soluble silica at 
the glass interface and the formation of silica-gel [175]. Similar changes were found in 
the rest studied CaCl2 containing glasses (Figure 9.2.6). Moreover, for the glass GCl 
0.0, a clear decrease in intensity of the peak at 721 cm-1 indicates the dissolution of 
crystalline CaSiO3. This is in good agreement with the XRD results shown above. 
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Figure 9.2.4 The FTIR spectra of the glass precipitates with 0.0 mol% CaCl2 collected 
after 3 days immersion in Tris. 
1600 1400 1200 1000 800 600
0 h 
3 d 
Wavenumber (cm-1)
Ab
so
rb
an
ce
 (a
.u
.)
 
Figure 9.2.5 The FTIR spectra of the glass precipitates with 2.2 mol% CaCl2 collected 
after 3 days immersion in Tris. 
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Figure 9.2.6 The FTIR spectra of the glass precipitates collected after 3 days immersion 
in Tris. 
9.3 Crystallisation Phase Identification 
9.3.1 X-ray Diffraction Results of Heat Treated Glasses 
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Figure 9.3.1 The XRD patterns of the GCl glass series upon heat treatment. The numbers 
in the brackets represent the heat treatment temperature. 
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Figure 9.3.2 The XRD patterns of the GCl glass series (CaCl2 content ≤ 16.1 mol%) upon 
heat treatment. The numbers in the brackets represent the heat treatment temperature. (I: 
β-CaSiO3; ∇: CaSiO3; ?: UP (unidentified phase) I; ?: UP II) 
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Figure 9.3.3 The XRD patterns of the GCl glass series (CaCl2 content ≥ 11.9 mol%) upon 
heat treatment. The numbers in the brackets represent the heat treatment temperature. (I: 
β-CaSiO3; ∇: CaSiO3; ?: UP II; ?: UP III; ?: UP IV; ?: UP V) 
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Figure 9.3.1 shows the XRD patterns of all the heat treated P free CaCl2 containing 
glasses. Several crystalline phases contribute to the diffraction lines that strongly 
overlap. In order to have a better and clearer view, the glasses with CaCl2 contents up 
to 10.5 mol% are presented in Figure 9.3.2, while the glasses with CaCl2 content equal 
to or higher than 11.9 mol% are shown in Figure 9.3.3. Figure 9.3.2 shows, the 
diffraction lines developed upon heat treatment for the studied glasses (≤ 10.5 mol%) 
largely match those for β-CaSiO3. In addition, for the glasses with CaCl2 content equal 
to or less than 6.5 mol%, the diffraction lines also match those of CaSiO3 are also 
seen. The intensity of those diffraction lines reduce when the CaCl2 content is over 3.1 
mol%. On close examination of the pattern for GCl 0.0, some unknown peaks that are 
labelled as red question mark corresponding to an unidentified phase are seen. 
However, due to the fact that more than one crystalline phase forms upon heating and 
the lack of reference patterns for chlorosilicate phases, it is extremely difficult to 
determine the crystalline phases upon heat treatment. In the case of GCl 11.9 and GCl 
16.7, apart from the diffraction lines corresponding to the β-CaSiO3 after heat 
treatment, additional diffraction lines (labelled as black question mark corresponding to 
unidentified phase two) at 6.06°, 24.44°, 29.55°, 29.79° and 30.56° 2θ are also 
observed. However, these diffraction lines do not match completely with any known 
phase in the database although some of them match the ones for Si3O6·H2O (00-25-
1332).  
The XRD patterns of the heat treated glasses GCl 27.4 and GCl 33.5  (in Figure 9.3.3) 
also have a similar distinct diffraction line at low two theta values (6.75° 2θ) as glasses 
GCl 11.9 and GCl 16.7. Moreover, several additional lines emerge at 7.99°, 10.3°, 
31.41°, 38.54° and 46.36° corresponding to unidentified phase three, which might be 
H2Si14O29·5.4H2O  (labelled as green question mark). In the case of GCl 43.0, the 
diffraction lines at 9.03°, 24.1°, 32.22°, 35.83°, 37.33° and 44.55° are visible after heat 
treatment at 565°C. These peaks are also found in the XRD pattern for glass GCl 33.5 
after heat treated at 675 °C and assigned to unidentified phase four (labelled as 
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magenta question mark), Ca10Si6O21Cl2 could be a possibility. Furthermore, diffraction 
lines at 10.3° 29.91°, 33.29° and 47.16° corresponding to unidentified phase five 
(labelled as orange question mark) present in the patterns of the heat treated GCl 27.4, 
GCl 33.5 and GCl 43.0. The unidentified phase five is very likely to be CaCl2. DSC 
traces of these three glasses all have a relatively sharp endotherm around 782°C. 
Moreover, one of the acquired XRD patterns of the heat treated GCl 43.0 showed a 
weak evidence of the diffraction lines corresponding to CaCl2·4H2O. Owing to the 
extremely reactive nature of these high CaCl2 containing glasses, the collected XRD 
patterns are very complicated and another technique is required for independent 
verification of possible phases forming. To further analyse the crystallisation phases, 
35Cl and 29Si MAS-NMR would be very useful.    
9.3.2 Fourier Transform Infrared Spectroscopy Results of Heat 
Treated Glasses 
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Figure 9.3.4 The FTIR Spectra of the heat treated GCl glass series. The numbers in the 
bracket represent the heat treatment temperature. 
The main features of the FTIR spectra of heat treated GCl glass series are the 
appearance of peaks at 550-1200, 1400-1650 and 3000-3700 cm-1, as shown in 
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Figure 9.3.4 and Figure 11.2.5 (in Appendix). The presence of bands at 560, 642, 666, 
710, 903, 915 937, 980, 1050 and 1084 cm-1 in the spectra of those glasses samples 
with CaCl2 equal or less than 10.5 mol% confirms the existence of the β-CaSiO3 phase 
in the structure [177]. This is consistent with the XRD results. The bands at 3345 and 
3412 cm-1 could be associated with the OH- absorption bands. The vibration of O-H is 
also reflected at about 1620 cm-1, indicating the presence of adsorbed water [175, 178]. 
The new bands emerge at 692, 721, 732 and 1112 cm-1 for glasses GCl 27.4, GCl 33.5 
and GCl 43.0 are related to Si-O-Si vibration mode [176], suggesting the presence of a 
silicate crystalline phase upon heat treatment. The double peaks at 1423 and 1475 cm-
1 match that of C-O stretching vibration band in CO32- in the literature [175, 178, 179]. 
According to the XRD and FTIR results, the potential crystallisation phases of the GCl 
glass series upon heat treatment are summarised in the appendix. 
Further Discussion 
The existence of such a wide glass forming region in this ternary system has not been 
anticipated because there is practically no information in the literature on a maximum 
amount of chloride possible to incorporate into silicate glasses. The fact that the glass 
composition with nearly equal amounts of SiO2, CaO and CaCl2 has been synthesised 
is surprising and could not have been predicted especially taking into account chloride 
losses. Moreover, the composition GCl 53.1 did not crystallise, thus, implying that it still 
would be possible to extend glass formation further to higher CaCl2 content. However, 
reactivity of the high chloride containing glasses is extremely high and the material 
would require a different quenching regime. 
The glass transition temperature, first crystallisation temperature and glass density 
reduce significantly with an increase in CaCl2 content, while the glass molar volume 
increases remarkably with increasing CaCl2 content. It is worth noting that a break in 
behaviour in these properties occurs when the incorporated of CaCl2 content is around 
19.2 mol%. The presence of a break in behaviour is likely to be attributed to a change 
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of glass structure. In the glasses with relatively low CaCl2 content (≤ 10.5 mol%), glass 
structure is dominated by the silica structure. With an increase of CaCl2 content to over 
19.2 mol%, the glass structure might be dominated by chloride clusters. 29Si and 35Cl 
MAS-NMR will be carried out to further investigate the glass structure.  
The expansion of the glass volume arising from the presence of CaCl2 aids glass 
degradation, the dissolution study in Tris buffer suggests the completion of glass 
degradation with 3 days immersion. Due to the absence of PO43- in Tris, no apatite or 
other phase formation was detected after immersion. For this glass series, SBF 
solution might be more informative for the apatite formation study, as it provides 
phosphate although the composition of SBF is deficient in phosphate relative to the 
apatite stoichiometry. The Ca:P ratio of SBF is approximately 2.5 compared with 1.67 
for apatite. However, the presence of P2O5 in the glass is not essential to achieve 
some bioactivity, as long as P can be provided from other sources, such as SBF and 
saliva. It was shown by Ebisawa et al. that P2O5 free glasses can also show some 
bioactivity in SBF [167].  
The XRD patterns and FTIR spectra of the heat treated GCl glass series consistently 
indicate that β-CaSiO3 is the main crystalline phases in the glasses with CaCl2 content 
equal or less than 16.1 mol%. CaSiO3 is the other crystalline phase in the glasses with 
CaCl2 content no more than 11.9 mol%. The amount of CaSiO3 formation reduced with 
increasing CaCl2 content over 4.3 mol%. It seems that CaSiO3 formation is favoured at 
high temperature. Multiple crystalline phases formed in the heat treated samples and 
the identification has proved to be very difficult as shown above. 
DSC results show that the glasses (≥ 19.2 mol%) with Tc1 less than 782 °C have the 
endothermic peak corresponding to CaCl2 melting at around 782 °C; in other words, 
CaCl2 is one of the potential crystalline phases for those three glasses. The XRD 
patterns of the heat treated glasses with high CaCl2 content (≥ 19.2 mol%) did 
demonstrate new crystalline phases which differ from wollastonite, however, those 
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developed diffraction lines do not match that of CaCl2. It seems to contradict to the 
DSC results shown above but it is necessary to note that those high chloride 
containing glasses have a strong tendency to react with atmospheric water during 
XRD data collection. Therefore it is possible that the obtained diffraction lines reflect 
the crystalline phase after reacting with atmospheric water, rather than the crystalline 
phase crystallised from the glass itself and calcium chloride is still thought to be the 
crystalline phase. To some extent, this suggests the possibility of forming Cl-Ca(n) 
species. The formation of CaCl2 suggests that the glasses may contain Cl-Ca(n) 
species. This can be related to the fluoride glasses which have F-Ca(n) species 
crystallise upon heat treatment to CaF2, Ca10(PO4)6F2 and Ca4(Si2O7)F2, which all have 
the F-Ca(n) species [111]. 
Summary 
The wollastonite stoichiometry glasses with varying CaCl2 content from 0.0 to 31.6 
mol% were synthesised by a melt-quenched route. The XRD results of the as-
quenched glasses indicate that the studied P free CaCl2 containing glasses are 
amorphous; while the glass that only consists of CaO and SiO2 (GCl 0.0) has partially 
crystallised to β-CaSiO3. The significant reduction of glass transition temperature and 
first crystallisation temperature with CaCl2 content suggest the possibility of forming Cl-
Ca(n) species. A reduction in glass density and the increase in the glass volume with 
an increase in CaCl2 content reveal that chloride expands glass volume. A break in 
behaviour in Tg, TC1, D and Vm was observed when the CaCl2 content is around 19.2 
mol%. On immersion, glasses dissolved within 3 days immersion in Tris but no apatite 
formation was found. Upon heat treatment, the glasses with CaCl2 content equal or 
less than 10.5 mol% that have Tc1 higher than the melting temperature of CaCl2 
crystallised to wollastonite (CaSiO3 and β-CaSiO3). For the glasses with CaCl2 content 
equal or higher than 19.2 mol%, which have Tc1 lower than 782°C are likely to 
crystallise to CaCl2. 
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10 Comparison of Halide Containing 
Bioactive Glasses 
The objective of this chapter is to compare the data from the four series of glasses, 
including the retention of chloride, the glass transition temperature, density, molar 
volume, structure, glass degradation and apatite-like phase formation.    
10.1 The Retention of Chloride 
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Figure 10.1.1 The percentage of the retained chloride in the initial glasses against the 
chloride content 
The percentages of the retained chloride in the initial glasses after chloride loss are 
plotted against CaX2 content for the three series of chloride glasses (GPCl, GPFCl and 
GCl series) in Figure 10.1.1. As mentioned in the previous chapters (Chapter 6, 
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Chapter 7 and Chapter 9), a large proportion (62 - 92%) of chloride was retained in the 
studied glasses which are predominantly Q2 in structure confirmed by the 29Si MAS-
NMR (Figure 6.1.5). Although in all of these glasses the formation of the Cl-Ca(n) is 
assumed. It is clear that the phosphate free CaCl2 containing glasses have a relatively 
lower chloride retention compared with the glasses with phosphate. To some extent, 
Cl-Ca(n) species might preferentially associates with orthophosphate tetrahedra. Thus, 
the absence of phosphate might lead to a higher amount of chloride loss. An 
unpublished molecular dynamics simulation study from Pedone [180] supports this. 
This indicates that the medium-range structure can influence retention of chloride and 
not just the immediate short-range local environment. To achieve a better 
understanding of the glass structure, future work i.e. 35Cl MAS-NMR and a systematic 
molecular dynamics simulation study should be carried out. 
10.2  The Glass Transition Temperature 
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Figure 10.2.1 Glass transition temperature of the frit profiled as a function of CaX2 
content. 
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Figure 10.2.1 presents the glass transition temperature of the frit against CaX2 
(X=F/Cl/F+Cl) content for GPF, GPCl,GPFCl and GCl glass series. For each of glass 
series, there is a reduction in Tg with an increase in CaX2 content. It is thought to be 
attributed to the formation of ‘CaX+’ species, which behave in a similar fashion to Na+ 
cations. Note that “CaX+” represents as “CaF+” for GPF glass series and “CaCl+” for 
both GPCl and GCl glass series, while “CaX+” could be “CaF+” plus “CaCl+” or 
“Ca(Fa/Cl(1-a))+” (0<a<1) for GPFCl glass series. As discussed previously in Chapter 5, 
the formation of ‘CaX+’ species knock out the ionic bridge between two NBOs by 
divalent calcium ions and therefore disrupts the glass network, which accounts for the 
observed reduction behaviour in Tg. 
Generally, Tg values for the P2O5 containing glasses with CaX2 (X=F/Cl/F+Cl) content 
less than 10 mol% are pretty much identical between the series. Owing to the 
significant crystallisation of fluoride containing phases, a higher Tg of GPF glass series 
relative to GPCl glass series is observed when CaX2 (X=F/Cl) content is higher than 
10 mol%. As discussed in Chapter 5, the crystallisation of fluoride containing phases 
effectively removes fluoride from the glass matrix; therefore, Tg reduced less in the 
glasses with higher crystallinity. Instead of having intermediate values, the Tg of mixed 
CaF2 and CaCl2 glasses lie below those of the glasses with a single calcium halide. To 
some extent, this might be similar to the known mixed alkali effect shown for instance 
by Isard [181] and Brauer et. al. [182]; there could be a mixed halide effect. Comparing 
the Tg values for the GPCl series with the ones for GCl glass series, no significant 
difference was observed. This indicates that phosphate does not play a significant role 
in changing the Tg of in the studied glasses. Theoretically, CaCl2 containing glasses 
should have a lower Tg reduce compared to CaF2 containing glasses, since the 
chloride ion is larger than the fluoride ion. A large ion would be expected to result in a 
more expanded open glass network that may lead to a lower Tg [183]. Interestingly, 
almost identical Tg values of the amorphous glasses (< 10 mol% CaX2) from both GPF 
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and GPCl glass series were found here. There is no certain answer about it at the 
moment. In the future, amorphous scattering studies may help here. 
Tg is a significant parameter, which can be used to indirectly predict glass solubility, 
degradability and hardness of glasses within certain compositional ranges [6, 42]. The 
hardness measurement of bioactive glasses is challenging, because of their tendency 
to crystallise during casting and their tendency to surface react during sample 
preparation. However, both Tg and glass hardness are expected to be determined by 
the average bond strength in the glass structure, thus hardness and Tg might be 
expected to exhibit a strong correlation. O’Donnell [41] proposed that a strong linear 
correlation between Tg and the hardness of bioactive glass exists, where the glass with 
a lower Tg is expected to have a lower hardness. In addition, Farooq et.al. have found 
a reduction of the hardness with a decrease in Tg for the CaF2 containing bioactive 
glasses when increasing the amount of Na2O in the glass [6]. According to the strong 
relationship between Tg and CaX2 content a glass with an optimised hardness can be 
designed for different applications. The glasses with a hardness lower than enamel are 
particularly of interest for desensitising toothpastes [41] and air abrasion polishing [6, 
98].  
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10.3  Glass Density and Molar Volume  
10.3.1 Glass Density  
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Figure 10.3.1 Glass density profiled as a function of CaX2 (X=F/Cl/F+Cl) content. Linear 
relationships (Y=0.0033X+2.9293, R2=0.9292 and Y=-0.0069X+2.9391, R2=0.9792) between 
density and CaX2 content are shown in GPF and GPCl glass series.  
Glass density values of the GPF, GPCl, GPFCl and GCl glass series are plotted 
against CaX2 content in Figure 10.3.1. A clear increase in density is visible with 
increasing CaF2 content for the GPF glass series, conversely, the density of GPCl 
glass series decreases with an increase in CaCl2 content. The presence of both CaF2 
and CaCl2 is likely to neutralize the changes in density, which accounts for the fact that 
the density values of GPFCl glass series fall in between the equivalent of GPF glass 
series and GPCl glass series. The values fluctuate between 2.9 and 2.93 g/cm3 and 
are practically independent of CaX2 content, though clear linear relationships were 
found for the single calcium halide containing glass series (GPF and GPCl series). 
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The density estimated (Dc) from the individual series density values assuming an equal 
effect of fluoride and chloride (in Appendix, Table 11.2.3) are higher than the obtained 
experimentally (De) for the mixed series. Thus, for the most glasses (GPFCl 5.3, 
GPFCl 12.1, GPFCl 16.0 and GPFCl 23.1) from GPFCl series, chloride has a stronger 
effect than fluoride.  
 In the case of the GCl glass series, the density reduces with increasing in CaCl2 
content. A comparison of the density values of the GPCl series and GCl series shows 
that the CaCl2 containing glasses with the absence of phosphate have lower density 
values. 
 As proposed by Brauer et al.[123], the density of CaF2 containing glasses consists of 
a combination of both silicate glass and CaF2-like phase. Chloride is thought to behave 
in the similar way to CaF2, therefore, the density of chloride containing glasses would 
be composed of both silicate glass and CaCl2-like species. For the GPCl glass series, 
the density of silicate glass part can be separated into silicate part (Q3 and Q2) and 
phosphate (Ca3(PO4)2) part, 31P MAS-NMR indicated that phosphate is present as 
orthophosphate in Chapter 6 (Figure 6.1.4). Ca3(PO4)2 has a density of 3.14g/cm3 
which is higher than the equivalent silicate part (Q3: 2.68g/cm3 and Q2:2.89g/cm3). The 
P free GCl glasses have the NC equal to 2, therefore the glass density are expected to 
be lower than the GPCl glasses series, this agrees with the experimental data.  
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10.3.2 Glass Molar Volume 
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Figure 10.3.2 Glass molar volume profiled as a function of CaX2 (X=F/Cl/F+Cl) content. 
Linear relationships (Y=0.223X+2.21.423, R2=0.999, Y=0.1037X+21.509, R2=0.9954 and 
Y=0.00278X+21.5, R2=0.9535) between density and CaX2 content are shown in GPF, GPCl 
and GPFCl glass series. 
Figure 10.3.2 shows the glass molar volume of the four series of glasses plotted as a 
function of CaX2 content. It is interesting to see that the glass molar volume increases 
linearly with an increase in CaX2 content for all three series of phosphate containing 
glasses. The increased slope for GPCl series is more pronounced than the equivalent 
GPFCl series, which is much more significant than the equivalent GPF glass series. 
The dominating factor resulting in this difference is the fact that the chloride ion is 
substantially larger than the fluoride ion. Therefore the expansion of glass volume by 
incorporating chloride is much more pronounced than by incorporating fluoride alone, 
whilst, incorporating mixed fluoride and chloride lies in between. It is interesting to 
know how fluoride and chloride affect the glass molar volume in the mixed glass 
system. Do they have same strength of the effect? According to the proportion of CaF2 
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content in CaX2 (59.5 %-62.5%) and CaCl2 in CaX2 (37.5 %-40.5%) and the slopes in 
the linear relationships between Vm and CaX2 content for GPF and GPCl series, the 
slope in the linear relationship for mixed series can be calculated. Suppose that the 
presence of CaF2 and CaCl2 show the same strength of the effect for the changes in 
glass molar volume, then the slope can be calculated by weighted sum model, which 
gives values between 0.101 to 0.1068. Compared these values to the slope (0.1037) 
from the experimental data, they are within 3% error. Thus, the conclusions can be 
drawn as that the presence of CaF2 and CaCl2 have same strength in affecting glass 
molar volume and it is possible to tailor the glass molar volume by changing the CaF2 
to CaCl2 ratio. 
By the comparison of the Vm from GCl series and GPCl series, it is clear that the Vm 
values for the GCl glass series are lower than the ones for the GPCl glass series when 
the CaCl2 content is less than 19.2 mol%. This is in a good agreement with the result 
found by Doweidar [184] that Vm increases with an increase in P2O5 content. 
The molar volume which was used to mirror the compactness of the glass can be also 
used to predict glass hardness [185]. On incorporation of CaX2, the glass hardness 
would be expected to decrease, as a consequence of a reduced compactness of the 
glass by expanding the glass volume. This is in a good agreement with the reduction in 
Tg with increasing in CaX2 content. Moreover, the glasses with larger molar volume are 
expected to have a lower crystallisation tendency and a faster glass degradation rate. 
10.4  Crystallisation Tendency of the As-Quenched Glasses  
The XRD patterns of the as-quenched glasses for the four glass series are 
summarized in Figure 10.4.1 (a)-(d) for convenient comparison purpose, although, 
they have been described and discussed in Chapter 5, 6, 7 and 9 in detail. Due to the 
fact that, chloride ion is bigger than fluoride ion, it is expected that within the four 
series of glasses, the fluoride containing glasses (GPF series) will crystallise most 
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readily, while the chloride containing glasses (GPCl and GCl series) will crystallise less 
readily and the mixed fluoride and chloride containing glasses (GPFCl series) will have 
an intermediate crystallisation tendency. The XRD patterns of the GPF glass series do 
suggest a high crystallisation tendency of this glass series. On incorporating CaCl2 
rather than CaF2, the tendency of the glasses to crystallise is suppressed for both 
GPCl and GCl glass series. All the CaCl2 containing glasses are largely amorphous, 
while the minor mixed hydroxy-chlorapatite detected by XRD is thought to form by 
reacting with atmospheric water on the surface of samples during the course of 
acquiring the XRD pattern for the GPCl glass series. Incorporating chloride as 
opposed to fluoride would be expected to result in a reduced tendency to 
crystallisation, since the lattice energies of the equivalent crystalline phase (ClAP) is 
likely to be smaller than FAP [186] and a large chloride ion is less likely to order 
calcium cations around itself than a smaller fluoride ion. A consequence of this is that 
larger amounts of CaCl2 (up to 31.6 mol%) than CaF2 can be incorporated into the 
glasses without significant crystallisation occurring during quenching. An intermediate 
crystallisation tendency in between GPF and GPCl glass series was not seen for the 
mixed CaF2 and CaCl2 glass series. In reality, the GPFCl glass series show a slightly 
increased tendency to crystallise compared to the equivalent GPF glass series but a 
lower crystallinity. As mentioned previously, the presence of chloride expands the glass 
volume effectively and therefore to some extent facilitates the arrangement of calcium 
cations around a fluoride ion. As a consequence, a higher tendency of crystallisation 
was observed for GPFCl series than GPF series.  
222 
 
Comparison of Halide Containing Bioactive Glasses 
 
 
20 30 40 50 60
* °*
*
*
*
+
+
+ *
*
° °
*
°
°
°
°
°
°
°
°
°
GPF 25.5  
GPF 17.8 
GPF 13.6  
GPF 9.3 
GPF 6.0  
GPF 4.5  
GPF 3.0  
In
te
ns
ity
 (a
.u
.)
GPF 0.0  
2θ (°)  
20 30 40 50 60
#
#
##
#
 GPCl 20.6 
 GPCl 14.0 
 GPCl 10.6
  GPCl 7.2
 GPCl 4.6
 GPCl 3.5 
 GPCl 2.3
In
te
ns
ity
 (a
.u
.)
 GPCl 0.0  
2θ (°)  
 
(a) 
 
(b) 
  
20 30 40 50 60
° °°
+
+
+°°°°
°°°
°
°°
°
°
°°
GPFCl 23.1 
GPFCl 16.0 
GPFCl 12.1 
GPFCl 8.3 
GPFCl 5.3 
GPFCl 4.0 
GPFCl 2.6 
2θ (°)
In
te
ns
ity
 (a
.u
.)
 
20 30 40 50 60
I
I
I
II
2θ (°)
In
te
ns
ity
 (a
.u
.) GCl 43.0 
GCl 33.5 
GCl 27.4 
GCl 16.1 
GCl 11.9 
GCl 9.3 
GCl 6.6 
GCl 4.3 
GCl 3.3
GCl 2.2 
GCl 0.0 
 
  
(c) (d) 
  
  
Figure 10.4.1 The XRD patterns of as-quenched (a) CaF2 containing glasses; (b) CaCl2 
containing glasses; (c) mixed CaF2 and CaCl2 containing glasses; (d) P free CaCl2 
containing glasses (о: Ca10(PO4)6F2; *: Ca4Si2O7F2; +: CaF2; #:Ca10(PO4)6(OH/Cl)2; I: β-
CaSiO3). 
10.5  31P NMR Results of the As-Quenched Glasses  
The 31P MAS-NMR spectra of the as-quenched CaF2 containing glasses, CaCl2 
containing glasses and mixed CaF2 and CaCl2 containing glasses suggest that 
phosphate is present as orthophosphate in the glasses. No evidence of Si-O-P bonds 
was found. The chemical shift of 31P NMR spectra and the FWHM of 31P MAS-NMR 
signal of those three glass series were estimated by using Bruker Top-Spin software 
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and is profiled as a function of CaX2 (X=F/Cl/F+Cl) content in Figure 10.5.1 and Figure 
10.5.2 respectively. Different glass series show different trends of the chemical shift. 
As a general observation, a constant chemical shift is shown in the GPF series, while a 
clear reduction of chemical shift is visible with incorporating CaCl2 into the GPCl glass 
series. As explained in Chapter 6, this is likely to be a consequence of the shielding 
effect caused by the presence of high electron density chloride ion. In addition, a slight 
increase in chemical shift is seen with an increase in mixed CaF2 and CaCl2 content. It 
is probably arising due to the deshileding effect from the presence of both fluoride and 
chloride as discussed in detail in Chapter 7. 
It is noteworthy that the FWHM of 31P NMR MAS-NMR signals for the amorphous 
glasses are much larger than the equivalent crystallised glasses. The difference is 
particularly distinguishable in the GPF glass series. As we can see the amorphous 
glasses with CaF2 content less than 9.3 mol% have FWHM values within the range of 
1500-1700 Hz, while the FWHM for those crystallised glasses (CaF2 content ≥ 9.3 
mol%) reduce to the values below 950 Hz. Nevertheless, the difference of the FWHM 
for the amorphous glasses and the crystallised ones are less pronounced in the 
GPFCl glass series compared to the equivalent GPF series, as a consequence of a 
small fraction of crystallisation in the glasses with CaX2 content higher than 2.4 mol% 
and the shielding effect by the high electron density chloride. Furthermore, the nearly 
identical FWHM are found for GPCl glass series, as these glasses are largely 
amorphous.  
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Figure 10.5.1 The chemical shift of 31P MAS-NMR spectra against CaX2 (X=F/Cl/F+Cl) 
content for all the calcium halide containing glasses.  
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Figure 10.5.2 FWHM for 31P MAS-NMR spectra plotted against CaX2 (X=F/Cl/F+Cl) content 
for all the calcium halide containing glasses.  
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10.6  The Percentage of Calcium Release 
0 5 10 15 20 25
30
35
40
45
50
55
60
65
70
75
80
85
90
CaX2 content (mol%)
Ca
lci
um
 (%
)
GPF series     
GPCl series   
GPFCl series  
 
Figure 10.6.1 Ca concentration measured after 3 hours immersion in Tris buffer plotted 
as the percentage of the total calcium content in the original glass composition against 
the CaX2 content for GPF, GPCl and GPFCl glass series. 
Bioactive glasses degrade on immersion in buffer solution. The ion exchange between 
protons from buffer solution and Ca2+ ions from glasses leads to an increase of Ca2+ 
ion concentration in solution. Figure 10.6.1 shows the measured calcium concentration 
after 3 hours immersion in Tris buffer presented as a percentage of total amount of 
calcium in the nominal glass compositions for GPF, GPCl and GPFCl glass series. 
Large differences of the measured Ca2+ concentrations for the same composition were 
noticed for the GPF glass series. This is a consequence of the instrument calibration, 
which makes the data unreliable, although a relative small change of Ca% is seen 
through the whole GPF glass series. Consequently, only the data for GPCl and GPFCl 
glass series will be discussed below.  
The main information delivered from Figure 10.6.1 is that the glass with a higher CaX2 
(X=Cl/F+Cl) content has a higher percentage of Ca released in buffer solution. This is 
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associated with a faster ion exchange between Ca2+ ions from glass and the protons 
from solution. As discussed in Chapter 6, the incorporation of chloride ion results in a 
dramatic expansion of glass molar volume and thereby effectively facilitates the 
diffusion of ions into and out of the glass. Note that the introduction of CaF2 also 
expands glass molar volume (shown in Figure 10.3.2) but the effect is much smaller 
than CaCl2. Therefore, the presence of chloride is the dominating factor controlling the 
rapid glass degradation and fast ion exchange. 
10.7  The Measured pH after 3 and 24 Hours Immersion in Tris 
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Figure 10.7.1 pH measured at the end of 3 and 24 hours immersion in Tris buffer plotted 
against CaX2 (X=F/Cl/F+Cl) content (a) for GPF glass series, (b) for GPCl glass series and 
(c) GPFCl glass series . 
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Upon immersion, the degradation of glasses not only results in an increase in Ca2+ 
concentration, but also an increase in pH value, however, the apatite-like phase 
formation might result in a decrease in pH. The pH values measured at the end of 3 
and 24 hours immersion in Tris buffer for the CaF2 containing glasses are shown in 
Figure 10.7.1 (a). The equivalent results for CaCl2 containing glasses and mixed CaF2 
and CaCl2 containing glasses are shown in Figure 10.7.1 (b) and (c) respectively. Note 
that, the Tris buffer has an initial pH values within the range of 7.25-7.4, as a 
consequence of that the initial pH values for different glass series might vary slightly 
from batch to batch. However, for the same glass series even for different immersion 
time points the same batch of Tris buffer was used. Therefore, the direct comparison of 
pH values a cross a series is not precise but it is feasible for same glass series at 
different time points.  
As shown in Figure 10.7.1 (a), (b) and (c), there are no clear trends of pH change with 
an increase in CaF2 content after 3 or 24 hours for GPF glass series owing to the fact 
that high CaF2 containing glasses (> 9.3 mol%) in GPF series are largely crystallised. 
Whilst an increase in pH after 3 hours and a decrease in pH after 24 hours with 
increasing CaX2 content are found for both GPCl and GPFCl glass series. This less 
pronounced rise in pH of the GPCl and GPFCl glasses with more CaX2 content after 
24 hours is due to the decrease in non-bridging oxygen content with an increase in 
halide content in the one base sample (75 mg). 
The studied glasses were designed by adding different amount of CaX2 to the SiO2-
CaO-(P2O5) based glass, while reducing the amounts of all other components 
proportionally so in order to keep glass structure constant (predominantly Q2 in 
structure). In a fixed weight of glass (75 mg) used for the bioactivity study in Tris buffer, 
the content of the silicate part of the glass (i.e. Si-O- 1/2Ca2+ bonds) allowing for 
exchange of modifier ions decreases with an increase in CaX2 content in the glass. 
This could result in a reduction of the total amount of ion exchange occurring, 
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consequently, a less pronounced pH rise was observed for glasses with higher CaCl2 
contents after the completion of ion exchange. 
Previous work on CaF2 containing bioactive glasses by Brauer et al. [20]showed that 
the pH rise was less pronounced with increasing CaF2 content in the glass, and this 
was originally interpreted as caused by another type of ion exchange occurring: 
hydroxyls (OH-) from the solution exchanging for F- from the glass in addition to H+ for 
modifier cations. If this was the case, the same effect would be seen here, with an 
exchange of OH- for Cl- resulting in a lower pH with increasing CaCl2 content in the 
glass, but in fact, the opposite trend was observed. This suggests that halides, such as 
CaF2 or CaCl2, presented in and released from bioactive glasses contribute only 
indirectly to pH changes in the dissolution medium. More detailed study [118] suggests 
that the pH rise typically observed for bioactive glasses is caused by the silicate part 
(i.e., by ion exchange between modifiers ionically connected to non-bridging oxygens 
and H+) only, with contributions from the CaF2 part being negligible. 
Generally, the pH values measured by 24 hours are higher than the equivalent pH 
after 3 hours for both GPF and GPFCl glass series. However, the opposite trend is 
observed in GPCl glass series. This ascribes to the fact that fluorapatite is the 
predominant phase formed on immersion for the CaF2 containing glasses (GPF and 
GPFCl glass series), while HAP is the dominating phase for the GPCl glass series. 
The consumption of OH- group for HAP formation results in a reduction in pH.  
Moreover, it is clear that the difference in pH by 3 and 24 hours is more distinct in a 
higher CaCl2 containing glass (GPCl series), while it is less pronounced in a glass with 
higher mixed CaF2 and CaCl2 content (GPFCl series).  
For GPCl glass series, if there is no consumption of OH- for HAP formation, it would be 
expected to see a similar scenario of pH after 3 and 24 hours immersion as the 
equivalent ones for GPFCl glass series (Figure 10.7.1(c)). In reality, the OH- ion is 
used to form HAP and the quantity of HAP formation relies upon the phosphate 
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content. Therefore, the glass with higher phosphate content forms more HAP and a 
more pronounced pH decrease is seen. Namely, the glass with lower CaCl2 content 
has a more distinct reduction in pH. Thereby, a bigger difference in pH between 3 and 
24 hours is found in the glass with a higher CaCl2 content. In the case of GPFCl glass 
series, the increase in pH from 3 to 24 hours is more distinct in lower CaX2 containing 
glasses. This can be also attributed to a slower ion exchange as a consequence of 
presenting less CaCl2 and also the presence of a bigger content of the silicate part of 
the glass (Si-O- 1/2Ca2+ bonds). 
10.8  Apatite-like Phase Formation in Tris Buffer Solution 
The XRD patterns of the precipitates collected after 3 hours glass immersion in Tris for 
GPF, GPCl and GPFCl glass series are summarised in Figure 10.8.1 (a)-(c) for 
comparison purposes. The major diffraction lines developed after 3 hours immersion 
match with that of apatite for all the studied P containing glasses. However, additional 
diffraction lines corresponding to cuspidine and fluorite are also detected for the GPF 
glasses with CaF2 content higher than 13.6 mol%. Due to the fact that the solubility of 
cuspidine and CaF2 are much lower than the amorphous glass phase, for the glasses 
that initially crystallised to cuspidine and fluorite, on immersion those crystalline 
phases still existed while the amorphous glass phase largely dissolved.  Furthermore, 
fluorite is also seen for the GPFCl 16.0 and GPFCl 23.1 glass compositions, which 
have 9.2 and 13.4 mol% CaF2 respectively. It is interesting that less CaF2 content was 
requested to see fluorite formation in the mixed CaX2 series than the single CaF2 
containing series (9.2 VS 17.8 mol%). This could be contributed by the presence of 
chloride, which expands glass volume and facilitates the ordered arrangement of Ca2+ 
ions around fluoride ion. 
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Figure 10.8.1 The XRD patterns of glass precipitates after 3 hours immerision in Tris for 
(a) CaF2 containing glasses; (b) CaCl2 containing glasses; (c) mixed CaF2 and CaCl2 
containing glasses (о: Ca10(PO4)6F2; *: Ca4Si2O7F2; +: CaF2; v:Ca10(PO4)6(OH)2). 
It is interesting and worth comparing the apatite-like phase formation among the four 
series of glass. XRD, FTIR and NMR results consistently show rapid apatite-like phase 
formation within 3 hours immersion in Tris for all the high phosphate containing 
glasses (GPF, GPCl and GPFCl series). In the case of CaF2 series, apart from forming 
apatite on immersion, additional fluoride containing phases were also detected in the 
high CaF2 containing glasses (over 9.3 mol%). The formation of cuspidine and fluorite 
might reduce the bioactivity. In the case of CaCl2 series, the apatite-like phase is the 
only phase formed on immersion. In addition, the increase of CaCl2 content expands 
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glass volume and stimulates glass degradation, which therefore facilitates apatite-like 
phase formation. In the case of mixed CaF2 and CaCl2 containing glasses, apatite 
(mixed hydroxy-fluoapatite for GPFCl 2.6 and fluorapatite for GPFCl 4.0, GPFCl 5.3 
and GPFGl 8.3) is the only phase formed for the glasses with CaX2 content less than 
12.1 mol%. CaF2 appears when the CaX2 content equal or above 12.1 mol% and the 
CaF2 content increases with increasing CaX2. 19F MAS-NMR spectra (Figure 5.3.16 in 
Chapter 5 and Figure 7.3.7 in Chapter 7) reveal that clear FAP formation was found 
after 6 hours immersion for the amorphous glasses in GPF glass series (GPF 3.0, 
GPF 4.5 and GPF 6.0) but after 3 hours immersion for the amorphous glass (GPFCl 
2.6) in GPFCl series. The observed faster FAP formation in GPFCl is thought to be 
caused by the presence of CaCl2 that aids the glass degradation. In the case of P free 
CaCl2 containing glasses (Figure 9.2.3), no apatite formation was detected after 3 days 
immersion in Tris, since both glasses and Tris buffer contain no source of phosphate. 
Thus, high phosphate content favours apatite-like phase formation, which is in a good 
agreement with the finding by Mneimne et al. [9] that high phosphate (> 6 mol% P2O5) 
glasses formed apatite within 6 hours, whilst the low phosphate glasses formed apatite 
in under 72 hours. In addition, O’Donnell et al. also demonstrated that higher P2O5 
contents in the glass resulted in faster apatite formation and greater amounts of apatite 
being formed [50].  
The formation of silica-gel is also considered important for bioactivity. Brauer et al. [20] 
suggested that the formation of silica-gel contributes to the nucleation of apatite, since 
phosphate concentration decreased when silicon concentration reached the solubility 
limit. However, as shown in Figure 6.2.5 in Chapter 6 and Figure 7.2.6 in Chapter 7, 
the silicon concentration reached the solubility limit (50-70 ppm) after 6 hours 
immersion for GPCl glass series and 9 hours for GPFCl glass series and were almost 
constant there afterwards, while phosphate decreased after 3 hours for GPCl glass 
series and 6 hours for GPFCl glass series. It seems that silica-gel forms after the 
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consumption of PO43-, which suggests that apatite-like phases might not necessary to 
form on the surface of silica-gel. 
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11 Conclusions and Further Work 
11.1  Conclusions 
Bioactive silicate glasses based on SiO2-P2O5-CaO-CaF2/CaCl2 and simple three 
component SiO2-CaO-CaCl2 glasses based on the wollastonite stoichiometry with 
increasing calcium halide contents have been successfully synthesised via a melt-
quench route. To the best of our knowledge, the studied chloride glasses are the first 
chloride containing bioactive silicate glasses in the world.  
The investigation of glass structure was carried out by MAS-NMR. The 19F MAS-NMR 
spectra indicate the presence of F-Ca(n) species in fluoride containing glasses (GPF 
and GPFCl series), with no evidence of the presence of Si-F bonds. The 31P MAS-
NMR spectra suggest that phosphate is present as orthophosphate in the glasses 
rather than Si-O-P species. The 29Si MAS-NMR spectra confirm that the studied 
glasses are predominantly Q2 in structure. 
Chemical analysis of the chloride content in the nominal glasses (in Chapters 6,7,9) 
reveals that the majority of chloride (up to 31.6 mol%) has been successfully retained 
in the Q2 type silicate glasses. This contrasts with the glasses in the literature the 
highest of which contains less than 2 mol% CaCl2.  
The incorporation of CaX2 leads to a significant decrease in the glass transition 
temperature by forming “CaX+” species for all the studied glasses. However, the 
introduction of fluoride and chloride has different effects on glass density, which 
increases with increasing CaF2 but decreases with CaCl2. The mixed fluoride and 
chloride containing glass series have an intermediate density values. Moreover, the 
glass molar volume increases markedly with an increase in calcium halide content, 
suggesting that both fluoride and chloride expand the glass volume and dilute glass 
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network, therefore facilitate glass degradation. However, the expansion effect by 
fluoride is much smaller than the equivalent chloride as the fluoride ion is substantially 
smaller than the chloride ion.  
The XRD, FTIR and NMR results consistently suggest that within the four series of 
glasses, the mixed fluoride and chloride containing glasses (GPFCl series) crystallised 
most readily, while the chloride containing glasses crystallise least readily (all the 
chloride containing bioactive glasses are largely amorphous) and the fluoride 
containing glasses have an intermediate crystallisation tendency. These are attributed 
to the fact that chloride ion is much bigger than fluoride ion (1.67 Å cf. 1.19 Å).  
Glass degradation behaviour and apatite formation upon immersion were investigated 
in both Tris buffer and simulated body fluid. The study revealed that sodium-free, high 
phosphate containing glasses are highly degradable and formed an apatite-like phase 
(fluorapatite for GPF and GPFCl glass series and hydroxyapatite for GPCl glass series) 
within 3 hours immersion in Tris and 9 hours in SBF. Glass degradation rate increases 
with an increase in CaCl2 content but not CaF2. In the case of phosphate free CaCl2 
containing glasses, rapid glass degradation occurred within 3 days immersion but no 
apatite formation. Therefore, sodium is not an essential component in the bioactive 
glasses and high phosphate content favours apatite-like phase formation. The sodium-
free, high phosphate calcium halide containing glasses are promising in dental and 
medical applications. Whilst, according to the known effects of CaF2 and CaCl2 on the 
glass bioactivity, the designable high phosphate chloride containing glasses with 
optimised fluoride content, which allow for rapid glass degradation, fast formation of a 
more durable FAP and providing a continuous release of F- ion are particularly 
attractive for remineralising toothpastes. 
Upon heat treatment, CaCl2 is likely the crystallisation phase for the glasses without 
phosphate, indicating that in the chloride containing glasses the chlorine is likely to be 
present as a Cl-Ca(n) species in an analogous fashion to F-Ca(n) in fluoride containing 
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glasses. However, the halogen-free phosphate containing glass surface crystallised to 
pseudowollastonite and a hydroxyapatite. On incorporating a halide, the glasses 
exhibited largely bulk crystallization to a haloapatite. In the case of fluoride and mixed 
fluoride and chloride, the glasses primarily crystallised to fluorapatite. In the case of 
chloride, the glasses crystallised to chlorapatite. This is the first time that chlorapatite 
has been shown to crystallise from a glass. The obtained ClAP glass-ceramics are the 
first ClAP glass-ceramics ever.  
 
11.2   Further work 
 The structural role of chloride in the glasses should be further explored by 35Cl 
MAS-NMR to obtain a direct evidence of forming Cl-Ca(n) species and address 
the arrangement of halide phase in the glass. A systematic molecular dynamics 
simulation study would be beneficial to achieve a better understanding of the 
glass structure, as 35Cl NMR is quite difficult.  
 Amorphous scattering on P free CaCl2 containing glasses will be helpful for 
understanding the glass structure and interpreting the break in linear Tg, density, 
Vm and Tc1 behaviours with increasing CaCl2 content. 
 29Si-enriched MAS-NMR on the as-quenched and heat treated P free CaCl2 
containing glasses should be carried out, in order to study the Q structure of 
the glasses and identify the crystallisation phase after heat treatment. 
 The dissolution study of phosphate containing bioactive glasses (GPF, GPCl 
and GPFCl series) within a short time immersion period (< 1h) should be 
carried out, in order to determine the mechanism of glass degradation, 
transformation into apatite without releasing PO43-? 
 The comparison of bioactivity between the as-quenched glasses and the 
formed glass-ceramics upon heat treatment should be carried out, in order to 
establish a better understanding on how the crystalline phase affect glass 
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bioactivity. 1H NMR should be carried out to determine the conversion of ClAP 
to HAP with the presence of water. 
 In regard to chlorapatite glass-ceramics, the influence of heat treatment time
and temperature on the crystal phases formed, microstructure, fracture
toughness and strength should be investigated.
 The cytotoxicity study of the investigated bioactive glasses.
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Table 11.2.1 Particle size analysis results for GPF glass series 
Glass Code 
Volume Median Diameter (SD, µm) 
Span 
D [v, 0.5] D [v, 0.1] D [v, 0.9] 
GPF 0.0 5.95 (0.07) 0.73 (0.01) 30.74 (0.17) 5.04 (0.08) 
GPF 3.0 6.61 (0.09) 0.71 (0.02) 30.89 (0.12) 4.57 (0.08) 
GPF 4.5 6.76 (0.07) 0.75 (0.01) 34.57 (0.07) 5.00 (0.06) 
GPF 6.0 6.43 (0.29) 0.74 (0.03) 30.10 (0.46) 4.57 (0.15) 
GPF 9.3 9.11 (0.08) 0.97 (0.03) 31.98 (0.07) 3.41 (0.03) 
GPF 13.6 8.66 (0.11) 0.96 (0.04) 34.68 (0.1) 3.89 (0.06) 
GPF 17.8 9.46 (0.1) 1.07 (0.1) 37.92 (0.67) 3.89 (0.04) 
GPF 25.5 8.40 (0.09) 0.94 (0.01) 33.49 (0.18) 3.87 (0.03) 
 
Table 11.2.2  P values obtained from Student’s t-test to estimate the statistically 
significant difference between groups for the FWHM of 31P MAS-NMR spectra; P<0.05 is 
considered as significant, p<0.0001 is considered to be extremely significant. 
GPF 4.5 in Tris 0 h 3 h 6 h 9 h 
0 h - P<0.0001 P<0.0001 P<0.0001 
3 h P<0.0001 - P<0.0001 P<0.0001 
6 h P<0.0001 P<0.0001 - P=0.0001 
9 h P<0.0001 P<0.0001 P=0.0001 - 
 
GPF 4.5 in SBF 0 h 3 h 6 h 9 h 
0 h - P<0.0001 P<0.0001 P<0.0001 
3 h P<0.0001 - P=0.0010 P<0.0001 
6 h P<0.0001 P=0.0010 - P<0.0001 
9 h P<0.0001 P<0.0001 P<0.0001 - 
 
GPF 13.6 in Tris 0 h 3 h 6 h 9 h 
0 h - P<0.0001 P<0.0001 P<0.0001 
3 h P<0.0001 - P<0.0001 P<0.0001 
6 h P<0.0001 P<0.0001 - P<0.0001 
9 h P<0.0001 P<0.0001 P<0.0001 - 
 
GPF 13.6 in 
SBF 
0 h 3 h 6 h 9 h 
0 h - P<0.0001 P<0.0001 P<0.0001 
3 h P<0.0001 - P<0.0001 P<0.0001 
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6 h P<0.0001 P<0.0001 - P=0.1361 
9 h P<0.0001 P<0.0001 P=0.1361 - 
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Figure 11.2.1 The XRD patterns of the glass precipitates with 25.5 mol% CaF2 collected 
after immersion in Tris up to 1 week (о: Ca10(PO4)6F2; *: Ca4Si2O7F2; +: CaF2). 
 
Figure 11.2.2 SEM images of the heat treated samples of GF 0.0 at 1030°C 
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Figure 11.2.3 The FTIR Spectra of the heat treated with low CaF2 content (≤ 6.0 mol%)  in 
GPF series. The numbers in the bracket represent the heat treatment temperature 
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Figure 11.2.4 The FTIR Spectra of the heat treated with high CaF2 content (≥ 9.3 mol%) in 
GPF series.  
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Figure 11.2.5 The FTIR Spectra of the heat treated GCl glass series. The numbers in the 
bracket represent the heat treatment temperature. 
Table 11.2.3 The experimental density and the calculated density of GPFCl glass series. 
De represents the experimental density and Dc represents the calculated density 
 
Glass Code De Dc 
GPFCl 2.6 2.9166 2.9337 
GPFCl 4.0 2.9252 2.9341 
GPFCl 5.3 2.9287 2.9341 
GPFCl 8.3 2.9129 2.9336 
GPFCl 12.1 2.9251 2.9360 
GPFCl 16.0 2.913 2.9352 
GPFCl 23.1 2.9006 2.9395 
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14 Appendix II - Academic Achievements 
Based on this PhD project, a world patent has been filed. Some of the results from this 
PhD work have been published in four peer-review papers and presented in different 
conferences and competitions. 
14.1  World Patent 
‘Chlorine-containing Silicate Glasses and Glass Ceramics’. WO2014154874 A3 
14.2  Peer-Reviewed Publications 
1. X.J.Chen, N.Karpukhina and R.Hill, Chlorapatite Glass-Ceramics, International 
Journal of Applied Glass Science, 2014, 5: 207-16. 
2. X.J.Chen, X.H.Chen, D.S.Brauer, R.M. Wilson, R.Hill and N.Karpukhina, Novel 
Alkali Free Bioactive Fluorapatite Glass-Ceramics, Journal of Non Crystalline Solid, 
2014, 402: 172-7. 
3. X.J.Chen, X.H.Chen, D.S.Brauer, R.M. Wilson, R.Hill and N.Karpukhina, 
Bioactivity Investigation of Sodium Free Fluoride Containing Glasses and Glass-
ceramics, Materials, 2014, 7: 5470-87. 
4. X.J.Chen, D.S.Brauer, N.Karpukhina and R.Hill, Novel Highly Degradable Chloride 
Containing Bioactive Glasses, Biomedical Glasses, 2015, 1:108-118.  
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14.3  Conference Presentations 
Oral Presentations: 
1. Glass can dissolve like sugar - Do you believe? X.J. Chen, 2015 Young Persons' 
Lecture Competition, February 2015, London, UK. (The Runner up of the South 
East Heat of the 2015 Young Person’s Lecture Competition) 
2. The Influence of Fluoride Content on the Crystallisation of Sodium Free 
Fluorapatite Glass-Ceramics, X.J.Chen, N.Karpukhina, D.Brauer and R.Hill, 5th 
International Congress on Ceramics, August 2014, Beijing, China.  
3. Novel Halide Containing Bio-glasses for Dental Applications, X.J. Chen, The 
competition on British Federation of Women Graduates Academic Awards, July 
2014, London, UK. (British Federation of Women Graduates (BFWG) 
Academic Awards - The Margaret KB Day Scholarship) 
4. Mixed Fluoride-Chloride Containing Bioactive Glasses for Remineralising 
Toothpaste, X.J.Chen, N.Karpukhina and R.Hill, International Association for 
Dental Research General Sessions and Exhibitions, June 2014, Cape Town, 
South Africa.  
5. Mixed Fluoride and Chloride Bioactive Glasses for Dental Applications, X.J.Chen, 
N.Karpukhina and R.Hill, PhD Day, April 2014, Barts and the London School of 
Medicine and Dentistry, London. (Best Verbal Presentation Prize) 
6. Novel Halide Containing Bioactive Glasses for Dental Application, X.J.Chen, 
N.Karpukhina, and R.Hill, British Society for Oral and Dental Research 2013, 
September 2013, Bath, UK. (Commendation VOCO Prize for Dental 
Biomaterials Prize)  
7. The Comparison between Novel Fluoride and Chloride Bioactive Glasses, 
X.J.Chen, N.Karpukhina, and R.Hill, The 'Living glass' Conference – Society of 
Glass Technology, September 2013, Cambridge, UK. 
8. Crystallization of Chlorapatite from Chloride Containing Bioactive Glasses, 
X.J.Chen, N.Karpukhina, R.M.Wilson and R.Hill, 23rd International Congress on 
Glass, July 2013, Prague, Czech Republic. 
9. Sodium-free Fluoride-Containing Bioactive Glasses, X.J.Chen, N.Karpukhina, 
X.H.Chen, D.S.Brauer and R.Hill, XIII International Conference on the Physics of 
Non-Crystalline Solids, September 2012, Wuhan, China. 
 
Poster Presentations 
1. Novel Highly Degradable Chloride Containing Bioactive Glasses, X.J.Chen, 
N.Karpukhina, R.M.Wilson and R.Hill, 12th International Conference on Structure 
of Non-Crystalline Materials, July 2013, Trento, Italy. (Best Poster Award)  
2. Alkali-free Oxyhalide Silicate Bioactive Glasses and Bioceramics, X.J.Chen, 
N.Karpukhina, and R.Hill, PhD Day, March 2013, Barts and the London School of 
Medicine and Dentistry, London. (Best Poster Award)  
3. Novel Bioactive Glasses for Drill Free Dentistry, X.J.Chen, N.Karpukhina, and 
R.Hill, William Harvey Day, October 2012, Barts and the London School of 
Medicine and Dentistry, London. 
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Abstract published for an oral presentation in the “2015 Young Persons' Lecture 
Competition”, London, UK, February 2015  
14.3.1  Glass Can Dissolve Like Sugar - Do You Believe? 
Xiaojing Chen 
Dental Physical Sciences, Institute of Dentistry, Barts and The London School of 
Medicine and Dentistry, Queen Mary University of London, London, United Kingdom 
Fluoride can prevent dental cavities and thus has been incorporated into bioactive 
glasses (BG) as mineralizing additives for toothpaste. Unlike un-dissolvable window 
glasses, fluoride containing BG dissolve rapidly in the mouth and form an acid 
resistant mineral on the tooth surface to reduce sensitivity.  
Many People suffer from sensitive teeth, which is caused by the exposure of small 
tubes in the tooth as a result of receding gums, tooth decay and enamel loss, when 
taking hot or cold beverages or food into mouth. 
There are regulatory issues with fluoride. Chlorine however behaves like fluorine in BG 
but results in chloride release. Chloride is naturally present in the body. In this talk we 
will discuss the first chloride-containing BG in the world. These can dissolve as fast as 
sugar and form acid resistant mineral very rapidly. They are attractive for toothpaste 
applications. 
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Abstract published for an oral presentation in the “The Competition on British 
Federation of Woman Graduates Academic Awards”, London, UK, July 2014  
14.3.2  Novel Halide Containing Bio-glasses for Dental Applications 
Xiaojing Chen 
Dental Physical Sciences, Institute of Dentistry, Barts and The London School of 
Medicine and Dentistry, Queen Mary University of London, London, United Kingdom 
Many People (8-35% of the adult population) experience sharp tooth pain when taking 
hot or cold beverages or food into mouth. This type of tooth pain is caused by the 
exposure of small tubes in the tooth (tubules) to the air as a result of receding gums, 
tooth decay and enamel loss. 
Fluoride can prevent dental cavities as it inhibits enamel and dentine loss. It has been 
incorporated into bioactive glasses as reminerallising additives for toothpaste. These 
glasses dissolve in the mouth and form an acid resistant tooth mineral on the tooth 
surface to reduce sensitivity. In addition, the small mineral particles can block the 
tubules, hence alleviate tooth pain. 
However, fluoride is classified as a drug and excess fluoride might result in dental 
fluorosis, which appears as unnoticeable, tiny white streaks or specks in the enamel of 
the tooth. It is important to find an alternative for the excess of fluoride. Chloride is 
likely to behave like fluorine but no potential problem as fluoride. Salt (sodium chloride) 
has been taken every day and also presents naturally in the body. Chloride containing 
bioactive glasses can also dissolve fast and form minerals rapidly. Therefore they are 
attractive reminerallising additive for toothpastes to treat tooth pain. 
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Abstract published for an oral presentation in the “British Society for Oral and 
Dental Research 2013”, Bath, UK, September 2013  
14.3.3  Novel Halide Containing Bioactive Glasses for Dental 
Application 
Xiaojing Chen*, Natalia Karpukhina, Robert Hill 
Dental Physical Sciences, Institute of Dentistry, Barts and The London School of 
Medicine and Dentistry, Queen Mary University of London, London, United Kingdom 
Objectives: Fluoride has often been incorporated into many glasses used in dentistry, 
for example, glass ionomer cements, apatite based glass-ceramics and more recently 
fluoride containing bioactive glasses. However, chloride containing glasses have rarely 
been investigated. The objective of this project is to investigate incorporation of 
chloride into sodium free bioactive glasses. 
Methods: Sodium free glasses with varying amounts of fluoride and chloride were 
synthesised by a melt-quench route and characterised using X-ray Diffraction (XRD), 
Differential Scanning Calorimetry (DSC) and Fourier Transform Infrared Spectroscopy 
(FTIR). Glass powders were heat treated for the crystallisation study. Glass bioactivity 
was investigated by the immersion of glass powders in Tris buffer solution. The apatite 
formation was evaluated by XRD, FTIR and Magic Angle Spinning Nuclear Magnetic 
Resonance (MAS-NMR). The ion release and glass degradation were quantified by 
Inductively Coupled Plasma-Optical Emission Spectrometer (ICP-OES). 
Results: The results show that glasses with high fluoride (>9.3 mol%) content are 
partially crystallised into fluorapatite, however, CaF2 was found in 25.5 mol% CaF2 
containing glass. Similarly, partial crystallisation of chlorapatite has been observed in 
the chloride containing glasses. Both glass series showed high bioactivity, the glasses 
degraded primarily within the first hour of immersion in Tris buffer and formed apatite 
within 3 hours. Fluorapatite and chlorapatite formed in the heat treated glasses. 
Conclusion: The presence of CaF2 / CaCl2 in sodium free bioactive glasses is 
beneficial for the fluorapatite/ chlorapatite formation. These highly bioactive halide 
glasses can be used for dental applications. 
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14.3.4   Novel Highly Degradable Chloride Containing Bioactive 
Glasses 
Xiaojing Chen1*, Natalia Karpukhina1, Rory M. Wilson2, Robert Hill1 
 
1Dental Physical Sciences, Institute of Dentistry, Barts and The London School of 
Medicine and Dentistry, Queen Mary University of London, London, United Kingdom 
2School of Engineering and Materials Science, Queen Mary University of London, 
London, United Kingdom 
 
Addition of CaF2 to a silicate glass typically reduces the glass transition temperature 
(Tg). The fluoride containing bioactive glasses investigated recently [4, 5] favour 
formation of fluoride substituted apatite which is less soluble in acidic conditions. In 
this paper we looked at the potential of chloride as an alternative to a fluoride addition 
to the bioactive glass. A slightly larger chloride ion can result in a more expanded glass 
network that may lead to a lower Tg, softer glasses and more rapid glass dissolution. In 
addition, chloride is naturally present in the human body, there is no restriction on 
chloride content in toothpastes and biomedical materials unlike with fluoride.  
The series of bioactive glasses based on the quaternary system SiO2-P2O5-CaO-CaCl2 
with varying CaCl2 content were successfully synthesised via melt-derived route and 
characterised by differential scanning calorimetry (DSC). The bioactivity study of the 
investigated glasses was performed in Tris buffer solution and simulated body fluid. 
The apatite formation was characterised by Fourier transform infrared spectroscopy, X-
ray diffraction (XRD) and nuclear magnetic resonance (NMR). Dissolution was 
followed by the ion release measurements.  
The DSC results showed a dramatic reduction in Tg with an increase in CaCl2 content. 
The results of the experiments in buffer solutions demonstrated that the designed 
chloride containing bioactive glasses are highly degradable and form apatite within 3 
hrs in Tris and 9 hrs in SBF. The 31P MAS NMR spectra of the glass powders before 
and after immersion in Tris indicate that phosphorus is present as orthophosphate. 
This study revealed that the chloride containing bioactive glasses that can be easily 
synthesized have the greatest innovative potential for novel applications in 
remineralising toothpaste and bone substitution. 
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Chlorapatite Glass-Ceramics
Xiaojing Chen, Robert Hill,* and Natalia Karpukhina
Dental Physical Sciences, Institute of Dentistry, Barts and the London School of Medicine and
Dentistry, Queen Mary University of London, Mile End Road, London, E1 4NS, UK
Apatite glass-ceramics are attractive for medical and dental applications, and fluorapatite glass-ceramics based on alumi-
nosilicate glasses have been extensively studied. This study is the first study of chlorapatite glass-ceramics based on calcium
chloride-containing Q2 bioactive phosphosilicate glasses. The crystallization behavior of oxychloride glasses is examined and
compared with mixed oxychloride/fluoride and oxyfluoride glasses. The glass transition temperature decreased for all three ser-
ies with increasing halogen content. On increasing the halogen content, there was an increasing tendency of the glasses to
crystallize. The halogen-free glass surface crystallized to pseudowollastonite and an apatite. On incorporating a halide, the
glasses exhibited largely bulk crystallization to a haloapatite. In the case of chloride, the glasses crystallized to chlorapatite.
This is the first time to our knowledge that chlorapatite has been shown to crystallize from a glass. Chlorapatite is very attrac-
tive for medical applications because it converts to hydroxyapatite the mineral phase of tooth and bone on immersion in
water.
Introduction
Apatite-based glass-ceramics are attractive for medi-
cal and dental applications, because the mineral phase of
bone and tooth is thought to be based on hydroxyapa-
tite. Kokubo et al. developed an apatite–wollastonite
(AW) glass-ceramic.1–3 This system exhibits excellent
integration with bone and relatively good mechanical
properties including high strength and fracture tough-
ness. However, it has to be machined to shape using dia-
mond tooling making it expensive to fabricate the
complex shapes required for substitute bone parts. The
AW glass-ceramic system developed by Kokubo et al.1–3
exhibits surface nucleation, and the processing route
involves crystallization and sintering to form a monolith,
prior to machining. The option of direct casting to
shape is not feasible because of the strong tendency of
this system to exhibit surface crystal nucleation. The
apatite phase present in the AW system is probably a
mixed fluoro/oxyapatite.4
Hill and coworkers developed fluorapatite–mullite
glass-ceramics5–14 with even better mechanical proper-
ties than the AW system that bulk-nucleated via prior
amorphous phase separation, giving rise to fluorapatite
crystals with a needle-like habit. These systems could
be cast to shape using loss wax casting. Compositions
exhibited excellent osseo-integration.15,16 However, flu-
orapatite is not very resorbable, mullite is almost com-
pletely inert, and concern was raised over the possibility
of aluminum release, despite the aluminum being in
the form of insoluble mullite.
H€oland and coworkers17–19 have also developed
fluorapatite glass-ceramics that crystallize with a
*r.hill@qmul.ac.uk
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needle-like habit and have developed them successfully
for dental crowns. Numerous other workers20–27 have
studied fluorapatite-based glass-ceramic systems following
the early studies of the groups led by Hill and H€oland.
It would be attractive to form hydroxyapatite, rather
than fluorapatite in a glass-ceramic system for medical
and dental applications, particularly where resorption
and replacement by bone is desired, as hydroxyapatite is
more readily dissolved under acidic conditions than fluo-
rapatite. However, hydroxyl groups are volatilized readily
during melting and are not retained in glass melts at suf-
ficient concentrations to form hydroxyapatite. This is the
reason for incorporating fluorides and making the fluo-
ride analogue of hydroxyapatite. The substitution of
fluoride for hydroxyls is used with a wide variety of
glass-ceramics.28–33 H€oland and Beall have discussed
such glass-ceramic systems in detail.34
Chlorine incorporation in glass forming systems
has rarely been investigated relative to fluorine, because
of more acute problems with chlorine volatilization.
Kiprianov and Karpukhina35 carried out a review of
oxyhalide glasses and identified the key problems. Most
chloride salts are appreciably volatile at glass melting
temperatures unlike fluoride salts, which are not.
Chlorapatite glass-ceramics would be more attrac-
tive than fluorapatite glass-ceramics for medical and
dental applications, because Elliott and Young36 have
shown that chlorapatite will convert completely to
hydroxyapatite in the presence of water. The key factor
controlling this property is the size of the ion. The
chloride ion is larger than the hydroxyl ion, which is
larger than the fluoride ion. The fluoride ion is small
enough to fit in the space at the center of the Ca(II)
triangle in the apatite crystal lattice, whereas the hydro-
xyl ion is too large and is displaced above the plane of
the triangle. The chloride ion which is even larger is
displaced even further above the plane of the Ca(II) tri-
angle. This results in a move from a hexagonal space
group toward a monoclinic space group and a less sta-
ble apatite.
Chlorapatite and fluorapatite exhibit extensive solid
solution phase formation,37–39 although the substitu-
tion of chlorine and fluorine in the lattice may not be
completely random. Forming a mixed fluor/chlorapatite
should enable the solubility of the apatite to be con-
trolled. The solubility could be further optimized by
substitution of strontium for calcium, which is known
to occur in hydroxyapatite40 and fluorapatite glass-
ceramics.41
The starting point for this study is a previous
study by Chen et al.42 that investigated a sodium-free
glass composition with CaF2. Calcium chloride was
added progressively to the fluorine-free version of
this glass. This series was chosen for the following
reasons:
1. The network connectivity was constant. This
assumes that the chlorine forms Cl-Ca(n) species in
an analogous fashion to F-Ca(n) species in fluoride-
containing glasses.43–45 This view is supported by a
limited study by Sandland et al.46
2. The glasses contained no sodium and one of the
possible routes to chlorine loss is thought to be loss
as NaCl35, and as these glasses contain no sodium,
this is not a possibility.
3. This series of glasses crystallized to fluorapatite
making them potentially attractive glass-ceramics.
Assuming the possibility of chlorine forming the
analogous Cl-M(n) species, these glasses would be
expected to crystallize to chlorapatite. In oxyfluo-
ride glasses, the fluorine speciation in the glass
always reflects the speciation in the first crystalline
phase to form.30
Experimental
Glass Synthesis
The glasses were produced by melting analytical
grade silica (Prince Minerals Ltd., Stoke-on-Trent, UK),
calcium carbonate, calcium fluoride, calcium chloride
dihydrate (all from Sigma-Aldrich, St. Louis, MO), and
diphosphorus pentoxide (AnalaR) in a 300 mL plati-
num/rhodium crucible at a temperature (Tm) of
1400°C to 1550°C for 1 h in an electrical furnace
(EHF 17/3; Lenton, Hope Valley, UK). The resulting
melts were rapidly quenched into deionized water to try
and prevent crystallization. The granular glass frits pro-
duced were dried and then ground using a vibratory
mill (Gy-Ro mill, Glen Creston Ltd., Twickenham,
UK) for two sets of 7 min and sieved to give fine pow-
der (<38 or <45 lm). The original frit (1–2 mm) and
fine powder were used in the subsequent analysis.
The glasses synthesized were comprised of three
series as given in Table 1. The CaF2 glass series (B1-
H1) were designed by introducing different amounts of
CaX2 into the E1 composition first studied by Mnei-
mne et al.47 The chloride glass series (B3-H3) were
designed by replacing CaF2 with CaCl22H2O and a
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mixed CaCl2/CaF2 series (B2-H2) by replacing 50% of
the CaF2 by CaCl22H2O.
X-ray Diffraction Analysis
An X’Pert Pro X-ray diffractometer (Panalytical,
Almelo, the Netherlands) with a copper (Ni-filtered
Cu-Ka, k1 = 0.1541 nm and k2 = 0.1544 nm) X-ray
source was used to characterize the glass and heat-trea-
ted glass-ceramic samples. The powdered samples were
recorded between 5 and 70° (2h range) at a step size
of 0.0334 and a step time of 200.03 sec. Calibration
was carried out using NIST standard reference mate-
rial 660a (lanthanum hexaboride). X-ray diffraction
(XRD) data were analyzed using X’Pret HighScore
Plus (v2.0; PANalytical) in conjunction with the
ICDD database.
31P Magic Angle Spinning–Solid-State Nuclear
Magnetic Resonance
31P magic angle spinning–solid-state nuclear mag-
netic resonance (MAS-NMR) experiments were carried
out using 600 MHz (14.1T) Bruker solid-state nuclear
magnetic resonance spectrometer. A spinning rate of
18K or 10K with the resonance frequencies of
249.2 MHz was employed. Sixty seconds was used as
recycle delay time. The data were collected after 16 or
32 scans. All the spectra were referenced using 85%
H3PO4.
Fourier Transform Infrared Spectroscopy
The glass powders and heat-treated samples were
analyzed using Fourier transform infrared spectroscopy
(Spectrum GX; Perkin-Elmer, Shelton, CT). The data
were collected from 500 to 4000 cm1 of wave num-
ber and presented between 500 and 1600 cm1.
Differential Scanning Calorimetry
A Stanton Redcroft DSC1500 (Rheometric Scien-
tific, Epsom, UK) with matched pair platinum cruci-
bles was used to determine the glass transition and
peak crystallization (Tc) temperatures of the glasses.
Fifty milligrams of fine (<38 lm) and frit (1–2 mm)
glass powder was run against an alumina reference at a
heating rate of 20°C/min in flowing nitrogen gas at
60 mL/min from 25°C to 1200°C. Two particle size
fractions were run (fine and frit) to assess the tendency
toward surface nucleation. Full-width half-maximum
values (FWHM) were calculated from the differential
scanning calorimetry (DSC) traces of frit samples for
the first peak crystallization temperatures as a sharper
peak is indicative of bulk nucleation.
Heat Treatment of the Glasses
The amorphous glasses were further investigated to
identify the crystal phases formed on heat treatment.
Glass powders (<38 lm, 1.0 g) were compacted into
disks and heat-treated on a platinum foil in a porcelain
and furnace (Ceram Press NEY Dental International,
Yucaipa, CA) at a rate of 20°C/min from 400°C to
Table 1. Experimental Glass Compositions
(in mol%)
Glass SiO2 CaO P2O5 CaF2 CaCl2
A1/A2/A3 38.1 55.5 6.3 – –
B1 37.0 53.9 6.1 3.0 –
C1 36.4 53.0 6.0 4.5 –
D1 35.9 52.2 6.0 6.0 –
E1 34.6 50.4 5.7 9.3 –
F1 32.9 48.0 5.5 13.6 –
G1 31.4 45.7 5.2 17.8 –
H1 28.4 41.4 4.7 25.5 –
B2 37.1 54.1 6.1 1.5 1.1
C2 36.6 53.4 6.0 2.3 1.7
D2 36.2 52.6 5.9 3.0 2.3
E2 35.0 51.0 5.8 4.7 3.6
F2 33.5 48.8 5.6 6.9 5.2
G2 32.1 46.7 5.3 9.1 6.9
H2 29.3 42.7 4.9 13.2 9.9
B3 37.3 54.3 6.2 – 2.3
C3 36.8 53.6 6.1 – 3.5
D3 36.4 53.0 6.0 – 4.6
E3 35.4 51.6 5.9 – 7.2
F3 34.1 49.6 5.7 – 10.6
G3 32.8 47.7 5.4 – 14.0
H3 30.3 44.1 5.0 – 20.6
The chemical compositions given here are the compositions assuming
no volatilization or loss of halogens. Fluoride retention was typically
90–96%, while chloride retention was slightly lower at 77–93%.
Generally lower halogen-containing glasses lost more halogen, and
this is thought to be a result of reaction with water to form HCl or
HF during melting. The analysis of the glasses was carried out by Lu-
cideon (using XRF.
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heat treatment temperatures (approximately 10°C above
Tc) based on the observed exotherms from the DSC
traces. Air quenching was applied after the heat treat-
ments. Glass with 2.3 mol% CaCl2 has also been held
at 913°C for 30 minutes. The heat-treated glass-ceram-
ics were ground into powder for XRD analysis. To
study the morphology of the crystallization phases, frit
specimens were embedded in resin, polished, gold
coated, and viewed using a field emission scanning elec-
tron microscope (FEI Inspect F; Oxford Instruments,
Buckinghamshire, UK) using a back-scattering mode.
Results and Discussion
All the glasses on quenching with the exception of
the higher fluoride content (>9 mol%) glasses gave
optically transparent glass frits. Figure 1 shows the
XRD patterns of the CaCl2-containing glasses. The
XRD patterns of glasses exhibited some evidence of dif-
fraction lines corresponding to apatite. In the case of
the oxychloride glasses, this is probably chlorapatite or
a mixed hydroxychlorapatite. In the case of the mixed
oxychloride/oxyfluoride glasses, the diffraction lines
could correspond to chlorapatite, fluorapatite, hydroxy-
apatite, or a mixed fluorochlorapatite. 31P MAS-NMR
showed a single broad peak for the CaCl2 glasses corre-
sponding to amorphous calcium phosphate (Fig. 2).
There was no evidence of crystalline apatite in the syn-
thesized glasses, and there was no evidence of apatite in
the Fourier transform infrared spectroscopy (FTIR)
spectra of the glasses. In contrast, the 31P MAS-NMR
spectra for the fluoride series (Fig. 3) showed a progres-
sive sharpening of the calcium orthophosphate peak
corresponding to crystalline apatite formation. The 31P
MAS-NMR spectra of the mixed series mainly gave
broad amorphous spectra. The apatite detected by
XRD in the chloride glasses is thought to arise through
reaction of the fine glass powder with atmospheric
water at the surface to form a mixed hydroxychlorapa-
tite during the time the XRD pattern was collected.
Fig. 1. XRD patterns of the CaCl2 glasses. CaCl2 content (mol%)
for each composition is indicated. Diffraction lines correspond to
apatite.
Fig. 2. 31P MAS-NMR spectra of the CaCl2-containing glasses,
compositions A3-H3 from bottom to top, CaCl2 content (mol%)
is indicated.
Fig. 3. 31P MAS-NMR spectra for the CaF2 series (A1-H1
compositions). The numbers indicate CaF2 content (mol%) in
glasses. The peak sharpens and FWHM reduces as fluorapatite
crystallizes above 9.3 mol% CaF2 (E1).
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Table 2 summarizes the crystallinity of the glasses based
on the XRD, FTIR, and 31P MAS-NMR spectra. The
hydroxyl groups in the apatite formed must come from
surface reaction with atmospheric water as there is unli-
kely to be significant quantities of hydroxyl groups in
the original glasses.
The glass transition temperature (Tg) values are
plotted against CaCl2 content in Fig. 4. The Tg of the
equivalent CaF2-containing glasses and mixed halogen
glasses were plotted for comparison. The Tg values for
the oxychloride glasses reduce by over 200°C with
increasing CaCl2 content and are typically about 30°C
above those of the equivalent oxyfluoride glasses. The
Tg of the mixed halide glasses lie below those of the
oxyfluoride glasses, rather than having intermediate val-
ues. There is a break in the Tg behavior of the CaF2
glasses (from 10 mol% CaF2), which corresponds to
crystallization of fluorapatite, which effectively removes
fluoride from the glass phase and consequently Tg
reduces less with increasing CaF2 content.
Brauer et al.44,45 and Mneimne et al.47 have both
shown previously that increasing the CaF2 content of
the glass reduces Tg. Brauer et al. proposed since fluo-
ride ions complex calcium ions that this effectively con-
verts a Ca2+ cation to a “CaF+” species, which unlike a
Ca2+ cation can no longer ionically bridge two non-
bridging oxygens. This is supported by 19F MAS-NMR
spectroscopy44,48 and the MD simulations of Christie
et al.49 On the basis that chloride incorporation gives
very similar reductions in Tg, this suggests that Cl-Ca
(n) species are forming in these glasses in an analogous
fashion to the F-Ca(n) species found in fluoride-con-
taining glasses. This is supported by the fact that Sand-
land et al.46 found evidence of Cl-Ca(n) species in
their study with glasses of very low chlorine content.
On incorporating CaCl2 rather than CaF2, the ten-
dency of the glasses to crystallize during synthesis is
suppressed and the Tg reduces more linearly with CaX2
content. Incorporating chloride as opposed to fluoride
would be expected to result in a reduced tendency to
crystallization, as the chloride ion is substantially larger
than the fluoride ion and the lattice energies of the
equivalent crystalline phases are likely to be smaller,
and furthermore, a large chloride ion is less likely to
order calcium cations around itself than a smaller fluo-
ride ion. A consequence of this is that larger amounts
of CaCl2 than CaF2 can be incorporated into the
glasses without significant crystallization occurring dur-
ing quenching from the melt.
The mixed CaCl2/CaF2 glasses also have a reduced
tendency to crystallize compared with the CaF2 glasses,
Fig. 4. Tg plotted against CaX2 (X = Cl/F/Cl + F) content
(mol%). ■ = Cl, = Cl/F, and □ = F.
Table 2. Summary of the Crystallinity Analysis of
as Quenched Glasses Based on XRD, FTIR, and 31P
MAS-NMR
Glass CaF2 CaCl2 Crystal Phases
A1/A2/A3 – – Amorphous
B1 3.0 – Amorphous
C1 4.5 – Amorphous
D1 6.0 – Amorphous
E1 9.3 – Ca10(PO4)6F2 (trace)
F1 13.6 – Ca10(PO4)6F2
G1 17.8 – Ca10(PO4)6F2,
Ca4Si2O7F2, CaF2
H1 25.5 – Ca10(PO4)6F2,
Ca4Si2O7F2, CaF2
B2 1.5 1.1 Amorphous
C2 2.3 1.7 Largely Amorphous
D2 3.0 2.3 Largely Amorphous
E2 4.7 3.6 Largely Amorphous
F2 6.9 5.2 Ca10(PO4)6F2 or HAP
G2 9.1 6.9 Ca10(PO4)6F2 or HAP
H2 13.2 9.9 Ca10(PO4)6F2 or HAP
B3 – 2.3 Amorphous
C3 – 3.5 Amorphous
D3 – 4.6 Amorphous
E3 – 7.2 Amorphous
F3 – 10.6 Amorphous
G3 – 14.0 Amorphous
H3 – 20.6 Amorphous
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and this effect is more pronounced at higher mol% of
CaX2. Fluorapatite forms in significant amounts in the
CaF2 series from 9.3 mol% CaF2. Cuspidine (3CaO-
CaF2-2SiO2 or Ca4Si2O7F2) and CaF2 crystallize from
the glass in increasing amounts during quenching as
the CaF2 content of the glass is increased.
Figure 5 plots the first peak crystallization temper-
ature (Tc1) for the three glass series. It can be seen that
Tc1 reduces with increasing CaX2 content mirroring the
Tg behavior. Figure 6 plots the first peak crystallization
temperature (Tc1) against CaCl2 content for fine and
frit (1–2 mm) particle sizes of the chloride series. The
zero CaCl2 content glass exhibits a marked temperature
difference between the Tc1 values for frit and fine pow-
der. In addition, the full-width half-maximum
(FWHM) increases markedly for the frit particles com-
pared with the fine micrometer particles. This indicates
pronounced surface nucleation. This halogen-free glass
crystallizes largely to wollastonite and an apatite. Pseu-
dowollastonite is a Q2 ring silicate, which is known to
strongly surface-nucleate. The apatite is thought to be a
hydroxyapatite, but given the low hydroxyl content of
silicate glasses, this is either thought to form as an oxy-
apatite, which subsequently reacts with water or more
likely is a result of water vapor in the furnace atmo-
sphere diffusing into the glass and enabling apatite for-
mation from the glass surface.
On incorporating CaCl2, the difference between
the Tc1 values for the different particle sizes reduces
markedly to <20°C, and at about 6–9 mol% CaCl2,
the two values are equal (Fig. 6) with Tc1 frit–Tc1 fine
going to approximately zero.
Figure 7 shows the FWHM of the first crystalliza-
tion peak temperature for the three glass series. The
FWHM decreases markedly with CaX2 content for all
three series and exhibits a minimum at about 6–9 mol
% for the chloride and mixed halide glasses, but there
is no distinct trend for the FWHM data for the fluo-
ride glasses above 9 mol%, which reflects the fact that
these glasses are significantly crystalline and also crystal-
lize to cuspidine (Ca4Si2O7F2) and fluorite (CaF2).
Both cuspidine and fluorite have an F-Ca(4) structure
with four Ca2+ cations surrounding each fluoride ion
and might be expected to form at higher fluoride
Fig. 5. Tc1 for frit particles plotted against CaX2 (X = Cl/F/
Cl + F) content (mol%). ■ = Cl, = Cl/F, and □ = F.
Fig. 6. First peak crystallization temperature (Tc1) for frit ( )
and fine (□) glass particles plotted against CaCl2 content and
Tc1 frit–Tc1 fine ( ). The error in the DSC measurements of
Tc1 is <1°C which is smaller than the data points.
Fig. 7. FWHM for first crystallization exotherm (Tc1) plotted
against CaX2 (X = Cl/F/Cl + F) content (mol%). ■ = Cl,
= Cl/F, and □ = F. The errors in determining the FWHM
are estimated to be <1°C, which is about the size of the data
points.
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contents relative to fluorapatite which has an F-Ca(3)
speciation.30 The minimum at 6–9 mol% CaX2 con-
tent for the mixed halide and chloride glasses indicates
that these glasses bulk-nucleate most readily making
them most suitable for forming apatite glass-ceramics.
The diffraction patterns of the heat-treated glasses for
the mixed halide system are consistent with fluorapatite
formation, rather than chloroapatite formation. The
minimum corresponds to about 2–3 times the halide
content in terms of crystallizing all the phosphate in
the glass to a haloapatite. A degree of caution must be
exercised with view to interpreting crystal nucleation
mechanisms from particle size studies with bioactive
glasses following Massera et al.56 largely as a result of
the fact that viscous flow sintering and crystallization
can occur simultaneously. However, in the present
glasses, the onset temperature for crystallization occurs
<100°C above the Tg, consequently viscous flow sinter-
ing is unlikely to occur and the interpretation of the
nucleation mechanisms is therefore valid. The ability to
bulk-nucleate is important, as it enables the ability to
cast the glass in the molten state and then heat-treated
to convert the glass to the glass-ceramic.
XRD patterns of the heat-treated samples of the
chloride glasses match that of chlorapatite although
some hydroxyl substitution in the lattice cannot be
ruled out and apatite is largely bulk nucleating. In con-
trast, Tc2, which corresponds to the crystallization of
pseudowollastonite, still increases markedly on going
from fine powder to frit indicating that pseudowollas-
tonite still has a strong tendency toward surface nucle-
ation. This is shown in Fig. 8a and b for DSC plots
for the 2.3 and 10.6 mol% CaCl2 glasses. The maxi-
mum in Tc2 not only moves to higher temperatures for
frit particles, but also reduces in amplitude and
becomes broader again indicating evidence of strong
surface nucleation. This becomes more pronounced
with increasing CaCl2 content. In contrast, Tc1 peak is
sharp for both fine and frit particles.
Figure 9 shows the XRD pattern of the 2.3 mol%
CaCl2 glass after heat treatment to 913°C slightly
higher than the first crystallization peak temperature
(Tc1) and to 1020°C slightly higher than the second
peak crystallization temperature (Tc2). The XRD pat-
tern shows the glass to have crystallized to a small
amount of chlorapatite at 913°C and to a much larger
amount at 1020°C, while the original glass is almost
entirely amorphous. There is also a small amount of
pseudowollastonite present.
Figure 10 shows the equivalent FTIR spectra. The
original glass shows a broad peak between 500 and
600 cm1 corresponding to the bending mode of P-
O in an amorphous calcium orthophosphate, and also
a Si–O–Si bending vibration is seen in this region.50–53
Around 720 cm1 in the glass spectrum is the broad
band due to Si–O bending vibrations.54,55 The domi-
nant bands at approximately 920 and 990 cm1 can be
attributed to Si–O (Q2) and Si–O–Si stretching vibra-
tions, respectively. On heat treatment, the broad band
at 500 to 600 cm1 is lost and two new peaks at 560
and 605 cm1 appear corresponding to P-O bending
in a crystalline orthophosphate and a peak at
1035 cm1 corresponding to P-O stretching appear. In
(a)
(b)
Fig. 8. DSC traces for frit and <38 lm powder of (a) 2.3
and (b) 10.6 mol% CaCl2 glasses showing largely bulk nucle-
ation of the first crystallization peak and surface nucleation of
the second crystallization peak.
www.ceramics.org/IJAGS Chlorapatite Glass-Ceramics 213
addition, the Si-O bending and stretching vibration
becomes more pronounced after heat treatment at
1020°C. The presence of the sharp peaks at 560 and
605 cm1 is indicative of apatite crystallization. The
presence of sharper peaks at 920 and 980 cm1 com-
pared with the original glass in the sample heat-treated
to 1020°C corresponding to Tp2 indicates a much
more ordered Q2 calcium silicate environment. On the
basis that following crystallization of chlorapatite, this
glass will have a CaO/SiO2 ratio close to the wollaston-
ite stoichiometry, and it might be expected that Tc2
might correspond to the crystallization of pseudowollas-
tonite. The FTIR spectra following heat treatment at
1020°C are consistent with the formation of a crystal-
line Q2 calcium silicate.
Figure 11 shows the 31P MAS-NMR spectra of the
2.3 mol% CaCl2 glass and the heat-treated samples.
There is a progressive sharpening of the major peak
upon crystallization. At 913°C, relatively little apatite is
formed and most of the phosphorus in the glass has
not crystallized. After heat-treating at 1020°C, most of
the phosphorus in the glass has crystallized to chlorapa-
Fig. 9. XRD patterns of the 2.3 mol% CaCl2 glass and heat-
treated glasses of this initial composition. ○ = apatite, + = wol-
lastonite/pseudowollastonite.
Fig. 10. FTIR spectra of the 2.3 mol% CaCl2 glass and heat-
treated glasses of this initial composition.
Fig. 11. 31P MAS-NMR spectra of the 2.3 mol% CaCl2 glass
and heat-treated glasses.
Fig. 12. SEM of the fractured surface of 2.3 mol% CaCl2
glass-ceramic heat-treated at 913°C.
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tite and consequently the peak sharpens and has a sharp
maximum at about 2.6 ppm corresponding to apatite.
The sample heat-treated to 913°C has a microstructure
(Fig. 12) that consists of uniform equiaxed hexagonal
crystals of chlorapatite. In contrast, the equivalent fluo-
ride-containing glass formed hexagonal needle-like crys-
tals of fluorapatite. Fluorapatite generally forms crystals
with a needle-like habit when crystallized from oxyfluo-
ride glasses,10–13,18 while chlorapatite has a tendency to
form equiaxed crystals56.
Conclusions
The glass transition temperature for the three glass
series reduced with increasing CaX2 content. The
reduction in the Tg is probably a result of the forma-
tion of X-Ca(n) species in the glass structure. The halo-
gen-free glass surface crystallized to wollastonite and
apatite. All the glasses with chloride or fluoride crystal-
lized first to a haloapatite. Fluoride-containing glasses
crystallized more readily and also tended to crystallize
to additional phases, including cuspidine and fluorite.
Glasses with 2.3 to 9.3 mol% CaX2 had a reduced ten-
dency to surface-nucleate to a haloapatite and are
attractive for potential apatite glass-ceramics. The sec-
ond crystallization process of the chloride glasses and
mixed halide glasses was wollastonite, which always
strongly surface-nucleated. The surface nucleation of
wollastonite is undesirable and would probably elimi-
nate the ability to produce apatite–wollastonite glass-
ceramics by a direct casting route. However, it would
be possible to crystallize these glasses to only apatite to
form apatite glass-ceramics with a bioactive residual
glass phase. Tailoring the fluorine/chlorine ratio should
enable mixed haloapatites to be produced, enable the
tailoring of the microstructure and in vivo resorbability
of the glass-ceramics.
The chloride glasses studied here are very reactive
and appear to react with atmospheric water, and further
work is required to develop practical chloroapatite and
mixed chloro/fluorapatite glass-ceramics and to study
their in vitro and in vivo biocompatibility.
Further work is required to characterize these oxy-
chloride glasses and chlorapatite glass-ceramics using
the 35Cl NMR to identify the chlorine speciation in
the glass and 29Si MAS-NMR to confirm that the Q
speciation does not change with the addition of
CaCl2.
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Alkali free bioactive glasses with the presence of Ca/SrF2 were synthesized and then characterised by Differential
Scanning Calorimetry, X-ray Diffraction, Fourier Transform Infrared Spectroscopy and Magic Angle Spinning–
Nuclear Magnetic Resonance Spectroscopy. The crystallisation of the glasses was explored by heat treatment.
An increased crystallisation tendency of the as quenched glasses was evident with an increase in the Ca/SrF2
content, where Ca10(PO4)6F2 (ﬂuorapatite), Ca4Si2O7F2 (cuspidine) and CaF2 crystallise in sequence for the
Ca-containing system, and Sr10(PO4)6F2, SrSiO3 and SrF2 for the Sr-containing system. Upon heat treatment,
Ca10(PO4)6F2 or Sr10(PO4)6F2, which is mainly nucleated from bulk is the primary crystalline phase. Although
partially crystallised these sodium free ﬂuorapatite glass ceramics are proposed to have enhanced bioactivity
comparable to bioactive glasses.
Crown Copyright © 2014 Published by Elsevier B.V. All rights reserved.
1. Introduction
Bioactive glasses and glass ceramics with the ability to form apatite-
like phases on heat treatment or on being exposed in physiological
solution have been used extensively inmedicine and dentistry [1,2]. Ap-
atite glass ceramics are attractive as bone ﬁllers and implant materials,
as a result of their favourable biocompatibility and osteoconductivity
arising from the presence of apatite [3,4]. Kokubo et al. [5] developed
an apatite wollastonite (AW) glass ceramics system, which has high
mechanical strength and shows good chemical bonding with living
tissue. However, as this system surface nucleates, it has to be sintered
and thenmachined to shape, which is unattractive commercially. In ad-
dition, the extremely low CaF2 content (b1 mol%) used in AW formula-
tions results in a restricted amount of ﬂuoride substitution in apatite
and mixed oxy-ﬂuorapatite crystals formation [3].
The castable apatite mullite (AM) glass ceramics based on the CaO–
Al2O3–SiO2–P2O5–CaF2 system synthesized by Rafferty et al. [6]
predominantly bulk nucleate and crystallise to ﬂuorapatite (FAP) and
mullite crystals. These bioactive glass ceramics can have high fracture
toughness and strength and as a consequence of exhibiting bulk
nucleation can be readily cast to shape. Nevertheless, the possibility of
toxicity caused by the release of aluminium in vivo is perceived as
being problematic for AM glass ceramics.
Brauer and co-workers [7,8] successfully developed two glass ceramic
series with different amounts of P2O5 in the system of Na2O–CaO–SiO2–
P2O5–CaF2. Mixed sodium calcium ﬂuoride phosphate, FAP, and combeite
(Na2Ca2Si3O9) were found as the main crystalline phases in the glasses
with high P2O5 content (N4.7 mol%) [7], whilst no FAP crystallised from
low P2O5 (b1.1 mol%) containing glasses [8]. Brauer et al. also found
that a sodium free high P2O5 containing bioactive glass composition
crystallised to FAP. Thus, it is clear that the crystallisation of apatite from
glass is strongly inﬂuenced by the phosphate content. The presence of
sodium is often considered to be essential for bioactive glasses to achieve
bioactivity. However, recently, apatite formation in simulated body ﬂuid
was also found for glass and glass ceramics that contain no sodium
[9–11]. Furthermore, sodium free formulations of bioactive sol–gel
glasses have been known for a long time [12] in addition to recently
developed hybrid materials [13]. This suggests that sodium is not an
essential component for bioactive glasses and glass ceramics [14–16].
In fact high sodium content can cause undesirable rapid rise in pH and
a cytotoxic effect.
Fluorapatite (Ca10(PO4)6F2) is analogous to hydroxyapatite (Ca10
(PO4)6(OH)2; HAP), which is close to the main mineral component of
bones and teeth [17,18]. However, FAP is much more stable in acidic
environment (pH b 4) compared to HAP, this is extremely favourable
in dentistry.
The Sr2+ cation is chemically similar to the Ca2+ cation but slightly
larger in size (effective ionic radius: 1.16 vs 0.94 Å), and therefore it can
potentially replace Ca2+ in the apatite crystal lattice to form strontium
ﬂuoride apatite (Sr10(PO4)6F2) [19]. Strontium has the capacity to facil-
itate enamel remineralisation [20], and the incorporation of strontium
into bioactive glasses was reported to promote osteoblast proliferation
and reduce osteoclast resorbtion [21,22]. Hence, the strontium contain-
ing bioactive glasses are attractive for dental remineralisation and bone
regeneration.
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To minimize the disadvantages caused by the presence of sodium
and also leverage the beneﬁts by introducing ﬂuoride into glasses, the
aim of this paper is to investigate the inﬂuence of CaF2 and SrF2 content
on the crystallisation behaviour of the novel sodium free, high
phosphate content bioactive glasses.
2. Materials and methods
2.1. Glass synthesis
Novel sodium free ﬂuoride containing bioactive glasses were de-
signed by introducing CaF2/SrF2 into the SiO2–P2O5–CaO ternary glass
system (Table 1). Glasses were synthesized by a melt–quench method
with analytical grade silica (Prince Minerals Ltd., Stoke-on-Trent, UK),
calcium carbonate, phosphorus pentoxide and calcium ﬂuoride or
strontium ﬂuoride (all Sigma-Aldrich, Gillingham, UK). A 200 g batch
wasmelted in a 300ml platinum/rhodium crucible for 1 h in an electri-
cal furnace (EHF 17/3, Lenton, UK). The melting temperature was
1550 °C for glasses with 0 and 3 mol% CaF2 and 1500 °C for the rest.
The melted glasses were quenched into cold deionised water to
suppress crystallisation. The as quenched granular glass frit was dried
overnight and ground into powder by a vibratory mill (Gyro mill, Glen
Creston, UK) for 14 min. The resultant powder was sieved through a
45 μm test sieve (Endecotts Ltd, UK) to obtain ﬁne powder.
2.2. Glass characterisation
2.2.1. X-ray diffraction (XRD)
The amorphous state of the glasses synthesised in the present study
was characterised by an X'Pert Pro X-ray diffractometer (PANalytical,
The Netherlands) with a copper (Ni-ﬁltered Cu-Kα) X-ray source. The
XRD patterns of the glasses were recorded between 5 and 70° 2θ with
a step size of 0.0334° and a step time of 200.03 s. Phase identiﬁcation
was carried out by using X'Pert HighScore Plus (v2.0, PANalytical, The
Netherlands) in conjunction with the ICDD PDF-4 database.
2.2.2. Fourier Transform Infrared Spectroscopy (FTIR)
Attenuated Total Reﬂectance–Fourier Transform Infrared Spectros-
copy (Spectrum GX, Perkin-Elmer, USA) was used to analyse the chem-
ical bonding in the glass powder and heat treated samples. Ten scans
were performed for each sample, and the data were collected for
wavenumbers from 500 to 1600 cm−1.
2.2.3. Magic Angle Spinning–Nuclear Magnetic Resonance (MAS–NMR)
31P and 19F MAS–NMRwere employed to investigate glass structure
and crystalline phases by using a 600 MHz (14.1T) Bruker solid state
NMR Spectrometer. Experiments were carried out at spinning rates of
18 or 21 kHz and resonance frequencies of 242.9 and 564.7 MHz for
31P and 19F MAS–NMR, respectively. Recycle delay time was 60 s for
31P and 30 s for 19F. Typically 16 or 32 scans were used for 31P, whilst
32 or 64 scans were adopted for 19F MAS–NMR. Chemical shift for 31P
and 19F was referenced by using 85% H3PO4 and 1 M NaF solution; the
latter signal was adjusted to –120 ppm relative to CFCl3.
2.2.4. Differential Scanning Calorimetry (DSC)
Differential Scanning Calorimetry (DSC) was used to characterise
the thermal properties of the glasses. Glass frit or ﬁne powder (50 ±
1 mg) were heated under Nitrogen (60 ml/min−1) at a rate of 20 °C/
min from room temperature up to 1100 °C against alumina using a
differential scanning calorimeter (DSC 1500 Stanton Redcroft,
Rheometric Scientiﬁc, UK). Glass transition temperature (Tg) and
crystallisation peak temperatures (Tp) of each glasses were then ob-
tained from the recorded DSC trace. The accuracy of all characteristic
temperatures obtained and further presented in ﬁgures and tables
was ±5 °C.
2.3. Crystallisation behaviour
1 g of ﬁne powder (b45 μm)was compacted into a disc, placed on a
platinum foil and heated up at a rate of 20 °C/min from 400 °C to the
heat treatment temperature (THT) in a porcelain furnace (CeramPress,
NEY Dental International, USA) without holding. According to the
width of the crystallisation peak from the DSC traces, THT was Tp or
approximately 10 °C above Tp. After heat treatment, samples were
immediately withdrawn from the furnace and air quenched.
The resulting sintered glass ceramics were then ground into powder
and characterised by using XRD, FTIR and NMR. In order to investigate
the morphology of the crystalline phases, the heat treated glass
ceramics were embedded in resin, polished with a series of silicon
carbide grinding paper and ﬁnished with 0.3 μm diamond paste (Met
Prep Ltd., UK). The polished specimens were gold coated and viewed
under a scanning electron microscope (FEI Inspect F, Oxford Instru-
ments, UK) using back-scatter and secondary electron imaging modes.
3. Results
3.1. Glass formation
The XRD patterns of the as quenched sodium free Ca- and Sr-
containing glasses are given in Fig. 1a and b. Amorphous halos at 30°
2θ were found in glasses with low CaF2 content (less than 9.3 mol%),
whereas clear diffraction peaks were noticed for higher CaF2 containing
glasses.With an increase in the CaF2 content (up to 9.3 mol%), addition-
al small features at 25.86°, 32.23° and 33.07° 2θ were evident. These
peaks were matched to the major apatite (FAP: 00-034-0011) diffrac-
tion lines. However, a minor peak at 31.89° 2θ was seen for glasses
with 4.5 and 6.0 mol% CaF2. A further increase in the CaF2 content up
to 17.8 mol% resulted in the crystallisation of cuspidine (Ca4Si2O7F2,
00-011-0075) with diffraction lines at 26.5° and 29.1°. At the same
time, additional lines at 28.28° and 47° 2θ corresponding to ﬂuorite
(CaF2, 00-004-0864) were also found.
The SrF2-based series demonstrated similar patterns (Fig. 1b).
Amorphous halos were exhibited at 29° 2θ in the glass with SrF2 con-
tents less than 4.5 mol%, and sharp peaks at 26.5°, 27.85°, 30.5° and
31.7° 2θ were observed for glasses with SrF2 content greater than
4.5 mol%, which were identiﬁed with the main diffraction lines of
Sr10(PO4)6F2 (00-050-1744). With increasing SrF2 content up to
13.6 mol%, peaks corresponding to SrSiO3 (00-034-0099) appeared at
24.95° and 43.9° 2θ. Furthermore, additional peaks at 43.19° and
52.23° in the XRD patterns of 17.8 and 25.5 mol% SrF2 glasses were
matched to the characteristic diffraction peaks of SrF2 (00-001-0644).
The crystalline phases identiﬁed in both glass series are summarised
in Table 2.
FTIR spectra of the as quenched CaF2 containing glasses (Fig. 2a)
show the typical non-bridging oxygen band and Si–O–Si stretch band
at 920 and 1030 cm−1 for the whole series. In addition, a small band
around 600 cm−1 was noticed in the glasses with CaF2 content lower
Table 1
Glass compositions in mol%. GF is used for CaO/CaF2 series and SF for SrO/SrF2 series.
Glass code SiO2 CaO/SrO P2O5 CaF2/SrF2
GF/SF 0.0 38.1 55.5 6.3 0.0
GF/SF 3.0 37.0 53.9 6.1 3.0
GF/SF 4.5 36.4 53.0 6.0 4.5
GF/SF 6.0 35.9 52.2 5.9 6.0
GF/SF 9.3 34.6 50.4 5.7 9.3
GF/SF 13.6 32.9 48.0 5.5 13.6
GF/SF 17.8 31.4 45.7 5.2 17.8
GF/SF 25.5 28.4 41.4 4.7 25.5
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than 9.3 mol%, whilst the characteristic apatite split bands at 560 and
613 cm−1 were visible with an increase in CaF2 content [23]. The spec-
trum of the Ca-containing glass with 25.5 mol% of CaF2 was
characterised with distinctly sharp band features in the region 800–
1050 cm−1 indicating presence of silicate crystalline phase [24].
SrF2 containing glasses demonstrated a similar trend as CaF2 series
(Fig. 2b). However, the typical apatite split bands at 595 cm−1 and
555 cm−1 were ﬁrst recognised in the strontium series with 4.5 mol%
SrF2 content. At the same time the spectra of the glasses with high
ﬂuoride content clearly showed presence of a silicate crystalline phase.
31P and 19F MAS–NMR were used to characterise the atomic
environment of phosphate and ﬂuoride in the glasses. Fig. 3a shows
the 31P MAS–NMR spectra of CaF2 containing bioactive glasses and
glass ceramics. Broad peaks with a centre at 3 ppm, corresponding to
amorphous calcium orthophosphate, are found in the spectra of low
CaF2 containing glasses. In addition, with an increasing amount of CaF2
the linewidth of the peak reduced, but without changing the peak
position. This suggests that glasses tend to partially crystallise to
calcium orthophosphate of which, apatite is an example, which leads
to a reduction in the linewidth of the 31P NMR signal.
Three types of ﬂuoride environment were presented by 19F MAS–
NMR spectra in Fig. 3b. The glasses with low CaF2 content have broad
peaks with a centre at about −96 ppm, whilst a tiny but sharp peak
at−103 ppm, corresponding to ﬂuorapatite is found on the shoulder
of a broad glass signal in the glasses with CaF2 content over 9.3 mol%.
Furthermore, an asymmetric and sharp peak at−108 ppmof the chem-
ical shift is obvious in the spectrum of the 25.5 mol% CaF2 containing
glass, indicating the crystallisation of CaF2.
3.2. Thermal properties
The glass transition temperature and crystallisation peak tempera-
tures for both glass powder and frit are summarised and listed in
Tables 3 and S1 (Supplemental material). Some of the compositions
had more than one exotherm. The corresponding crystallisation peak
temperatures, of the ﬁrst (Tp1), second (Tp2), third (Tp3) and fourth
(Tp4) exotherms were deﬁned from the DSC traces. Particle size had
no signiﬁcant effect on Tg and some of the crystallisation temperatures,
which result in close values for Tg, Tp1 and some of the Tp2 and Tp3
values. However, some crystallisation peak temperatures of coarse
Table 2
The summary of crystalline phases identiﬁed from XRD patterns.
Glasses Crystallisation phases Glasses Crystallisation phases
GF 0.0
Amorphous
SF 0.0
AmorphousGF 3.0 SF 3.0
GF 4.5 SF 4.5
Sr10(PO4)6F2GF 6.0 SF 6.0
GF 9.3
Ca10(PO4)6F2
SF 9.3
GF 13.6 SF 13.6 Sr10(PO4)6F2, SrSiO3
GF 17.8 Ca10(PO4)6F2, Ca4Si2O7F2, CaF2 SF 17.8 Sr10(PO4)6F2, SrSiO3, SrF2
GF 25.5 SF 25.5
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Fig. 2. FTIR spectra of the as quenched glasses. (a) CaF2 glasses; (b) SrF2 glasses. The
numbers are nominal molar percentage of the CaF2/SrF2 in the compositions.
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Fig. 1. XRD patterns of the as quenched glasses. (a) CaF2-based glasses (о: Ca10(PO4)6F2; *:
Ca4Si2O7F2; +: CaF2); (b) SrF2 glasses (#: Sr10(PO4)6F2; ^: SrF2; ●: SrSiO3). The numbers are
nominal molar percentage of the CaF2/SrF2 in the compositions.
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particles (frit) are higher than the equivalent ﬁne powder, which were
highlighted in Table 3.
As shown in Fig. 4, the glass transition temperature and ﬁrst
crystallisation peak temperature showed a similar trend, both reducing
with increasing CaF2 or SrF2 content. Comparing Tg and Tp1 of the two
glass series, the Tp1 values for the SrF2 glasses are much lower
(30–70 °C) than the equivalent ones for the CaF2 series, though the Tg
values were about the same.
3.3. Crystallisation behaviour
XRD results of heat treated glasses GF 3.0 and GF 25.5 are presented
in Fig. 5. For GF 3.0 after heat treatment at Tp1 (867 °C), sharp diffraction
lines corresponding to apatite develop, and there is a trace of wollaston-
ite present as well. Interestingly no new crystalline phases were found
for the heat treatments at the higher temperatures. The partially
crystallised glass GF 25.5, that already contains apatite, cuspidine and
ﬂuorite shows increase in diffraction line intensity of in particular
cuspidine and ﬂuorite indicating further crystallisation on heat treat-
ment at 713 °C. The crystal phases formed on heat treatment of the
glasses are presented in Table 4. Fig. S1 (Supplemental material)
shows the XRD pattern of GF 0.0 heat treated at 1030 °C. Compared to
Fig. 3. (a) 31P MAS–NMR and (b) 19F MAS–NMR spectra of CaF2-based glasses. The
asterisk shows the spinning side bands. The numbers are nominal molar percentage
of the CaF2 in the compositions.
Table 3
Characteristic temperature of glass powder (b45 μm) for ﬂuoride containing glasses. The
glasses mainly nucleated form surface are highlighted in bold.
XF2 (mol%) Glass powder (CaF2 series) Glass powder (SrF2 series)
Tg (°C) Tp1 Tp2 Tp3 Tg (°C) Tp1 Tp2 Tp3 Tp4
GF 0.0 790 925 – – 783 918 1042 – –
GF 3.0 735 867 888 979 735 821 862 955 848
GF 4.5 722 860 – – 706 801 827 918 –
GF 6.0 693 817 844 942 680 778 795 859 –
GF 9.3 655 780 806 878 657 744 – 862 –
GF 13.6 618 732 758 977 618 705 716 853 –
GF 17.8 601 720 – – – – – – –
GF 25.5 558 713 – – 562 638 699 713 847
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Fig. 4.Glass transition temperature (Tg) and ﬁrst crystallisation peak temperature (Tp1) of
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the amorphous halo of the initial glass, distinct diffraction lines, which
match with hydroxyapatite and pseudowollastonite are evidenced.
4. Discussion
4.1. Glass formation
XRD patterns, FTIR and NMR spectra all demonstrated that the low
ﬂuoride content glasses were amorphous, but the glasses with higher
CaF2 (≥9.3 mol%) and SrF2 (≥4.5 mol%) content were partially
crystallised to FAP (Ca10(PO4)6F2, and Sr10(PO4)6F2). The GF 13.6 glass
crystallised to FAP and cuspidine. Crystalline CaF2 and SrF2 were found
in addition on increasing the ﬂuoride content to over 17.8 mol% CaF2
and 13.6 mol% SrF2, respectively. Interestingly, based on XRD results,
the highest CaF2 content (25.5 mol%) glass demonstrated a pronounced
increase in the intensity of the diffraction lines corresponding to
cuspidine, and this increase was at the expense of the intensity of the
lines corresponding to FAP compared with the GF 17.8.
The SrF2 containing glasses had a higher tendency to crystallise than
CaF2 ones. This can be attributed to the more expanded glass structure
causing by the larger size of Sr2+ [22,25].
31P MAS–NMR spectra suggest that in the sodium free ﬂuoride con-
taining bioactive glasses and glass ceramics, phosphorus is present as a
calcium orthophosphate. 19F MAS–NMR conﬁrmed the presence of
amorphous F–Ca(n) species and also identiﬁed spontaneous FAP
(F–Ca(3)) crystallisation in the glasses with over 9.3 mol% CaF2 content
on quenching, whilst CaF2 with a F–Ca(4) environment crystallised
spontaneously from the glass with 25.5 mol% CaF2.
Cuspidine has been found to crystallise from sodium and ﬂuoride-
containing bioactive glasses [8], glasses in the CaO–CaF2–SiO2 system
[26,27] and mould-ﬂux glasses [28]. Our study suggests that for glasses
in the CaO–CaF2–P2O5–SiO2 system with a constant SiO2:CaO:P2O5
molar ratio of 6:8.8:1, an increase in the CaF2 content leads to an
increased crystallisation tendency, where FAP, cuspidine and CaF2 crys-
tallise sequentially. Atmoderate ﬂuoride content (at 9.3 mol%) only FAP
forms in the as quenched glass, with increasing in ﬂuoride content, two
ﬂuoride containing phases are present in the as quenched glass, i.e. FAP
and cuspidine. The glasses with the highest ﬂuoride content have all
three ﬂuoride containing phases.
Theminute amount of apatite seen in the ground glass powderswith
the lowest ﬂuoride content is due to the reaction with atmospheric
moisture.
4.2. Thermal properties
Owing to ﬂuoride complexing calcium, glass transition and
crystallisation temperatures decreased markedly with increasing
CaF2/SrF2 content (0 to 25.5 mol%) [8]. In the ﬂuoride free glass
(0 mol%), divalent calcium ions bind together silicate anions by electro-
static forces and the calcium ions effectively act as ionic bridges be-
tween two non-bridging oxygens (NBOs). When CaF2/SrF2 is added,
hypothetical ‘CaF+’/‘SrF+’ species are formed, and the electrostatic
forces between NBOs are reduced considerably, resulting in a decrease
in Tg [8,29]. The effect of CaF2/SrF2 on Tg was less pronounced at high
ﬂuoride content (Fig. 4). This could be attributed to the crystallisation
of ﬂuoride containing phases (such as FAP and CaF2/SrF2) in the as
quenched glasses. However, as Sr2+ is larger in size compared to
Ca2+, it is thought to expand the glass network more [22,25], resulting
in a less stable glass which crystallises more readily and at a lower
temperature.
The glass transition temperature of the ﬂuoride free glass (0 mol%,
790 °C) was considerably higher than that of the equivalent soda
containing glass (ICSW9, 491 °C) studied by O'Donnell et al. [30]. This
can be explained by differences in cross-linking. Owing to Ca2+ being
replaced for two Na+ (i.e. a reduced charge-to-size ratio of themodiﬁer
cation), ionic cross-linking between NBOs of neighbouring silicate
chains is reduced, and as a consequence Tg increases. Tg is determined
by the strength of the bonding in the glass and is also known to correlate
with degradability and hardness of glasses [31]. In the absence of sodi-
um, the addition of ﬂuoride is particularly beneﬁcial since ﬂuoride de-
creases Tg and melting temperature in a similar fashion, facilitates
melting and is expected to reduce glass hardness.
In Tables 3 and S1 (Supplemental material), the similar ﬁrst
crystallisation peak temperatures (Tp1) of powder and frit indicate
that in the CaF2 and SrF2 containing glasses the ﬁrst crystalline phases,
which are believed to be Ca10(PO4)6F2 or Sr10(PO4)6F2, respectively,
are mainly nucleated from bulk. Whilst Tp1 of the frit is higher than
ﬁne powder for GF 0.0 (ﬂuoride free), this is ascribed to wollastonite,
which is a phase known to strongly surface nucleate. The second or
third crystallisation phases of some compositions are also strongly nu-
cleating from the surface. They are highlighted in Table 3. Compared
with frit, ﬁne powder has larger surface area, which provides more
nucleation sites for crystallisation. Therefore ﬁne powder is prone to
crystallise at a lower temperature [32]. In contrast, when the
crystallisation peak temperature is independent of particle size, then
this may indicate bulk nucleation.
Crystallisation of a bioactive glass has been shown to reduce its bio-
active properties [33] as the crystalline phases are generallymore stable
than the equivalent glass phase and generally crystallisation results in a
residual glass phasewith a higher network connectivity (NC). However,
in the present glasses, crystals of FAP (Ca10(PO4)6F2 and Sr10(PO4)6F2)
are able to serve as nuclei for the further growth of the apatite phase,
whichmay therefore increase its bioactivity. In addition, the apatite for-
mation will not result in a less reactive residual silicate glass since the
NC of the glass will remain unchanged. The bioactivity of these glasses
and glass-ceramics has been presented and discussed in a separate
report [34].
4.3. Glass heat treatment
Two or three crystal phases were typically found upon heat treat-
ment. The ﬁrst was apatite, which is thought to be HAP, presenting as
a hexagonal-like morphology in the ﬂuoride free composition.
Pseudowollastonite (β-CaSiO3) also formed at the heat treatment tem-
perature of 1030 °C (Fig. S1, Supplementalmaterial). It is surprising that
Table 4
Summary of phases crystallising on heat treatment. β-CaSiO3: pseudowollastonite,
Ca10(PO4)6(OH)2: hydroxyapatite, Ca10(PO4)6F2: ﬂuorapatite, CaSiO3: wollastonite-2M,
CaSiO3 (hexagonal): wollastonite-1A, Ca4Si2O7F2: cuspidine, CaF2: ﬂuorite, SrSiO3: stron-
tium silicate, Sr10(PO4)6F2: strontium phosphate ﬂuoride and SrF2: strontium ﬂuoride.
Glasses THT (°C) Crystalline Phases
GF 0.0 1030 β-CaSiO3 and Ca10(PO4)6(OH)2
GF 3.0 867 Ca10(PO4)6F2 and CaSiO3
888
979
GF 4.5 860
GF 6.0 817
844
942 Ca10(PO4)6F2 and CaSiO3 (hexagonal)
GF 9.3 780 Ca10(PO4)6F2
806 Ca10(PO4)6F2 and Ca4Si2O7F2
878
GF 13.6 732
758
977
GF 17.8 720 Ca10(PO4)6F2, Ca4Si2O7F2 and CaF2
GF 25.5 713
SF 3.0 1040 SrSiO3 and Sr10(PO4)6F2
SF 4.5 860
1000
SF 6.0 830 SrSiO3, Sr10(PO4)6F2 and SrF2
960
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an apatite was formed in the absence of ﬂuoride since in AM glass
ceramics, apatite only forms when ﬂuoride is present [6]. It may be
that the apatite formed is an oxyapatite which transforms to HAP by re-
action with atmospheric water. The crystallisation peak observed for
this composition was broad and is probably a result of the overlapping
of apatite and pseudowollastonite crystallisation events.
GF 3.0 crystallised to FAP with an elongated and interlocking crystal
structure (dendritic) (Fig. S2, Supplemental material) at 888 °C with
coexisting FAP and wollastonite phases. All the heat treated samples
of 4.5 and 6.0 mol% CaF2 containing glasses crystallised to FAP and wol-
lastonite. The heat treatment temperatures are too high to see the
crystallisation of FAP without wollastonite. The wollastonite phase
was expected on the grounds that the residual glass phase following
crystallisation of FAP would have a Q structure close to Q2 and also
close to the stoichiometry of wollastonite.
FAP, cuspidine and CaF2 are found as crystalline phases in the glasses
with over 6 mol% CaF2 following heat treatment. It is worth noting that
in these series of glasses the Q structure did not change on
crystallisation and remained at 2.08 (NC) irrespective of howmuch ap-
atite crystallises. Cuspidine and CaF2 are phosphate free crystalline
phases and therefore should not restrict bioactivity. This is an attractive
feature of these glasses and glass ceramics, since the essentially Q2 spe-
ciation of the amorphous structure part will confer bioactivity. In addi-
tion, the presence of FAP is also extremely desirable and FAP glass
ceramics have demonstrated excellent osseointegration [35]. The FAP
may also provide seed crystals for the formation of more apatite as the
Q2 residual glass phase dissolves in body ﬂuids. These glass ceramics
combine the beneﬁcial effects of a bioactive glass phase and the FAP
crystals.
5. Conclusion
This study revealed that novel sodium free low ﬂuoride content
(CaF2 b 9.3mol% and SrF2 b 4.5 mol%) bioactive glasses can be obtained
in an amorphous state. Bioactive glasses with high ﬂuoride content
(CaF2 ≥ 9.3 mol% and SrF2 ≥ 4.5 mol%) crystallised spontaneously to
ﬂuorapatite during quenching, whilst CaF2 and SrF2 were found in the
glasses with 17.8 and 25.5 mol% ﬂuoride. Fluorapatite crystallised
from all glasses upon heat treatment. An addition of ﬂuoride into bioac-
tive glasses leads to a dramatic reduction in Tg and Tp1. In order to obtain
the glass ceramics for dental applications which show FAP as the only
crystal phase, large crystallisationwindows and optimised ﬂuoride con-
tent (about 6.0 mol% CaF2 and 4.5 mol% SrF2) are required.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.jnoncrysol.2014.05.025.
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Abstract: The bioactivity of a series of fluoride-containing sodium-free calcium and 
strontium phosphosilicate glasses has been tested in vitro. Glasses with high fluoride 
content were partially crystallised to apatite and other fluoride-containing phases.  
The bioactivity study was carried out in Tris and SBF buffers, and apatite formation was 
monitored by XRD, FTIR and solid state NMR. Ion release in solutions has been measured 
using ICP-OES and fluoride-ion selective electrode. The results show that glasses with low 
amounts of fluoride that were initially amorphous degraded rapidly in Tris buffer and 
formed apatite as early as 3 h after immersion. The apatite was identified as fluorapatite by 
19
F MAS-NMR after 6 h of immersion. Glass degradation and apatite formation was 
significantly slower in SBF solution compared to Tris. On immersion of the partially 
crystallised glasses, the fraction of apatite increased at 3 h compared to the amount of 
apatite prior to the treatment. Thus, partial crystallisation of the glasses has not affected 
bioactivity significantly. Fast dissolution of the amorphous phase was also indicated. There 
was no difference in kinetics between Tris and SBF studies when the glass was partially 
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crystallised to apatite before immersion. Two different mechanisms of apatite formation for 
amorphous or partially crystallised glasses are discussed. 
Keywords: sodium-/alkali-free bioactive glass; bioactive glass-ceramics; fluorapatite; fluoride 
 
1. Introduction 
The bioactivity of glasses and ceramics is often investigated on immersion of the solid in a buffer 
solution simulating physiological fluids. Formation of an apatite-like layer on the surface of the solid 
as a result of the reaction with fluid is then evaluated. This laboratory procedure has a number of 
drawbacks and cannot be used directly for predicting the bioactivity of the same solid in vivo [1,2]. 
However, testing apatite formation in buffer solution is a useful inexpensive model for comparative 
evaluation of the bioactive glasses and bioceramics of different formulations in order to preselect 
compositions with potentially the most promising biological activity.  
The earliest immersion time when apatite can be identified is typically used as a measure of 
bioactivity. However, the rate and ability of bioceramics to form apatite is dependent on the type of 
physiological buffer used even when the same formulation of bioceramics or glass is tested. In 
particular, concentrations of calcium and phosphate available in solution as well as the presence of 
other species affect the rate of apatite formation. The composition of the simulated body fluid (SBF) 
solution is close to the saturation level of apatite [2]. Therefore, potentially any surface exposed to 
SBF can aid precipitation of apatite irrespective of whether it is bioactive or not. On the other hand, 
only calcium- and phosphate-rich bioceramics and glasses can be tested for bioactivity in Tris buffer 
solution, owing to apatite precipitation following the initial release of these components from the solid 
into solution.  
Alkali- or specifically sodium-containing bioactive glasses generate a high alkaline pH that can 
cause a cytotoxic cells response [3]. Although plenty of alkali-free bioceramics [4,5] based on  
calcium-rich crystalline phases have been studied including phosphates [6], carbonates [7] and  
silicates [8,9], there are only few reports on alkali-free bioactive glasses [10–16]. The majority of the 
available sodium-free bioactive glasses are of sol-gel origin [17–22], and the nominal composition of 
these glasses cannot be directly compared with melt-derived glasses owing to the presence of 
substantial amounts of, if not water, then hydroxyl groups in the glass. In a report where exclusively 
sodium-free melt-derived glasses were studied, the bioactivity of the glasses was clearly inhibited 
owing to the presence of significant amounts of MgO in the composition [12]. 
Typically, the rate of apatite formation is lower for ceramics than for amorphous glasses, as a 
crystalline solid has a lower dissolution rate and thus would be expected to exhibit lower bioactivity 
than an amorphous glass of a bioactive-type composition. For instance, sintered apatite bioceramics 
dissolves slower than apatite resulting from the degradation of bioactive glass [23]. Sintered glass 
exhibits a bioactivity lower than the one before sintering [24]. Moreover, partial crystallisation  
often occurs during sintering, for instance with 45S5, which will further decrease the reactivity of  
the glass [25–27]. 
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Recent success in fluoride-containing bioactive glasses showed that there is a concentration limit 
for fluoride to be added to the glass before spontaneous crystallisation occurs [10,11,28–30]. This is 
owing to the known effect of fluoride destabilising glass against crystallisation [31]. It is also known 
that the type of the fluoride-containing crystalline phase is dependent on the composition of the glass. 
For example, in low phosphate content bioactive glasses, calcium fluoride crystallises out [32].  
An increase in phosphate content caused formation of apatite in the glasses [33].  
In the present study, the design of glasses is typical for bioactive compositions [34,35] and it is such 
that the silicate component is present mostly as chains [32,36,37], while fluoride is coordinated by  
calcium [38] and phosphate is present as orthophosphate [32,36]. Partial crystallisation of an apatite 
phase should not involve the silicate chain domains [32,33,38,39], and these will still remain 
amorphous, which means the silicate phase would still continue to dissolve rapidly. In addition, apatite 
crystals pre-formed in the system can minimise the nucleation energy via providing their surface for 
further precipitation and growth of the apatite crystals. Although apatite-containing systems have been 
known before, none of the bioactivity studies considered this in combination with a reactive glass 
phase. We propose that the bioactivity of these glasses will not be significantly affected by partial 
crystallisation of the glasses. 
Thus, the aim of this paper is to investigate the bioactivity of sodium-free amorphous or partially 
crystallised glasses and compare the bioactivity of the two. 
2. Results and Discussion 
2.1. Apatite Formation  
2.1.1. X-ray Diffraction (XRD) Results 
XRD results of four compositions after immersion in Tris and SBF solutions are presented in  
Figure 1a–h. The compositions with 3 mol% CaF2 and SrF2 were amorphous as quenched, whereas 
compositions with 9.3 mol% CaF2 and SrF2 were partially crystallised upon quenching. 
In Figure 1a,b, clear characteristic apatite peaks developed at 25.9° and 31.8° 2 after short 
immersion times. The intensities of these diffraction lines increased with immersion time. However, it 
is seen that the intensities grew more rapidly in Tris buffer compared to SBF. The presence of 
significant amounts of apatite is revealed in the XRD patterns after immersion in Tris between 3 and 9 h, 
whereas a similar intensity of the apatite diffraction lines is seen after immersion in SBF for 3 days 
only. Immersions for durations longer than 9 h in Tris and 3 days in SBF did not reflect significant 
changes on the XRD patterns. Similar results were obtained for compositions with 0, 4.5, and 6 mol% 
CaF2 (not shown). 
Glasses with higher CaF2 content that had partially crystallised to mainly fluorapatite (FAP) also 
exhibited bioactivity. As seen from Figure 1c,d, the intensity of apatite peaks increased after 
immersion compared to the non-immersed glass. However, there was no significant difference in the 
intensity of the apatite diffraction lines obtained after immersion in Tris and SBF for the same time 
period. It is clearly seen that the apatite diffraction lines are significantly broader for the compositions 
with low CaF2 content (Figure 1a,b) than for the compositions with high CaF2 content (Figure 1c,d) 
owing to the presence of crystalline FAP in the untreated glasses with high CaF2 content. 
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Figure 1. XRD patterns of glasses after immersion in buffer solutions: (a) GF 3.0 in Tris; 
(b) GF 3.0 in SBF; (c) GF 9.3 in Tris; (d) GF 9.3 in SBF; (e) SF 3.0 in Tris; (f) SF 3.0  
in SBF; (g) SF 9.3 in Tris; (h) SF 9.3 in SBF. Label Ap in CaF2 series is fluorapatite 
Ca5(PO4)3F (00-034-0011), and strontium fluorapatite Sr5(PO4)3F in SrF2 series  
(00-050-1744). 
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Figure 1. Cont. 
  
(g) (h) 
Figure 1e,h show the XRD patterns of SrF2-containing glasses after immersion, and the results are 
similar to those seen in the CaF2 series. The diffraction peaks at 30.5° and 31.7° 2, which correspond 
to strontium phosphate fluoride (Sr10(PO4)6F2), developed after immersion of the composition with  
3 mol% SrF2 in Tris and SBF (Figure 1e,f). The intensity of the apatite diffraction lines after 
immersion in Tris is much stronger than after immersion in SBF. However, the difference in intensity 
after immersion in Tris or SBF is not significant when the SrF2-containing glass contains crystalline 
fractions of apatite as observed for the composition with 9.3 mol% SrF2 (Figure 1g,h). 
Thus, for both the CaF2 and SrF2 series, the fraction of apatite detected from the XRD patterns grew 
faster during immersion in Tris than in SBF solution when the immersed glass powders were XRD 
amorphous before immersion. The higher initial intensity of the apatite lines for the partially 
crystallised glasses indicates that the apatite crystals present in the untreated glass served as nuclei for 
the apatite phase formed during immersion in buffer solution, and newly formed apatite crystals 
precipitated on the surface of the pre-existing crystalline phase. 
2.1.2. Fourier Transform Infrared (FTIR) Spectroscopy Results 
FTIR spectroscopy was used to monitor glass degradation and apatite formation upon immersion of 
glasses in buffer solution, and Figure 2a–h presents the FTIR results for the same four compositions 
shown in Figure 1. Each bottom spectrum in Figure 2 corresponds to the non-immersed glass powder 
mainly showing three strongly overlapped bands at about 1000, 920 and 870 cm
−1
, which are known 
for bioactive type silicate glass and are assigned to the Si-O vibration modes, i.e., Si-O-Si stretch,  
non-bridging oxygen Si-O
−
 stretch and bend, respectively [10]. This assignment is consistent with the 
IR spectra computed by using accurate DFT calculations recently reported for phosphosilicate 
bioactive glasses [40,41]. The spectra of the samples collected after immersion reveal clear changes 
compared to the non-immersed glasses. 
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Figure 2. FTIR spectra of glasses after immersion in buffer solutions: (a) GF 3.0 in Tris; 
(b) GF 3.0 in SBF; (c) GF 9.3 in Tris; (d) GF 9.3 in SBF; (e) SF 3.0 in Tris; (f) SF 3.0 in SBF; 
(g) SF 9.3 in Tris; (h) SF 9.3 in SBF. 
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Figure 2. Cont. 
  
(g) (h) 
The non-bridging oxygen Si-O
−
 band at 920 cm
−1
 decreased in intensity immediately upon 
immersion and disappeared at longer immersion times. All the spectra clearly show sharpening of the 
band at about 1035 cm
−1
 which is associated with both Si-O-Si and crystalline orthophosphate. The 
latter additionally accounts for the shoulder appearing at about 1100 cm
−1
 [10,11]. However, it is seen 
that the sharpening occurs more rapidly during immersion in Tris rather than SBF. Very clear changes 
can be seen in the region 500–600 cm−1. The typical crystalline orthophosphate or apatite split bands at 
560 cm
−1
 and 613 cm
−1
 are present for GF 3.0 glass at 3 h immersion in Tris (Figure 2a) and can be 
distinguished at 9 h of immersion in SBF (Figure 2b). The spectra indicating the presence of crystalline 
apatite have another band at about 960 cm
−1
 corresponding to the P-O stretch in the orthophosphate 
tetrahedron. The spectra for the samples collected after immersion contain bands at 1450, 1420 and 
870 cm
−1
, which are associated with the presence of carbonate substitution in the apatite. The band at 
790 cm
−1
 appearing in the spectra after immersion is assigned to Si-O-Si between the two adjacent 
silicate tetrahedra [11,42]. This forms as a result of condensation reactions on glass degradation and 
essentially presents a silica-gel. Figure 2a shows that starting from 6 h of immersion the spectra  
are very similar to each other. No changes can be seen in the spectra at 24 h of immersion in SBF 
(Figure 2b). 
The evolution of bands in the FTIR spectra for the GF 9.3 composition after immersion in Tris and 
SBF (Figure 2c,d) is similar to the one observed for glass GF 3.0. The spectrum of the original glass 
reveals signs of the presence of crystalline FAP in addition to the typical bands of Si-O vibration. On 
immersion, the spectra clearly reveal changes owing to glass dissolution. In addition, it is seen that the 
sharpening of the bands occurs at earlier time points after immersion in Tris than in SBF. Similar 
results were obtained for other compositions with CaF2 contents higher than 9.3 mol% (not shown). 
The FTIR spectra of SF 3.0 and SF 9.3 (Figure 2e–h) reveal similar results for the SrF2-containing 
series. Upon immersion, non-bridging oxygen band disappeared, and a crystalline orthophosphate band 
develops. The position of the split bands characteristic for crystalline orthophosphate is slightly 
different from the CaF2 series. These developed at 590 and 555 cm
−1
 which may be explained by  
the presence of strontium cations [39]. The FTIR spectra of SF 9.3 are similar to those of other 
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compositions with SrF2 contents higher than 3.0 mol%. The differences in the rate of sharpening of the 
FTIR bands in Tris compared to SBF immersion is clearly seen in this series, too. 
On comparison with the calcium series, it is seen that the spectrum of SF 3.0 immersed in Tris for  
1 day (Figure 2e) displays sharper features than the spectrum of GF 3.0 at the same immersion time 
(Figure 2a), which indicates that the strontium-containing glass may dissolve and form apatite slightly 
faster than the calcium-containing one. FTIR spectroscopy characterises both amorphous and 
crystalline species present in solids unlike XRD, which reveals changes in the crystalline domains of a 
solid only. The presented FTIR results indicate that glass dissolution may occur faster in Tris buffer 
solution than in SBF for amorphous or partially crystallised bioactive silicate glasses. 
2.1.3. Magic Angle Spinning-Nuclear Magnetic Resonance (MAS-NMR) Spectroscopy Results 
Figure 3 displays the 
31
P and 
19
F MAS-NMR spectra of the calcium fluoride-containing series 
immersed for 6 h in Tris buffer; the spectra are plotted for increasing fluoride content from bottom to 
top. The 
31
P MAS-NMR spectra in Figure 3a are very similar for the entire series and reveal a 
relatively sharp peak with the centre between 2.8 and 3.0 ppm, assigned to crystalline apatite [43]. 
Some of the spectra show an asymmetry of the signal indicating presence of multiple phosphorus 
species that can include the residual glass signal as well. The latter is expected to be around 3 ppm, 
though is broader than the signal assigned to apatite. 
Figure 3. 
31
P (a) and 
19
F (b) MAS-NMR spectra of the samples collected after immersion 
in Tris buffer solution for 6 h. 
  
(a) (b) 
The 
19
F MAS-NMR spectra shown in Figure 3b revealed multiple overlapping signals including the 
crystalline species of a fluoride-substituted apatite with a signal at about −103 ppm and calcium 
fluoride at about −108 ppm characterised by a sharp peak [11]. No crystalline calcium fluoride appears 
to be presence in the spectra of the compositions with low fluoride content (GF 3.0, GF 4.5 and GF 6.0); 
these glass compositions showed only formation of fluorapatite during immersion. The asymmetry of 
the signal is explained by the presence of fluoride species in the residual glass; the spectra of the initial 
glasses are characterised by a broad signal at about −95 ppm [39]. Starting from composition GF 9.3 
the sharp feature at about −108 ppm corresponding to CaF2 can be distinguished in the spectra  
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(Figure 3b), increasing in intensity at higher fluoride contents in the glass. Finally, in composition GF 
25.5, most of the fluoride is present as crystalline calcium fluoride at 6 h immersion in Tris, although a 
crystalline fluorapatite in addition to calcium fluoride and fluorine in the glass phase was detected in 
the original glass before immersion. 
The MAS-NMR results in Figure 3 indicate that 6 h immersion of the glass powders in Tris buffer 
produced a fluoride-substituted apatite as the major solid phase in most of the compositions. Although 
this result is consistent with those obtained from XRD and FTIR, the results from 
19
F NMR in  
Figure 3b provide evidence that the apatite formed is fluoride-substituted. The 
31
P MAS-NMR spectra 
of this glass series at 9 h of immersion were similar to the spectra in Figure 3a (6 h), although the line 
width decreased slightly at 9 h of immersion compared to 6 h. However, in the glass with the highest 
fluoride content most of the fluoride was detected as crystalline CaF2 with only a small fraction of 
fluorapatite present. In addition, for the composition GF 25.5, the spectra of 6 and 9 h of immersion 
are practically identical. The latter is consistent with the XRD results, where the patterns were 
practically identical. 
The 
31
P NMR spectra of the partially crystallised glasses that contained an apatite phase before 
immersions (GF 9.3, GF 13.6, GF 17.8) were deconvolved [44], and the results show an increase in the 
apatite fraction at 9 h of immersion compared to the immersion for 6 h and the fraction of apatite in the 
untreated glass. A fraction of 20%–30% of the original phosphorus in GF 9.3, GF 13.6, GF 17.8 
glasses was crystallised to an apatite; this increased up to 30%–40% at 6 h of immersion, which further 
increased to 40%–50% at 9 h of immersion in Tris. This indicates that the crystalline apatite formed in 
the glass spontaneously during quenching can serve as a seeding phase for the apatite precipitating 
during immersion in physiological solutions. This may also affect the morphology of the apatite formed 
on precipitation; the bigger apatite crystals of a more regular shape that formed spontaneously during 
glass quenching can further grow during immersion in buffer solution, whereas small nanometre-sized 
apatite crystals were formed when an amorphous bioactive glass powder was immersed in buffer  
solution [45].  
2.2. Dissolution Study 
2.2.1. pH Measurements Results 
Figure 4 shows pH changes in Tris buffer solution during immersion of glass powders measured  
at the end of the immersion time. The general trend is similar for all compositions: pH increased on 
initial immersion, which is explained by substitution of protons from the solution for the cationic 
components of the glass, which increases the alkalinity of the solution. However, as the apatite phase 
starts precipitating, pH does not increase any longer and may even slightly decrease. It is seen that the 
highest increase in pH at the initial stage was observed for the fluoride-free glass GF 0.0. This is 
consistent with the effect of fluoride incorporated into a bioactive glass to reduce an increase in pH on 
initial dissolution which was previously seen and discussed [11,46]. However, overall, it is seen that 
the strontium-containing glasses gave a slightly lower pH during dissolution (mostly between 7.5 and 7.6) 
than the calcium-containing ones (mostly between 7.6 and 7.7). 
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Figure 4. pH measured at the end of the immersion time in Tris buffer. Open symbols are 
for the CaF2 series (GF) and closed symbols are for the SrF2 series (SF) with the same 
nominal fluoride content. 
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2.2.2. Ion Release Results 
Figure 5a presents the relative phosphate concentration in Tris solution at 9 hours’ immersion of 
glass powders of the calcium fluoride series, presented as a percentage of the phosphate in the nominal 
glass composition. It is seen that two different trends are observed depending on whether the original 
glass was amorphous or contained a crystalline phase. Amorphous glasses with low fluoride content 
show only presence of very small percentages (less than 2%) of phosphate in solution. By contrast, the 
partially crystallised glasses containing high amounts of fluoride show higher concentrations (up to 
11% of phosphate) at early time points (1 h), followed by a decrease in phosphate concentration, which 
is consistent with the precipitation of an apatite phase during which phosphate is consumed. The 
higher the fluoride content in the glass, the higher the phosphate concentration at 1 h. However, the 
subsequent drop in the release was most pronounced for the GF 25.5 glass composition. 
The concentrations of calcium and strontium from the glass powders upon immersion up to 1 week 
are presented in Figure 5b. It is seen that at 24 h of immersion 40%–50% of calcium and strontium are 
present in solution, and this concentration does not change significantly at the later time points. There 
seems to be no trend with fluoride content. 
The percentage of fluoride present in Tris buffer is shown in Figure 5c for 3 and 6 h of immersion. 
It is seen that the highest concentration (over 35% of the nominal fluoride content in the glass) was 
observed for composition GF 9.3. However, the lowest concentration of fluoride (about 10%) is seen 
for the glass with the highest fluoride content, GF 25.5, although most of the fluoride in the original 
composition was in the crystalline phase as seen from its 
19
F MAS-NMR spectrum. There was only  
a small difference between fluoride concentrations at 3 and 6 h of immersion, which is at the level of 
accuracy of the measurements. Thus, it is seen that fluoride concentrations increase with increase in 
fluoride content in the glass as long as fluoride remains in the amorphous glass. Once a fluoride-containing 
phase starts crystallising from the glass the fluoride concentrations decrease. This suggests that  
the amorphous fluoride-containing glass phase is the source of the fluoride release rather than the 
crystalline phase. 
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Figure 5. (a) The percentage of phosphate presented as concentration of elemental 
phosphorus in Tris for CaF2-containing glasses; (b) The percentage of cations (Sr
2+
 or Ca
2+
) 
concentration in Tris; (c) The percentage of fluoride concentration measured at 3 and 6 h in 
Tris for CaF2-containing glasses. 
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2.3. Final Discussion 
This study presents bioactivity data for two fluoride-containing series of glasses that were either 
amorphous or partially crystallised. Those glasses which had partially crystallised can be considered as 
fluoride-containing glass-ceramics. All the glasses and glass-ceramics showed fast glass degradation 
and apatite formation upon immersion in buffer solutions. However, the results indicate that there is a 
clear difference in mechanism of bioactivity depending on whether the glass was amorphous or 
contained a fluoride-containing crystalline phase. 
Based on FTIR, XRD and 
31
P MAS-NMR data, the initially amorphous glasses containing relatively 
low amounts of fluoride (below 9% in Ca-containing and below 4.5% in Sr-containing series) 
degraded rapidly upon immersion in Tris buffer and formed apatite within 3 h. Results from  
19
F MAS-NMR revealed that the apatite, which formed within 6 h in Tris, was fluorapatite.  
No crystalline CaF2 phase was detected after immersion for glasses with low fluoride contents. 
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For dissolution studies in Tris buffer, the glass was the only source of phosphate for apatite 
formation. This proves that a high amount of phosphate present as orthophosphate in the bioactive 
glass is clearly beneficial for early apatite formation. The ionic concentration in solution confirm rapid 
glass degradation in Tris buffer. However, the results for phosphate were surprising, as concentrations 
observed for the initially amorphous glasses were very low, despite apatite having formed at very early 
immersion time points. This suggests that either phosphate was released at even earlier time points 
than the earliest investigated here (1 h), or apatite might form via a different mechanism than  
via dissolution-precipitation. 
The kinetics of glass degradation and apatite formation was slower in SBF compared to Tris buffer 
for the initially amorphous glasses, as seen particularly from comparison of FTIR spectra. Apatite 
formation was noted in SBF by 24 h compared to 6 h in Tris. This delay can be explained by the higher 
ionic strength of the SBF solution, which alters the kinetics of glass degradation via inhibiting the 
dissolution of ionic species. The presence of Mg
2+
 in SBF is known to suppress apatite formation [47] 
and can additionally contribute to a delayed formation of apatite [48]. 
Fluorapatite was not the only crystalline phase found in the partially crystallised glasses. Strong 
presence of CaF2 dominated in compositions with the highest fluoride contents starting from composition 
GF 13.6 with fluorapatite being present as a minor phase. However, the results presented above show 
that the fraction of crystalline apatite had grown in these bioceramics after immersion. The intensity of 
the signal assigned to apatite increased from XRD and FTIR. In addition, 
31
P MAS-NMR suggested an 
increase of the apatite fraction after immersion in Tris. 
The decrease in phosphate concentrations from 1 h in solution confirms a consumption of phosphate 
for apatite formation. The phosphate concentrations for the partially crystallised glasses was 
significantly higher than for the amorphous glasses, despite it being assumed that phosphate is released 
from the amorphous phase of the glass-ceramics rather than the crystalline. Despite this distinct 
difference, growth of the apatite fraction of the glass-ceramics is estimated to have occurred by 3–6 h, 
which is a similar time frame as for the amorphous glasses with low amounts of fluoride. 
Presence of apatite crystals in the untreated materials, even in minor amounts compared to the 
amorphous part, clearly affected the bioactivity of the glass-ceramics during immersion. The observed 
increase in the apatite fraction with time indicates that the existing apatite crystals served as a seeding 
phase for further apatite crystal growth. As the amorphous phase of the glass-ceramics rapidly 
degraded with time in buffer solution, the additional apatite had precipitated from the solution via a 
dissolution-precipitation mechanism. Presence of a seeding phase reduces the energy required for 
formation of apatite nuclei, which is typically the limiting factor of apatite crystallisation. Comparison 
of apatite formation for (partially crystalline) glass-ceramics immersed in Tris and SBF showed that 
there was no significant difference in the kinetics between the two solutions unlike for the amorphous 
glasses. This is owing to elimination of the rate limiting stage of apatite nucleation for the partially 
crystallised glass-ceramics. 
There was no significant difference between the Ca- and Sr-containing series, except for a higher 
tendency of the Sr-containing glasses to crystallise. 
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3. Experimental Section 
3.1. Glass Preparation 
A melt-quench method was employed to synthesise sodium-free, fluoride-containing bioactive 
glasses. The glasses were designed by introducing different amounts of CaF2/SrF2 into a  
SiO2-P2O5-CaO/SrO glass system (Table 1). In order to preserve the predominantly Q
2
 glass structure, 
calcium fluoride was added to the glasses with the ratios between other components kept constant. 
Table 1. Glass compositions in mol%. 
Glass code SiO2 CaO/SrO P2O5 CaF2/SrF2 
GF/SF 0.0 38.1 55.5 6.3 0.0 
GF/SF 3.0 37.0 53.9 6.1 3.0 
GF/SF 4.5 36.4 53.0 6.0 4.5 
GF/SF 6.0 35.9 52.2 5.9 6.0 
GF/SF 9.3 34.6 50.4 5.7 9.3 
GF/SF 13.6 32.9 48.0 5.5 13.6 
GF/SF 17.8 31.4 45.7 5.2 17.8 
GF/SF 25.5 28.4 41.4 4.7 25.5 
A 200 g batch of analytical grade silica (Prince Minerals Ltd., Stoke-on-Trent, UK), calcium 
carbonate, calcium fluoride and phosphorus pentoxide (Sigma-Aldrich, Gillingham, UK) were 
weighed out, mixed and transferred into a 300 mL platinum/rhodium crucible, melted at 1550 °C 
(glasses with 0 and 3 mol% CaF2/SrF2) and 1500 °C (all other glasses) for 1 h in an electrical furnace 
(EHF 17/3, Lenton, Hope Valley, UK). The melted glasses were quenched into cold deionised water to 
suppress crystallisation. The as-quenched granular glass frits were dried overnight and ground into 
powder by using a Gyro mill (Glen Creston, London, UK) for two sets of 7 min. A mesh analytical 
sieve (Endecotts Ltd., London, UK) with a size of 45 µm was applied to obtain fine powder. 
3.2. Bioactivity Testing and Ion Release Measurements 
Glass and glass-ceramics bioactivity was tested in Tris buffer solution and SBF. SBF was prepared 
following the recipe described by Kokubo and Takadama [2] for the corrected SBF (c-SBF).  
The preparation of Tris buffer solution was according to that described by Mneimne et al. [10].  
The specimens were prepared in duplicate; 75 mg of glass powder was dispersed in 50 mL of buffer 
solution and transferred to a shaking incubator (KS 4000i Control, IKA, Staufen, Germany) at  
37  1 °C at an agitation rate of 60 rpm for 1, 3, 6, 9, 24, 72 and 168 h. 
pH was measured using an Oakton
®
 pH meter with 35811-71 pH electrode at the end of each 
immersion period. The solutions were filtered using the filter papers with pore size of 5–13 μm and 
precipitates were collected. The filtered solution was kept at 4 °C until further analysis. 
The filtered solutions were acidified with 69% nitric acid to quantify ions concentrations using an 
inductively coupled plasma-optical emission spectroscopy (ICP-OES; Varian Vista-PRO, Yarnton, 
UK). The solutions were diluted by a factor 1:20 for measurements of the calcium and silicon content 
and no dilution was used for measurements of phosphate ion content. Calibrations were performed 
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using diluted multi-element stock solution. Fluoride content in solution was quantified using a fluoride 
ion selective electrode (Orion 9609BN, 710A meter, South Burlington, VT, USA) and NaF stock 
solution was used for preparation of the fluoride-containing calibration solutions. 
3.3. Characterisation of Apatite Formation after Immersion 
The precipitates collected after the immersion were dried and analyzed by X-ray Diffraction (XRD), 
Fourier Transform Infrared Spectroscopy (FTIR) and solid state Nuclear Magnetic Resonance (NMR). 
An X’Pert Pro X-ray diffractometer (PANalytical, Eindhoven, The Netherlands) with a copper  
(Ni-filtered Cu-Kα) X-ray source was employed to characterise the glasses, glass-ceramics and the 
samples collected after immersion in buffer solutions. The patterns of powder samples were recorded 
between 5 and 70° 2θ at a step size of 0.0334°. Calibration was carried out using NIST standard 
reference material 660a (lanthanum hexaboride). XRD data were analyzed using X’Pert HighScore 
Plus (v2.0, PANalytical, Almelo, The Netherlands) in conjunction with the ICDD database. 
The samples collected after immersion were assessed using Fourier Transform Infrared 
Spectroscopy (Spectrum GX, Perkin-Elmer, Cambridge, UK). The data were recorded from 500 to 
1600 cm
−1
 of wavenumber. 
Powders of the CaF2-containing glasses after soaking in buffer solutions were investigated using 
solid state NMR on a 600 MHz (14.1T) Bruker NMR spectrometer (Bruker AV 600 NMR, Conventry, 
UK). 
31
P MAS-NMR was run at the 242.9 MHz resonance frequency using a standard single resonance 
Bruker probe in a 4 mm rotor at spinning conditions of 8 and 10 kHz. Sixteen scans were run with a 
recycle delay of 60 s for each sample. The chemical shift was referenced using the primary reference, 
85% H3PO4. 
19
F MAS-NMR measurements were run at the 564.7 MHz resonance frequency using a 
standard double resonance Bruker probe with low fluorine background for a 2.5 mm rotor spinning at a 
speed of 18 kHz and 21 kHz. Typically, 32 or 64 scans were acquired with eight preliminary dummy 
scans and 30 s recycling delay. The chemical shift was referenced using the signal from 1M NaF 
solution scaled to −120 ppm relative to the CF3Cl primary standard. The free dmfit software [44] was 
used for deconvolution of the NMR spectra. 
4. Conclusions  
Amorphous glasses with low amounts of fluoride (below 9 mol% CaF2) degraded rapidly in Tris 
buffer solution and formed apatite within 3 h, which by 6 h could be identified as fluorapatite by  
19
F MAS-NMR. Glass degradation and apatite formation were significantly slower in SBF compared 
to Tris buffer. 
Partially crystallised glasses (containing crystalline phases such as fluorapatite or calcium/strontium 
fluoride) showed degradation of the amorphous phase and an increase in fraction of apatite by 3–6 h in 
Tris and SBF buffers, with no difference in kinetics observed for the two solutions. The increase in 
apatite fraction is thought to occur by precipitation of apatite onto the surface of apatite crystals 
already present within the glass-ceramics. High phosphate concentrations at 1 h followed by a decrease 
were observed for the glass-ceramics, which is in contrast to the amorphous glasses. It is proposed that 
two different mechanisms of apatite formation occur, depending on presence or absence of apatite 
crystals in the original glass. 
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Abstract: Addition of CaF2 to a silicate bioactive glass
favours formation of fluorapatite, which is less soluble
in acidic environment than hydroxyapatite. However, ex-
cess CaF2 in the glass is problematic, owing to the for-
mation of crystalline calcium fluoride rather than fluora-
patite on immersion. In this paper we investigate chloride
as an alternative to fluoride in bioactive silicate glasses
and in particular their bioactivity for the first time. Melt-
derived bioactive glasses based on SiO2-P2O5-CaO-CaCl2
with varying CaCl2 contents were synthesised and char-
acterised by DSC. Chemical analysis of the chloride con-
tent was performed by using an ion selective electrode.
Glass density was determined using Helium Pycnometry.
The glass bioactivity was investigated in Tris buffer. Ion re-
lease measurements were carried out by using ICP-OES.
The chemical analysis results indicated that the majority
of the chloride is retained in the Q2 type silicate glasses
during synthesis. Tg and glass density reduced with in-
creasing CaCl2 content. Apatite-like phase formation was
confirmed by FITR, XRD and 31P MAS-NMR. The results
of the in vitro studies demonstrated that the chloride con-
taining bioactive glasses are highly degradable and form
apatite-like phase within three hours in Tris buffer and,
therefore, are certainly suitable for use in remineralising
toothpastes. The dissolution rate of the glass was found
to increase with CaCl2 content. Faster dissolving bioactive
glasses may be attractive for more resorbable bone grafts
and scaffolds.
Keywords: chloride containing silicate glass; sodium free;
highly degradable; bioactive glass; apatite
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1 Introduction
Bioactive glasses are compelling for extensive use in med-
ical and dental applications, for example bone grafts and
toothpastes, due to their ability to degrade in physiologi-
cal solutions and form a biomimetic apatite-like mineral
layer [1–4]. Incorporation of various elements into the
glass can tailor and improve the glass properties. For in-
stance, zinc introduces an antibacterial effect [5], stron-
tium stimulates bone regeneration [6, 7],magnesium facil-
itates processing [8] and fluoride enhances the bioactivity
by forming fluorapatite (FAP) [9, 10].
FAP (Ca10(PO4)6F2), the fluoride analogue of hydrox-
yapatite (HAP, Ca10(PO4)6(OH)2), is chemically more sta-
ble in an acidic environment than HAP [11, 12]. In addi-
tion, fluoride is the key agent in preventing dental caries
by encouraging remineralisation and inhibiting deminer-
alisation [13, 14]. Moreover, fluoride is able to reduce the
glass melting temperature, glass transition temperature
and potentially reduces the glass hardness. Softer glasses
with lower hardness are potentially less abrasive in tooth-
pastes. The fluoride containing bioactive glasses are there-
fore particularly suitable for dental applications, espe-
cially for remineralising toothpaste.
Recently, Chen et al. [15] found that high fluoride con-
tents in bioactive glasses result in the formation of crys-
talline calcium fluoride on quenching, rather than FAP. A
high fluoride content in the toothpaste for children might
result indental fluorosis [16]. The regulatory authorities set
a restriction on the fluoride content of toothpastes at 1500
ppm in Europe and 1200 ppm in the US. Hence, an alterna-
tive to fluoride component in bioactive glass that also po-
tentially reduces the hardness and abrasivity of the glass
is highly desirable.
Chlorine belongs to the same halogen group as flu-
orine and may have similar effects on the glass proper-
ties. However, chloride volatilisation is a significant prob-
lemduring synthesis [17] and the incorporation of chloride
into glasses has rarely been investigated compared to flu-
Delia S. Brauer: Otto-Schott-Institut, Friedrich-Schiller-Universität
Jena, Fraunhoferstr. 6, 07743 Jena, Germany
Brought to you by | Queen Mary University of London
Authenticated
Download Date | 10/5/15 4:54 PM
Novel Highly Degradable Chloride Containing Bioactive Glasses | 109
Table 1: Glass compositions in mol%. For each glass, the first row is the nominal composition as-designed and the second row is composi-
tion re-calculated based on the chloride component analysis.
Glass code SiO2 CaO P2O5 CaCl2
GPCl 0.0 38.1 55.5 6.3 0.038.1 55.6 6.3 0.0
GPCl 2.3 37.3 54.3 6.2 2.337.5 54.6 6.2 1.7
GPCl 3.5 36.8 53.6 6.1 3.537.2 54.1 6.2 2.5
GPCl 4.6 36.4 53.0 6.0 4.636.7 53.4 6.1 3.9
GPCl 7.2 35.4 51.6 5.9 7.235.7 52.0 5.9 6.3
GPCl 10.6 34.1 49.6 5.7 10.634.7 50.5 5.8 9.0
GPCl 14.0 32.8 47.7 5.4 14.033.6 48.9 5.6 11.9
GPCl 20.6 30.3 44.1 5.0 20.631.8 46.3 5.3 16.7
Figure 1: The percentage of the retained chloride in the initial
glasses against the as-designed chloride content.
oride. The chloride ion is much larger than the fluoride
ion (1.67 Å vs 1.19 Å) and when introduced into a glass,
the chloride might expand the glass volume resulting in
a more open and less compact glass structure. This could
result in softer and less abrasive chloride containingbioac-
tive glasses that can also dissolve faster and form apatite
more rapidly. The larger size of the chloride ion compared
to fluoridemight also hinder crystallisation during synthe-
sis.
Apatite stability follows the order FAP, HAP and chlo-
rapatite (ClAP), with ClAP being the least stable [18]. We
therefore would expect HAP tomainly form on dissolution
of a chloride containing bioactive glass. Chloride is natu-
rally present in the human body so is biologically accept-
able and there is no restriction on the chloride content in
toothpastes andbiomedicalmaterials unlikewithfluoride.
This paper investigates the properties of chloride con-
taining glasses free of sodium based on the SiO2-P2O5-
CaO-CaCl2 system. Kiprianov et al. [17] proposed that chlo-
rinemight volatilise asNaCl.Hence, the absence of sodium
would effectively minimise chlorine volatilization during
melting. To the best of our knowledge, this study is the first
ever investigationof thebioactivity of the chloride contain-
ing bioactive silicate glasses.
2 Materials and methods
2.1 Glass synthesis
The studied glasses were designed by incorporating var-
ious amounts of CaCl2 into a sodium free calcium-silica-
phosphate glass system and the ratio of CaO, SiO2 and
P2O5 was kept constant (Table 1). Analytical grade silica
(Prince Minerals Ltd., Stoke-on-Trent, UK), calcium car-
bonate, phosphorus pentoxide and calcium chloride dihy-
drate (all Sigma-Aldrich, Gillingham, UK) were mixed and
melted at high temperature (1550∘C for GPCl 0.0 and GPCl
2.3; 1500∘C for the rest glasses) for 1 hour in a platinum
crucible in an electrical furnace (EHF 17/3, Lenton, UK). A
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200 g batchwas prepared. Themolten glasseswere rapidly
quenched into deionised water to prevent crystallisation.
The collected glass frit was dried overnight, ground into
powder by a vibratory mill (Gyro mill, Glen Creston, UK)
for 14minutes and sieved through a 38 µmmesh sieve (En-
decotts Ltd, UK).
2.2 Glass characterisation
2.2.1 Compositional analysis
The chloride contents in the initial glasses were quanti-
fied using a chloride ion selective electrode (ELIT Cl− 2844,
NICO 2000 UK). Glass powder (75 mg) with particle size
smaller than 38 µm was dissolved in the 50 ml solution
(48ml deionizedwater, 1ml 69%HNO3 and 1ml 5MNaNO3
(ISA solution)). The samples were prepared in triplicate.
The 1000 ppm Cl− stock solution was prepared by dissolv-
ing 1.649 g NaCl (Sigma-Aldrich, Gillingham, UK) into 1 L
distilled water and diluted to different concentrations to
calibrate the electrode.
2.2.2 Differential Scanning Calorimetry (DSC)
The thermal properties of the glasseswere evaluatedbyus-
ing a differential scanning calorimeter (DSC 1500 Stanton
Redcroft, Rheometric Scientific, UK). The experiment was
carried out under Nitrogen (60 ml min−1). Both glass frit
and glass powderwith particle size less 38 µm(50 ±0.1mg)
were heated from room temperature to 1100∘C at a heat-
ing rate of 20∘C/min using alumina as a reference. The
glass transition temperature (Tg) was obtained from the
DSC trace with an accuracy of ± 5∘C.
2.2.3 Density Measurement
The density of each glass was determined by Helium
Pycnometry (AccuPyc 1330-1000, Micromeritics, GmbH,
Aachen, Germany). Two grams of glass powder (< 38 µm)
was used and measured with the pressure at 1.6 bar. The
density values reported are themean of tenmeasurements
performed during the experiment.
The experimental molar volume of the glasses is cal-
culated by using the relation [19]:
Vm = MD (1)
Where M is the relative molecular mass of glass and D is
the experimental density.
2.3 Bioactivity investigation
Glass bioactivity in terms of glass degradation and apatite
formation was assessed in Tris buffer solution at pH=7.4
with concentration of tris(hydroxymethyl)aminomethane
of about 0.06M. The buffer solution was prepared as de-
scribed according to Mneimne et al. [9]. Glass powder
(75 mg) with a particle size smaller than 38 µm was im-
mersed in 50 ml buffer solution for different immersion
periods (1, 3, 6, 9 and 24 hours). In order to simulate the
humanbody environment, experimentswereperformed in
a shaking incubator (KS 4000i Control, IKA, Germany) at
an agitation rate of 60 rpm at 37∘C. The samples were pre-
pared in duplicate.
After the immersion periods, the pH values of the
solution were measured immediately using a pH meter
(Oaktonr, Malaysia). The solution and deposit were sepa-
rated by filtering using papers with a pore size of 5–13 µm.
An inductively coupled plasma-optical emission spec-
trometer (ICP-OES; Varian Vista-PRO, UK) was employed
to determine the changes in concentration of calcium, sil-
icon and phosphate in the filtered buffer solution after dif-
ferent immersion times. The diluted multi-element stock
solutions were used to calibrate the machine.
2.4 Characterisation of apatite formation
Multi-techniques involving X-ray Diffraction (XRD),
Fourier Transform Infrared Spectroscopy (FTIR) andMagic
Angle Spinning-Nuclear Magnetic Resonance (MAS-NMR)
were employed to characterise the precipitates.
The initial glass powder and the collected precipitates
were analysed using an X’Pert Pro X-ray diffractometer
(PANalytical, The Netherlands) with a copper (Ni-filtered
Cu-Kα) X-ray source. The data were recorded from 5 to
70∘2θ at a step size of 0.0334∘ and a step time of 200.03 s.
XRDdatawere analysed using X’Pert HighScore Plus (v2.0,
PANalytical, The Netherlands) in conjunction with the
ICDD powder diffraction database.
The glass powders and the collected samples were
also characterised using Fourier Transform Infrared Spec-
troscopy (Spectrum GX, Perkin-Elmer, USA) to study the
chemical bonding in the materials. The data were pre-
sented from 500 to 1600 cm−1 wavenumbers.
In order to understand the evolution of glass after im-
mersion, 31P MAS-NMR was run using a 600 MHz (14.1T)
Bruker NMR spectrometer (AV 600 NMR, UK). The spectra
were acquired at the resonance frequencies of 242.9 MHz
and spinning rate of 10 kHz in a 4 mm rotor. The exper-
iments were set up using 30 s recycling delay and scan
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Figure 2: Glass transition temperature (Tg) of fine powder (< 38 µm)
plotted against the actual CaCl2 content.
Figure 3: Glass density (Tg ( )) and molar volume of glasses (Vm ( ))
profiled as a function of the actual CaCl2 content.
number of 16 or 32. The chemical shift was referenced to
the signal of 85% H3PO4 at 0 ppm.
3 Results
All the glass frits producedwere optically clear. The higher
chloride content glasses exhibited a small amount of crys-
tallinity by XRD which is thought to be a result of the fine
glass powder surface reacting with atmospheric water to
form a mixed hydroxychloroapatite during the collection
of the XRD data, since no evidence of crystallinity was
found by either 31P MAS-NMR or FTIR [18].
In Figure 1, the percentages of the retained chloride
in the initial glasses after volatilization are plotted against
the as-designed chloride content. A large fraction 73–87%
of chloride has been successfully incorporated into the
glasses.
In Figure 2, the glass transition temperature (Tg) of
fine powder (< 38 µm) is plotted against CaCl2 content; the
data were first presented in [18]. It is clear that Tg values
decrease dramatically and linearly (R2 = 0.9825) with in-
creasing CaCl2 content.
Glass density and molar volume of glasses are also
plotted as a function of the actual CaCl2 content (Figure 3).
The changes in glass density caused by increasing the
CaCl2 content are similar to the change of Tg as a result
of increasing CaCl2 content. A continuous reduction of
glass density is observed with an increase in CaCl2 con-
tent. While the molar volume of glasses increases linearly
(R2 = 0.999) with increasing CaCl2.
Figure 4a shows the pH values measured after 3 and
24 hours immersion in Tris buffer solution for each glass.
Interestingly, the glass with a higher CaCl2 content has
a higher pH value after 3 hours, while a relatively lower
pH value after 24 hours, compared to the compositions
with lower CaCl2 content. Overall, a reduction of pH from
3 hours to 24 hours was found; the change was more sig-
nificant at high CaCl2 content in the glass.
The concentration of calcium in solutionmeasured af-
ter 6 hours of immersion plotted as percentage of the to-
tal amount in the as-designed composition is presented
in Figure 4b. There is a clear increase in the percentage
of Ca concentration with an increase in CaCl2 content.
For example on increasing the CaCl2 content from 0 to
16.7mol% the percentage of Ca found in solution increases
from 58.6% to 83.2%. The trend is practically linear.
The evolution of phosphate concentration measured
in solution with increasing immersion time is shown
in Figure 4c. In general, all the CaCl2 containing glasses
show similar trend of phosphate concentration with re-
spect to time. The phosphate concentration increases in
the first 3 hours and drops down afterwards.
The silicon concentration (mg/l) measured in solution
is plotted as a function of immersion time in Figure 4d. It
is seen that Si concentration increases up to 60–70 mg/l
in the first 6 hours, with no significant change observed
after longer immersion period. No substantial difference
in measured silicon concentration between different glass
compositions is observed.
The XRD patterns of each chloride containing bioac-
tive glass on immersion up to 24 hours in Tris buffer are
similar. The one for 1.7 mol% CaCl2 containing glass (GPCl
2.3) is selected and presented as an example in Figure 5a.
A broad amorphous halo centred at 30∘2θ belongs to the
untreated glass (0 h). After immersion for 3 hours, the halo
broadens out and the peaks at 25.9∘(002) and 32∘(211) 2θ,
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Figure 4: (a) pH value of solution after 3 and 24 hours immersion in Tris; (b) the Ca concentration measured after 6 hours immersion in Tris
buffer solution plotted as the percentage of the total calcium content in the as-designed glass composition against the actual CaCl2 con-
tent; (c) the concentration of phosphate measured after immersion in Tris buffer presented as the percentage of the total phosphorus con-
tent in the as-designed glass composition plotted as a function of immersion time; (d) the concentration in mg/l of silicon measured in Tris
buffer plotted as a function of immersion time.
Figure 5: (a) The XRD patterns and (b) FTIR spectra of the 1.7 mol% CaCl2 glass precipitate collected after the immersion in Tris up to 1 day.
The numbers are immersion times.
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Figure 6: (a) The XRD patterns and (b) FTIR spectra of the glass precipitates collected after 3 hours immersion in Tris buffer solution.
Figure 7: The 31P MAS-NMR spectra of the glass precipitate with
1.7 mol% CaCl2 collected after the immersion in Tris up to 9 hours.
The numbers are immersion times.
which match the typical apatite diffraction lines, develop.
The intensities of the peaks increase with immersion time
up to 9 hours. Longer immersion times do not show any
further change in the patterns. After 24 hours, the peak at
25.9∘2θ is slightly narrowed down, suggesting the growth
of apatite crystals. Similar results were obtained for the
rest CaCl2 containing glasses.
In addition, the XRD patterns of glass precipitates af-
ter 3 hours immersion are summarised in Figure 6a. It is
clear that the peaks at 25.9∘, 32∘ and 32.6∘, corresponding
tomain diffraction lines of apatite appear after 3 hours im-
mersion. The intensities of the diffraction peaks increased
with CaCl2 content of the glass. However, the diffraction
lines are relatively broad, rather than sharp, indicating the
formed apatite crystals are small.
Figure 5b shows the FTIR spectra of 1.7 mol% CaCl2
containing glass precipitate after immersion up to 9 hours
in Tris. The bands at 1028 and 920 cm−1, which corre-
spond to Si-O-Si stretching bands and non-bridging oxy-
gen bands (Si-NBO−) respectively, were seen in the spec-
trumof the untreated glass at the bottom. After 3 hours im-
mersion the spectra change markedly, including the elim-
ination of band at 920 cm−1, the sharpening of band at
1030 cm−1, the development of split peaks at 560 and
613 cm−1 and twin peaks at 1420 and 1450 cm−1 [9]. These
changes suggest rapid glass degradation and apatite-like
phase formation. Similar changes to the spectra were
found for the rest of the CaCl2 containing glasses as shown
in Figure 6b.
31PMAS-NMRwas used to investigate phosphorus en-
vironment and identify apatite-like phase formation after
immersion. The spectra of glass GPCl 2.3 before and af-
ter immersion are shown in Figure 7. In the spectrum of
the untreated glass, a single peak at about 3 ppm, corre-
sponding to amorphous calcium orthophosphate is visi-
ble. Upon immersion, the peaks narrow down, first after
3 hours and then further after 6 hours of immersion. How-
ever, the chemical shift remains constant. Similar changes
in the spectra of the rest of the glass compositionswere ob-
served.
4 Discussion
The results of the chemical analysis of the chloride con-
tent indicate that between 70 and 90% of the chlorine is
retained in the glasses after melting. Thus, the majority of
the chloride is retained in the silicate glass duringmelting.
In general, the higher amount of CaCl2 losses is found in
the lower CaCl2 containing glasses. This can be attributed
to a higher melting temperature of 1550∘C for synthesis of
the lower CaCl2 containing glasses (GPCl 2.3 and GPCl 3.5).
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Volatilisation of chloride is probable by two routes;
direct volatilisation as CaCl2 and loss as HCl by reaction
with water vapour in the furnace atmosphere. If chloride
volatilises as HCl, the CaO content in the actual glass com-
position would increase and the SiO2 and P2O5 contents
would decrease. Therefore, the glass network connectiv-
ity (NC) would decrease with an increase in CaCl2 con-
tent and also the glasses would tend to crystallise. If chlo-
ride volatilises as CaCl2, the CaO, P2O5 and SiO2 would in-
crease in proportion and the glass NC would remain con-
stant.
The XRD patterns of the initial glasses suggest a very
small fraction of glass crystallisation, which is probably
caused by reaction with water on the glass surface dur-
ing data collection rather than crystallisation on quench-
ing [18]. In addition, the 29Si MAS-NMR spectra (Figure S.1
(Supplementalmaterial)) suggest that theobtainedglasses
have mainly the Q2 structure and not a mixture of Q1 and
Q2. Thereby, the chloride loss is likely to occur as CaCl2
rather than HCl. The actual glass compositions have been
calculated and summarised in Table 1.
It is important to note here that most chlorides with
the notable exception of CaCl2 have low boiling points and
this has generally resulted in either no chloride remain-
ing in the silicate glass or very little. Consequently chloride
containing glasses have rarely been studied and those that
have CaCl2 content typically less than 2 mol%. This con-
trasts with the glasses here the highest of which contains
16.7 mol% CaCl2.
This work reveals that the incorporation of CaCl2 re-
sults in a very marked reduction in the glass transition
temperature and density. It is proposed that in this CaCl2
containing glass system, the Cl-Ca(n) species form in an
analogous fashion to the F-Ca(n) species in the CaF2 con-
taining glasses [18, 20, 21]. The formation of Cl-Ca(n)
species has been found in very low CaCl2 (< 2 mol%) con-
taining glasses by Sandland et al. [22].
The formation of hypothetical “CaCl+” species, which
has same field strength as Na+ but lower than Ca2+, will
weaken the electrostatic force between two NBOs in the
glass structure. Therefore, the more CaCl2 is introduced
into the glass composition, the weaker electrostatic forces
between the twoNBOs formand the lower is the glass tran-
sition temperature. Tg is a significant parameter, which
can be used to indirectly predict glass solubility, degrad-
ability and hardness of glasses within certain composi-
tional ranges [23–25]. Thehardnessmeasurement of bioac-
tive glasses is challenging, because of their tendency to
surface react during sample preparation. However, both
Tg and glass hardness are determined by the average bond
strength in the glass structure, thus hardness and Tgmight
be expected to exhibit a strong correlation. Farooq et al.
found that the hardness of the CaF2 containing bioactive
glasses with different amounts of Na2O reduces with de-
creasing Tg [25].
Additionally, the packing density which was used to
mirror the compactness of the glass can be also used to
predict glass hardness [26]. As shown in Figure 3, the glass
density decreases with an increase in CaCl2 content. This
is due to the fact that the chloride ion is substantially large.
Incorporation of chloride therefore increases the glassmo-
lar volume and results in a more open and less compact
glass structure. Hence, to some extent the presence of
chloride dilutes the glass network and expands the glass
volume, which leads to a decrease in density and pack-
ing density of the glass. Moreover, the formation of large
“CaCl+” species in the glasses results in a weakening of
the silicate glass network. The effect shown in this study
is comparable with the effect on the replacement of Na2O
for CaO (replaced one Ca2+ ion by two Na+ ions) and K2O
for Na2O (K+ is larger than Na+, ion radius: 1.52 Vs 1.16 Å)
in the glass. On incorporation of CaCl2, the glass hardness
would be expected to decrease, as a consequence of a re-
duced compactness of the glass. Therefore, the incorpora-
tion of CaCl2 results in a reduction in Tg and probably the
glass hardness.
The glasses with lower hardness are attractive for the
desensitizing toothpastes for treating dentine hypersensi-
tivity. A contributory cause of dentine hypersensitivity is
loss of enamel at the cervicalmargins due to brushingwith
an abrasive toothpaste. Bioglassr 45S5 has been used in
commercial toothpastes as NovaMinr technology for the
remineralisation of teeth and for treating dentine hyper-
sensitivity [27]. The hardness of the 45S5 composition is
4.68GPa,whilst the enamel hardness is about 3.5GPaonly.
In order to avoid enamel wear, a glass with a hardness
value less than 3.5 GPa is attractive. Chloride containing
bioactive glasses with their low Tg are one potential route
to achieve this, since the hardness of a glass is expected
to correlate to the glass transition temperature. The lower
is the Tg, the softer the glass is likely to be. Thus chlo-
ride containing bioactive glasses could potentially reduce
the abrasivity and enamel loss caused by tooth brushing.
Moreover, rapid glass degradation and fast apatite forma-
tion found in this study make these chloride containing
bioactive glasses also attractive for use in the remineralls-
ing toothpastes.
According to the mechanism of dissolution of bioac-
tive glasses proposed by Hench et al. [28, 29], the first step
is the ion exchange of alkali ions (glass modifier cations)
with protons (H+) from body fluids. In the studied glasses,
Ca2+ will be exchanged for protons in the Tris buffer during
Brought to you by | Queen Mary University of London
Authenticated
Download Date | 10/5/15 4:54 PM
Novel Highly Degradable Chloride Containing Bioactive Glasses | 115
glass degradation. The removal of protons from solution
causes an accumulation of hydroxyl groups; hence, an in-
crease in both Ca2+ release and the pH of the Tris buffer in
the early period of glass immersion can be explained.
Previous work on CaF2-containing bioactive glasses
by D.S. Brauer et al. [20] showed that this pH rise was less
pronouncedwith increasing CaF2 content in the glass, and
we originally interpreted this as caused by another type of
ion exchange occurring: hydroxyls (OH−) from the solution
for F− from the glass in addition to H+ for modifier cations.
If this was the case, however, we would observe the same
effect here, with an exchange of OH− for Cl− resulting in
a lower pH with increasing CaCl2 content in the glass,
but we do, in fact, observe the opposite trend. This sug-
gests that halides, such as CaF2 or CaCl2, present in and
released from bioactive glasses contribute indirectly only
to pH changes in the dissolution medium. More detailed
study [14] suggests that the pH rise typically observed for
bioactive glasses is caused by the silicate part (i.e., by ion
exchange between modifiers ionically connected to non-
bridging oxygens and H+) only, with contributions from
the CaF2 part being negligible.
The ion exchange process between modifier cations
and protons in the present study is aided by incorpora-
tion of large chloride ions, which have the capacity to ex-
pand the glass network. This more open and expanded
glass structure allows ions to diffusemuchmore easily into
and out of the glass and therefore facilitates ion exchange,
particularly for short immersion times. As a consequence
there is a more rapid release of Ca2+ ions and a more rapid
rise in pH in the glasses with higher CaCl2 content during
the first few hours of immersion. However after a longer
immersion period (24 hours), a less pronounced rise in pH
of the glasseswithmore CaCl2 contentwas found. This can
be attributed to a decrease of glass modifier content (here:
CaO only), with an increase in CaCl2 content.
The studied glasses were designed by adding CaCl2 to
glass, while reducing the amounts of all other components
proportionally so as to keep glass structure constant (Q2
glass structure). In a fixed weight of glass (75 mg) used for
the bioactivity study in Tris buffer, the amount of the sil-
icate part of the glass (i.e. Si-O− 1/2Ca2+ bonds) allowing
for exchange of modifier ions decreased with an increase
in CaCl2 content in the glass. This could result in a reduc-
tion of the total amount of ion exchange occurring, there-
fore a less pronounced pH rise was observed for glasses
with higher CaCl2 contents. Additionally, the consumption
of hydroxyl ions during the formation of hydroxycarbon-
ated apatite and probably also the dissolution of atmo-
spheric CO2 lead to a reduction of pH after 24 hours im-
mersion compared to 3 hours.
Rapid glass degradation and release of Ca2+ and
PO3−4 ions facilitate apatite-like phase formation. Apatite-
like phase formation of these CaCl2 containing bioactive
glasses was evaluated in Tris Buffer. Unlike simulated
body fluid (SBF) and artificial saliva (AS), Tris buffer con-
tains no Ca2+ or PO3−4 ions. The Ca and P detected in so-
lution and any apatite detected therefore originate en-
tirely from the glass composition. This considerably sim-
plifies the analysis and interpretation of the degrada-
tion/dissolution of the glass. As discussed above, chloride
promotes glass degradation as a result of expanding glass
volume and the rapid glass degradation provides ions,
such as Ca2+, PO3−4 and OH− for apatite-like phase forma-
tion.
From the ion release data, the highest amount of phos-
phatewas present in solution is around 7.85%after 3 hours
immersion, this indicates a consumption of phosphate for
apatite-like phase formation at an even earlier immersion
time than 3 hours. The tests are done under phosphate
deficient condition, as with the glass being only source
of Ca2+ and PO3−4 . The ratio of Ca:P ratio in glasses are
4.4:1, while the Ca:P ratio in apatite is 1.67:1. Therefore, the
amount of apatite-like phase formation depends mainly
on the phosphate content and high phosphate contents in
bioactive glass are favourable for apatite-like phase forma-
tion, as also suggested by the earlier finding in paper by
Mneimne et al. [9].
Brauer et al. [20] suggested that the formation of sil-
ica gel contributes to the nucleation of apatite, since phos-
phate concentration decreased when silicon concentra-
tion reached the solubility limit. However, as shown in Fig-
ure 3d, the silicon concentration reached the solubility
limit (60–70mg/l) after 6 hours immersion andwas almost
constant there afterwards, while phosphate decreased af-
ter 3 hours. This suggests that apatite-like phases might
not be necessarily forming only on the surface of silica gel.
All the XRD, FTIR and NMR results suggest rapid
apatite-like phase formation within 3 hours immersion
in Tris, which is comparable to the equivalent CaF2 con-
taining bioactive glasses [30]. From the XRD patterns,
the diffraction lines developed after 3 hours immersion
matched those for the typical diffraction lines of hydroxya-
patite, however, the intensities of the threemain peaks be-
tween 31∘to 33∘2θ are not completely identical with those
for hydroxyapatite. This suggests the possibility of the
presence of CO2−3 or Cl− in the apatite lattice.
In the apatite crystal lattice, the hydroxyl ion is too
large to fit in the space at the centre of Ca(II) triangle and
is displaced above the plane of the triangle. The chloride
ion is larger than thehydroxyl ion, it displaces even further
above the plane of the Ca(II) triangle. Therefore, chlorap-
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atite is less stable than hydroxyapatite and is unlikely to
form after immersion of the bioactive glass. Furthermore,
chlorapatite is known to convert to hydroxyapatite with
time in the presence of water [31].
The constant chemical shift (3 ppm) of the glass pow-
ders before and after immersion in Tris in the spectra of 31P
MAS-NMR indicates that almost all phosphorus is present
as orthophosphate charge balanced by Ca2+ cations [20].
In the case of before immersion, the amorphous calcium
orthophosphate results in a broad amorphous peak, since
there are local variations in the local environment around
the phosphorus. In the case of after immersion, the cal-
cium orthophosphate peak gradually becomes sharper as
the result of the formation of a crystalline calcium or-
thophosphate (apatite) and the amorphous calcium phos-
phate species in the glass dissolving. Thus, a progressive
reduction in width of the 31P peak was seen with an in-
crease in immersion time.
It is worth comparing the chloride containing bioac-
tive glasses studied here with the closely related fluo-
ride containing glasses [30], both glass series show rapid
apatite-like phase formation within 3 hours immersion in
Tris. In the case of CaF2 series, apart from forming fluo-
rapatite on immersion, an additional phase of CaF2 was
also detected in the high CaF2 containing glasses (over
9.3 mol%). Furthermore, CaF2 is present as the main flu-
oride containing phase in the glass with 25.5 mol% CaF2.
The formation of CaF2 might reduce the bioactivity in
terms of the ability to bond to bone. However, in the case
of CaCl2 series, the apatite-like phase is the only phase
formed after immersion for all CaCl2 contents. In addi-
tion, the increase of CaCl2 content stimulates glass degra-
dation, which therefore facilitates apatite-like phase for-
mation. The high bioactivity of the chloride containing
glasses with their rapid dissolution rate are attractive for
use in toothpastes and resorbable materials, especially
bone grafts and scaffolds.
5 Conclusion
In this paper, the bioactive silicate glasses with chloride
have been synthesised and studied for the first time. These
novel chloride containing bioactive glasses contain up to
16.7mol%of the chloride thus it is demonstrated that a sig-
nificant retention of chloride is possible to achieve in this
type of the silicate glass. This study has revealed that the
chloride containing bioactive glasses are highly degrad-
able and form an apatite-like phase within 3 hours im-
mersion in Tris buffer. Glass degradation rate has been
found to increase with CaCl2 content. A reduction of den-
sity and an increasing of glassmolar volume on increasing
CaCl2 suggest that chloride expands the glass volume and
dilutes glass network, therefore, promoting ion exchange
and glass degradation. The DSC results demonstrated a
distinct reduction in the glass transition temperature (Tg)
correlating linearly with an increase in chloride content.
The decrease of Tg indicates a potential decrease in the
glass hardness. These novel chloride containing bioactive
glasses have outstandingpotential for applications in rem-
ineralising toothpastes and resorbable bone substitutions.
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Supplementary Material
Figure S.1: 29Si MAS-NMR spectra of the as-quenched 1.7 mol% and 16.7 mol% CaCl2 containing glasses.
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